University of Kentucky

UKnowledge
Theses and Dissertations--Chemistry

Chemistry

2021

MASS SPECTROMETRY METHOD DEVELOPMENT FOR THE
DISCOVERY AND CHARACTERIZATION OF SECONDARY
METABOLITES
Zachary Kelley
University of Kentucky, zachkelley64@yahoo.com
Author ORCID Identifier:

https://orcid.org/0000-0002-7076-5450

Digital Object Identifier: https://doi.org/10.13023/etd.2021.282

Right click to open a feedback form in a new tab to let us know how this document benefits you.

Recommended Citation
Kelley, Zachary, "MASS SPECTROMETRY METHOD DEVELOPMENT FOR THE DISCOVERY AND
CHARACTERIZATION OF SECONDARY METABOLITES" (2021). Theses and Dissertations--Chemistry. 143.
https://uknowledge.uky.edu/chemistry_etds/143

This Doctoral Dissertation is brought to you for free and open access by the Chemistry at UKnowledge. It has been
accepted for inclusion in Theses and Dissertations--Chemistry by an authorized administrator of UKnowledge. For
more information, please contact UKnowledge@lsv.uky.edu.

STUDENT AGREEMENT:
I represent that my thesis or dissertation and abstract are my original work. Proper attribution
has been given to all outside sources. I understand that I am solely responsible for obtaining
any needed copyright permissions. I have obtained needed written permission statement(s)
from the owner(s) of each third-party copyrighted matter to be included in my work, allowing
electronic distribution (if such use is not permitted by the fair use doctrine) which will be
submitted to UKnowledge as Additional File.
I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and
royalty-free license to archive and make accessible my work in whole or in part in all forms of
media, now or hereafter known. I agree that the document mentioned above may be made
available immediately for worldwide access unless an embargo applies.
I retain all other ownership rights to the copyright of my work. I also retain the right to use in
future works (such as articles or books) all or part of my work. I understand that I am free to
register the copyright to my work.
REVIEW, APPROVAL AND ACCEPTANCE
The document mentioned above has been reviewed and accepted by the student’s advisor, on
behalf of the advisory committee, and by the Director of Graduate Studies (DGS), on behalf of
the program; we verify that this is the final, approved version of the student’s thesis including all
changes required by the advisory committee. The undersigned agree to abide by the statements
above.
Zachary Kelley, Student
Dr. Bert Lynn, Major Professor
Dr. Yinan Wei, Director of Graduate Studies

MASS SPECTROMETRY METHOD DEVELOPMENT FOR THE DISCOVERY AND
CHARACTERIZATION OF SECONDARY METABOLITES

________________________________________
DISSERTATION
________________________________________
A dissertation submitted in partial fulfillment of the
requirements for the degree of Doctor of Philosophy in the
College of Arts and Sciences
at the University of Kentucky
By
Zachary David Kelley
Lexington, Kentucky
Director: Dr. Bert C. Lynn, Professor of Chemistry
Lexington, Kentucky
2021

Copyright © Zachary David Kelley 2021
https://orcid.org/0000-0002-7076-5450

ABSTRACT OF DISSERTATION

MASS SPECTROMETRY METHOD DEVELOPMENT FOR THE DISCOVERY AND
CHARACTERIZATION OF SECONDARY METABOLITES
Secondary metabolites are organic compounds produced by an organism for
reasons other than growth and development. In plants, secondary metabolites generally
act as defense agents produced to deter predators and inhibit other competitive species.
For humans, these compounds can often have a beneficial effect and are pursued and
utilized as natural pharmaceuticals. The development of sensitive, high-throughput
analytical screening methods for plant derived metabolites is crucial for natural
pharmaceutical product discovery and plant metabolomic profiling. Here, metabolomic
profiling methods were developed using a microfluidic capillary zone electrophoresis
device and evaluated against traditional separation approaches. An alkaloid screening
assay was constructed to analyze transgenic mutant plant extracts for novel metabolites.
Putatively identified novel features were detected, elucidated, and then isolated and
purified for pharmaceutical evaluation. Additionally, methods for the analysis of
polyphenolic plant-derived secondary metabolites, such as cannabinoids, were also
developed and evaluated. In this case, the occurrence of cross-instrumental variation was
addressed, given the tight legal restrictions regarding commercialization the products in
question. Lastly, the microfluidic CZE-MS methods were further applied for both
primary and secondary metabolite profiling in a DMPK assay. This assay was developed
to inclusively monitor metabolic changes as a response to varying concentrations of a
therapeutic in circulation. The metabolomic methods developed and evaluated in this
work displayed high sensitivity, efficiency, and accuracy and can be utilized across a
wide variety of applications.
KEYWORDS: Mass Spectrometry, Capillary Electrophoresis, Alkaloids, Secondary
Metabolites, Metabolomics
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CHAPTER 1. INTRODUCTION
Background
The term “natural products” refers to the class of chemical compounds arising from
biological sources of production ranging from simple bacteria to complex plants, fungi,
and animals. These chemical entities arise from both primary and secondary metabolic
pathways. Natural products have been used medicinally across the world for thousands of
years, with recorded uses dating back as far as 2600 BC in Mesopotamia.1–3 Though
diverse in origin, it has been reported that over 50% of natural products commercially
available for a variety of uses are plant derived secondary metabolites.3–6 These plantderived natural products are also the foundation behind a majority of traditional Chinese
medicines (TCM).2,7 Organic and medicinal chemists have found interest in these novel
metabolites and extensively investigate their chemical properties and pharmacological
activities. These investigations of natural products have motivated method development
for new practical separation techniques, structure elucidation experiments, and synthetic
methodologies that now constitute the foundations of modern organic, analytical, and
medicinal chemistry. This interest in natural products has been both academic and driven
by the potential industrial impact of their complex biosynthesis and application.7 Natural
products are commonly commercialized as dyes, industrial fibers, adhesives, oils, waxes,
flavors, fragrances, and, most importantly, pharmaceuticals.2,7 Recognition of the
potential biological activity associated with a myriad of natural products has fueled the
current focus of this field, specifically, the search for new pharmaceuticals, antibiotics,
and pesticides. This field is also a source of many analytical challenges. The complex
nature of these metabolites paired with the wide variety of compounds with subtly
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different variations to their structures all found within the same organism greatly
complicate the analysis and characterization of these compounds. These complexities and
similarities also complicate downstream purification for pharmacological testing and
production. The focus of this work is to develop new metabolomics-centered analytical
methods for the discovery and characterization of several types of secondary plant
metabolites.

Secondary Metabolites and Metabolomics
The metabolic products produced by all living organisms are classified as either
primary or secondary metabolites. Primary metabolites are fairly conserved across all
living organisms and consist of groups of small molecules that are crucial for survival
such as nucleic acids, amino acids, and lipids.7 Secondary metabolites are organic
molecules that are not necessarily essential to the normal growth or development of an
organism.7 While primary metabolites have a key role in the survival of the species, the
absence of secondary metabolites does not result in immediate death, but rather in longterm impairment of the organism’s survivability, as they often play an important role in
defense. There is some ambiguity in the classification, however, as many primary and
secondary metabolites share biosynthetic pathways or similar base structures. Secondary
metabolites are produced by all types of organisms, but the most commonly discussed
secondary metabolites are those produced by plants.7–10 Most plant secondary
metabolites, such as terpenes, phenolic compounds, and alkaloids are classified based on
their biosynthetic origin or key chemical functional groups. Figure 1.1 displays some
common examples of terpenes, phenolics, nitrogen-based compounds (alkaloids), and
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Figure 1. 1 Common classes of secondary plant metabolites with representative
examples.
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sulfur-based compounds. Terpenes, the largest class with over 25,000 known compounds,
consist of varying combinations of isoprene subunits, with subclasses based on the
number of subunits. Terpenes are highly volatile compounds often associated with the
scent of a plant (pinene, limonene, myrcene, linalool, etc). Phenolic compounds, though
less diverse with approximately 8000 identified secondary metabolites, make up a larger
portion of the total biomass of plants due to lignin falling under the category. This
subclass also contains more homologous secondary metabolites conserved across
numerous species such as various stilbenes, flavonoids, anthraquinones, and tannins.
Lastly are the more exotic nitrogen or, less common, sulfur containing compounds. These
metabolites are usually derived from amino acids, specifically in the case of true
alkaloids, and are the most heterologous of secondary metabolites.11 Despite the vast
diversity of these secondary metabolites, both within and between classes, similarities
can be observed in their biosynthesis (Figure 1.2). Primary biosynthetic pathways, such
as the shikimate, phenylpropanoid, and polyketide pathways, are fairly conserved across
species, with differences not usually occurring until the later enzymatic conversions.12
The role of many of these metabolites in plants has been a subject of debate as
there are multiple plausible explanations for their presence. Several hypotheses have been
presented: 1) they are the byproducts of mutations and are not harmful or beneficial, 2)
they are an example of “evolution in progress” in that they are the result of the organism
attempting to make new functional metabolites, 3) they are waste products, 4) further
expanding on 2), the enzymes responsible for their production are the result of
prophylactic measures to ensure primary metabolism is unhindered, 5) they formerly had
a functional role that has since been defunct, and lastly, and most likely, 6) they have
4

Figure 1. 2 Simplified biosynthetic pathway for the sources of polyphenolic and alkaloid
secondary metabolites.

5

resulted as evolutionary responses to aid in the survival of the plant by acting as
attractors or deterrents.13,14 It is also likely that all six hypotheses are true to an extent,
however the sixth would confer the most evolutionary advantage. As attractors, such as
pigments or fragrances, these metabolites could function to attract for pollinators or be
secreted in resins as defense agents to trap predators and insects.14,15 As deterrents, bitter
taste as well as antibiotic and antimicrobial activities are often associated with many
secondary metabolites. A defense-centric evolutionary impact can also be inferred in that
environmental stressors, such as microbial exposure, UV light, temperature, and chemical
exposure can often affect the relative expression rate of these metabolites.16
The activity and application associated with these plant secondary metabolites has
been of interest to humans for centuries. Traditional Chinese Medicine (TCM) texts, such
as the The Chinese Materia Medica (1100 B.C.), list various plant-based treatments in the
form of ointments, tinctures, and extracts.2 Unfortunately, many of the both beneficial
and determinantal effects discovered before the advent of modern science were the result
of trial and error driven by the growing necessity of curing new diseases and ailments.17
Modern controlled in vitro and in vivo assays have since reduced the risk behind testing
the efficacy of these metabolites and have allowed scientists to uncover the specific
sources of the activity. These scientific advances have resulted in not only a massive
academic field, especially in eastern cultures, focusing on understanding how ancient
remedies, such as those found throughout TCM, function, but also in the development of
lead compounds with industrial application and as treatments for many diseases and
conditions. Figure 1.3 shows an example of three out of the thousands of naturally
derived compounds, of varying complexity, that see use in both industry and as
6

Figure 1. 3 Common industrial and pharmaceutical natural products.
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pharmaceuticals. Gallic acid, a simple acidic, phenolic secondary metabolite, is widely
utilized as a dye, an excellent base molecule for organic synthesis, and even as a
treatment for reducing coronary arterial disease and arterial thrombosis.18 Quinine, a
more complex quinoline alkaloid approved by the FDA in 2004 for pharmaceutical use,
had been used for centuries for the treatment of malaria, fever, indigestion, mouth and
throat diseases and cancer.2,7,19 Increasing in complexity, paclitaxel (Taxol®) isolated
from the bark of Taxus brevifolia, has been widely utilized as a chemotherapeutic agent
for the treatment of ovarian, esophageal, breast, lung, cervical, and pancreatic
cancer.2,4,17,19–24 Despite paclitaxel’s complexity, the application of the metabolite has
caused the demand to exceed what is practical in terms of natural isolation (~2g per
treatment requires the bark of six 100-year-old trees versus 50,000 treatments annually),
therefore synthetic and semi-synthetic methods have been developed.2,19 The demand for
these naturally-derived products has increased exponentially over the past few decades,
owing to the success of therapeutics like paclitaxel and the avoidance of complex organic
synthesis to design lead compounds for initial testing. Additionally, the public desire for
more “natural” consumer products has further compelled interest in refocusing research
towards identification and application of these metabolites.
Not all aspects of the secondary metabolite natural product field are positive,
however. Drug abuse has plagued society throughout the history of both modern and
ancient medicine. Almost all commonly abused drugs (Figure 1.4) are of natural origin.
The most historically well-known abused natural products would be those derived from
the alkaloid, morphine, produced by the opium poppy, Papaver somniferum. Morphine is
a schedule II-controlled substance that acts on the opioid receptors and is a powerful
8

Figure 1. 4 Secondary plant metabolites often abused as recreational drugs.
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narcotic analgesic and highly addictive drug of abuse. It is also the precursor to heroin,
diacetylmorphine, a schedule I-controlled substance twice as potent as its precursor.16,22
Cocaine is a tropane alkaloid derived from the leaves of Erythroxylon coca. It is a
schedule II-controlled topical anesthetic, potent central nervous system stimulant, and
adrenergic blocking agent.16,22 Cannabinoids, such as ∆9−ΤΗC, are a unique class of
secondary metabolites derived from the buds of various Cannabis plant species, such as
Cannabis sativa and Cannabis indica. Various schedules (III-V) are assigned to the
cannabinoids, however, they are not considered to be of high risk for abuse and have
been legalized for reactional use in several states. Psilocybin (fungal secondary
metabolite derived from various members of the genus Psilocybe), lysergic acid
(precursor to LSD, or “acid”, derived from ergot fungus and found in the seeds of various
flowering plants), and mescaline (protoalkaloid found in the peyote cactus, Lophophora
williamsii) all hallucinogenic or psychedelic schedule I-controlled substances.7,22 Despite
the risk of abuse, the beneficial applications of secondary metabolite natural products
maintain the necessity for the continued effort and investigations in regards to these
complex and novel metabolic entities.
The discovery and characterization of these complex metabolites presents an
analytical challenge. When testing for possible activity, inclusive whole plant extracts or
simple partitions of the extracts are screened in a high-throughput manner. If activity is
observed, analytical chemists are then tasked with the difficult process of generating
inclusive metabolite profiles of the whole or fractionated extracts to determine the
molecular constituents that may be the source of the activity. The generation of these
metabolite profile is the basis for the field of metabolomics (Figure 1.5).
10

Figure 1. 5 Metabolomics, a branch of the "-omic" sciences, and the general workflow for
metabolomic profiling.
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Metabolomics is a branch of the “-omic” sciences defined as the “systematic
study of the unique chemical fingerprints that specific cellular processes leave behind.”25–
27

When paired with the other “-omic” sciences, such as genomics, transcriptomics, and

proteomics, metabolomics can provide information in regards to the phenotypic
expression of different organisms, especially plants. The analytical targets of these
analyses are largely primary and secondary metabolites with molecular weights less than
1500 Da.26 Comprehensive metabolomic profiling assays typically focus on dividing the
metabolome into subsets of metabolites, usually based on compound polarity, common
functional groups, or structural similarity. From there, specific sample preparation or
extraction methods and analytical procedures are developed and optimized for each
subset.25,26 This leads to a patchwork effect when attempting to discuss an organisms
entire metabolome. Focused efforts have been placed on developing new and efficient
separation and analytical techniques to aid in the deconvolution of these complex
datasets. With over 6,500 common known metabolites recorded, these analyses can be
cumbersome and complicated.25 Metabolomic databases, such as METLIN - developed
by the Scripps Research Institute, have been developed to aid in the process and, as of
2021, consist of over 850,000 entries. The primary analytical tools used for metabolomic
profiling consist of a form of chromatographic or electropherographic separation (gas
chromatography -GC, liquid chromatography – LC, or capillary electrophoresis – CE)
coupled to mass spectrometry. As new metabolomics methods are developed and
technological advancements are made in the field of mass spectrometry, metabolomic
profiles will become more and more pivotal to our understanding of an organism’s
metabolic expression and aid in the discovery of new and novel secondary metabolites.
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Mass Spectrometry
The framework for what we now know as modern mass spectrometry was first laid
by Sir J. J. Thompson with his discovery of the electron in 1897 and description of an
analytes mass-to-charge ratio, or “m/z”.28,29 Over a decade later in 1912, Thompson
invented the first mass spectrometer, then known as the “parabola spectrograph”.28 In the
century since its invention, the field of mass spectrometry has seen numerous
revolutionary advancements, furthering the technology to a point where it is regularly
applied across nearly every scientific discipline. To better understand the magnitude of
these advancements, for example, the improvement of mass resolution can be examined.
A mass spectrometer’s resolving power is described as the ability of the instrument to
separate two mass spectral peaks and is calculated by analyzing the ratio of an analytes’
mass to the width of the observed mass spectral peak.28 Thompson’s parabola
spectrograph had a resolving power (RP) of approximately 13, meaning that an ion at m/z
150 would have a mass spectral peak ranging ~11.5 mass units from approximately m/z
144 to m/z 156.28 Modern instruments, such as the widely utilized Thermo Q Exactive
High Resolution Accurate Mass (HRAM) orbitrap mass spectrometer (RP=140,000) or
the Bruker Scimax (RP= 20,000,000) would detect the same mass peak with widths less
than 0.001 and 0.000001 respectively. The continued evolution, development, and wide
application of this analytical tool has further strengthened mass spectrometry as one of
the most useful and important analytical tools in modern science.
Though a variety of different types of mass spectrometers have been developed,
their general working principle is fairly conserved. Samples and analytes are delivered to
the instrument using an external device such as an LC, GC, or a simple syringe pump.30
13

Upon delivery, the analytes are ionized, using a variety of ionization sources, and
introduced into the mass spectrometer. Ionization source selection is dependent on the
nature of the sample matrix and chemical properties of the analytes themselves. Upon
ionization, the newly formed ions are separated by a mass analyzer. The mass analyzer is
the section of the instrument responsible for the instruments’ resolving power and they
are significantly more diverse than the ionization sources. Modern instruments often
employ more than one of these components, aiding to their higher resolving powers and
allowing them to be utilized for controlled fragmentation of selected ions, thus providing
structural information of the analytes as well. Following separation of the ions by the
analyzers, the ions strike a detection plate inducing an electron cascade, in the case of an
electron multiplier, and the amplified response is converted into the aforementioned
mass-to-charge ratio (m/z). In addition to these components, a complex high vacuum
system is employed throughout the mass spectrometer to maintain a “mean-free path” to
allow the ions to travel through to the detector uninterrupted. These high vacuum systems
can reach pressures often as low as 10-10 mbar. A general block diagram of a mass
spectrometer can be seen in Figure 1.6. The following sections will discuss the finer
details of some of these mass spectral components to further elucidate the inner workings
of these complex instruments.
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Figure 1. 6 Mass spectrometer block diagram.
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1.1.1

Ionization Sources

As stated above, analytes must be ionized prior to their separation by the mass
analyzer. There are a number of ionization techniques employed by modern mass
spectrometers and the choice is usually dependent on the particular experiment,
specifically, if a prior form of separation is in place (i.e. LC or GC) and the physical
nature of the analyte. Ionization sources can be generally grouped by the phase
requirements of the analytes for proper ionization. Electron ionization (EI) and chemical
ionization (CI) require analytes to be in the gas phase under vacuum for ionization using
electrons emitted by a heated filament.28,30,31 These methods are generally employed for
GC applications and result in fragmentation of the analytes into fragment ions,
classifying these as “hard ionization methods”. Other, more niche, ionization methods,
like MALDI (matrix-assisted laser desorption ionization) and SIMS (secondary ion mass
spectrometry), employ lasers or primary ion beams to ‘desorb’ sample molecules that
ionize in the subsequent gas phase from a solid surface, such as a MALDI target. These
sources are better suited for higher mass analytes (>500). The work found in this
dissertation centers around the use of atmospheric pressure ionization (API) methods,
specifically, electrospray ionization (ESI). API methods are considered to be “soft”
ionization methods, in that the analytes are usually detected as intact ions resulting from
either protonation/deprotonation or cation/anion adduct formation, depending on the
polarity of the source.32–35 Aside from ESI, atmospheric pressure chemical ionization
(APCI) and atmospheric pressure photoionization (APPI) are also classified as API
methods. In APCI, a coronal discharge is used to ionize a reagent gas which then
interacts with and subsequently ionizes the desolvated analytes through interactions such
16

as a proton transfer.28,30,33 In APPI, a hydrogen or krypton discharge lamp is used to
produce 10-10.6 eV photons to ionize analytes that have ionization energy below that of
the emitted photon.30 Both APPI and APCI are fairly similar and only differ in the usage
of a photon source rather than the coronal discharge. The method primarily used in this
work, however, is ESI. John Fenn first developed ESI in 1988 and subsequently was
awarded a Nobel Prize in 2002 for his contributions.28,30,32 It is arguably the most widely
utilized ionization source in modern mass spectrometry applications, especially when
coupling liquid chromatography. In ESI, analytes within a solution are pumped through a
stainless-steel emitter, or “spray needle”, that is held at a higher potential in regard to the
inlet of the mass spectrometer. As the solvent solution is pumped through the needle, the
applied potential causes a “Taylor cone” to form as a combinatorial result of the dipole of
water in the solvent solution and repulsion of the cations/anions dissolved in solution
depending on the polarity of the applied potential. In addition to the applied potential, a
stream of nitrogen gas is also supplied to aid in aerosolization and desolvation of the
solvated analytes into ions. Droplets are emitted from the tip of the Taylor Cone as a
result of increasing charge density. The droplets consist of both charged species (protons
and cations for positive ion mode) and solvated analytes and move toward the inlet of the
mass spectrometer, driven by both the supplied nitrogen stream and the potential
difference. The subsequent mechanism of ESI in which the droplets convert to single
ionized analytes has been explained using two separate models, though it is likely that the
actual mechanism is a combination of both models. The first model, the Ion Evaporation
Model (IEM – Figure 1.7) states that, as the droplets evaporate as a function of the
desolvation process, the charge density increases.
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Figure 1. 7 Electrospray ionization diagram displaying both the ion evaporation model
(IEM) and the charged residue model (CRM).
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Once the charge density has reached a point known as the Rayleigh limit, the repulsion of
the like-charged ions overcomes the surface tension of the droplet and analyte ions are
ejected in a similar manner to how the droplets are ejected from the Taylor Cone.28,30,32–35
For the second model, the Charged Residue Model (CRM – Figure 1.7), when the
Rayleigh limit has been reached, it is believed that the droplets undergo serial fissions as
a result of coulombic explosions. These sequential fissions continue until only single
analyte ions remain and enter the gas phase.1,3,5-8 The electrospray process is widely
applicable and can be utilized at a variety of flow rates ranging from mL/min to nL/min
depending on the application and the parameters in place.30
1.1.2

Mass Analyzers

Mass spectrometers are usually classified in terms of their mass analyzers. The
two main classes of analyzers are “beam” analyzers, such as magnetic sector, quadrupole,
and time-of-flight analyzers, and “trapping” analyzers, such as ion trap, ion cyclotron
resonance, and orbitrap analyzers. Within each class, however, the difference between
analyzers is vast and certain metrics must be utilized to make accurate comparisons.
These metrics are the mass range limit, the analysis speed, the transmission of ions, the
mass accuracy, and the resolving power (described above).28 Mass range limit and
analysis speed are fairly self-explanatory, the mass range limit describes the operating
window in which ions can be measured and the speed is a measure of how long it takes to
measure the ions in that range. Transmission describes the ratio of ions that enter the
instrument versus the amount that make it all the way to the detector due to more
mechanical loss, such as collisions with transfer lenses. This is not to be confused with
19

the “duty cycle” which describes the proportion of time that a system is active within a
given period. For example, if a wide m/z window is being analyzed but only single m/z’s
are transmitted at a time, the duty cycle will be low.30 The transmission of an instrument
is a direct function of the instruments design whereas the duty cycle is a function of the
applied parameters (full scan vs single ion monitoring- SIM, 100% duty cycle). Mass
accuracy is directly related to the resolving power of the mass analyzer. An analyzer with
low resolving power will also have low accuracy. The mass accuracy is derived from the
difference between m/zobserved and m/zexpected on a ppm or mmu scale. The mass analyzers
primarily used in this work are quadrupoles and orbitraps.
Quadrupole mass analyzers are currently among the most popular analyzers
installed in modern mass spectrometers and are often utilized in tandem with other
analyzers. Figure 1.8 displays the general setup of a quadrupole mass analyzer. The
analyzer consists of four parallel metal rods connected pairwise to combination of RF (V)
and DC voltages (U) with the pairs being 180o out of phase from each other. 30,36–38 At a
given RF and DC voltage, only ions of a certain m/z are allowed to pass through and
reach the detector. Ions traveling through the z-axis will experience the electric field and
be transmitted if their trajectories are stable in the xy plane and do not exceed r0 (Figure
1.8). For a beam of positively charged ions traveling in the xz plane, as the x electrodes
cycles between a positive and negative potential, ions will oscillate from being focused
toward the center axis (positive potential) to moving towards the rods (negative
potential). The y electrodes operate with an equal potential in magnitude but 180o out of
phase from the x electrodes.
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Figure 1. 8 Quadrupole mass analyzer.
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Through this, ions are filtered based on their m/z. This motion is better describe using the
following equations:28,30,36–38
The force of the applied electric fields in the x and y axes are define as:
𝐹𝐹𝑥𝑥 = 𝑚𝑚
𝐹𝐹𝑦𝑦 = 𝑚𝑚

𝑑𝑑2 𝑥𝑥
𝜕𝜕𝜕𝜕
= −𝑧𝑧𝑧𝑧
2
𝑑𝑑𝑑𝑑
𝜕𝜕𝜕𝜕

𝑑𝑑2 𝑦𝑦
𝜕𝜕𝜕𝜕
= −𝑧𝑧𝑧𝑧
2
𝜕𝜕𝜕𝜕
𝑑𝑑𝑑𝑑

Where ze is the charge and 𝜙𝜙 represents the applied potentials and are defined as:
𝜙𝜙0 = +(𝑈𝑈 − 𝑉𝑉 cos 𝜔𝜔𝜔𝜔) 𝑎𝑎𝑎𝑎𝑎𝑎 −𝜙𝜙0 = −(𝑈𝑈 − 𝑉𝑉 cos 𝜔𝜔𝜔𝜔)

𝜙𝜙(𝑥𝑥,𝑦𝑦) = 𝜙𝜙0 (𝑥𝑥 2 − 𝑦𝑦 2 )/𝑟𝑟02 = (𝑥𝑥 2 − 𝑦𝑦 2 )(𝑈𝑈 − 𝑉𝑉 𝑐𝑐𝑐𝑐𝑐𝑐 𝜔𝜔𝜔𝜔)/𝑟𝑟02
Further rearrangement and differentiating leads to the Paul equation named after
the scientist who pioneered the mass analyzer in the 50s:
𝑑𝑑 2 𝑥𝑥 2𝑧𝑧𝑧𝑧
+
(𝑈𝑈 − 𝑉𝑉 cos 𝜔𝜔𝜔𝜔) 𝑥𝑥 = 0
𝑑𝑑𝑑𝑑 2 𝑚𝑚𝑚𝑚02

𝑑𝑑 2 𝑦𝑦 2𝑧𝑧𝑧𝑧
+
(𝑈𝑈 − 𝑉𝑉 cos 𝜔𝜔𝜔𝜔) 𝑦𝑦 = 0
𝑑𝑑𝑑𝑑 2 𝑚𝑚𝑚𝑚02

While these equations describe the trajectory of an ion at a given m/z, further
information is required to truly understand the stable trajectory on an ion through the
quadrupoles. Here, incorporation of the Mathieu equation is employed:
𝑑𝑑 2 𝑢𝑢
+ (𝑎𝑎𝑢𝑢 − 2𝑞𝑞𝑢𝑢 cos 2𝜉𝜉) 𝑢𝑢 = 0
𝑑𝑑𝑑𝑑 2
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Where u is either x or y (with signs changing respectively) and 𝜉𝜉 2 =

𝜔𝜔2 𝑡𝑡 2
4

.

Finally, implementation of the above equations can be used to plot the stable
combinations of applied RF and DC voltages for an ion at a given m/z to have a stable
trajectory through the mass analyzer, as depicted in Figure 1.9 where:
𝑎𝑎𝑢𝑢 =

8𝑧𝑧𝑧𝑧𝑧𝑧
4𝑧𝑧𝑧𝑧𝑧𝑧
2 𝑎𝑎𝑎𝑎𝑎𝑎 𝑞𝑞𝑢𝑢 =
2
𝑚𝑚𝜔𝜔 𝑟𝑟0
𝑚𝑚𝜔𝜔 2 𝑟𝑟02

As depicted in Figure 1.9, the specific combinations of different DC (U) and RF
(V) voltages are the driving factors behind the stable trajectory. The area under the
triangular region corresponds to the combinations of U and V in which a specific m/z is
stable, however, not all m/z’s stability diagrams superimpose, as seen in the above
equation. The dashed line stability curves in Figure 1.9 represent other m/z’s stable
trajectories. The “scan line” denotes the slope at which U and V are ramped. The angle of
the slope can be adjusted to increase or decrease the resolution of ions with differing
m/z’s, which is inversely proportionate to the signal intensity. Quadrupoles generally
have a working m/z limit of 4000 and a maximum resolution of 2000.30 Additionally, the
usage of RF only and no application of DC voltages allows for the passage of all ions
with no resolution. This is referred to as an “ion guide” and is used to focus or transmit
ions in larger, complex mass spectrometers. Quadrupoles are the most robust and costeffective mass analyzers and are widely employed. Further aiding to their recent widespread adoption, modern mass spectrometers automatically make the RF and DC voltage
adjustments for the operator depending on their desired m/z limits, easing their usage for
less experienced users and making them more accessible to a wider audience.
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Figure 1. 9 Mathieu stability diagram describing the stable trajectory of an ion through
the quadrupole mass analyzer.
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Another mass analyzer that, recently, has become increasingly popular is the
orbitrap. First developed by Makarov in 1999 and commercialized in 2005, the orbitrap is
an electrostatic ion trap that uses the axial harmonic motion of ions to determine the
m/z.30,39 The orbitrap, as depicted in the lower left side of the box diagram of the Thermo
Fisher Q Exactive in Figure 1.10, consists of a pair of electrodes, shaped like a barrel cut
in half, with a central spindle electrode in the z axis. In the case of positive ion mode
detection, ions are injected through a hole in the outer electrode (ground), attracted by a
negative kV voltage applied to the spindle. Once injected into the orbitrap, the ions adopt
a circular/oval trajectory around the central spindle and oscillate along the z-axis as
defined by the following:
𝑈𝑈(𝑟𝑟,𝑧𝑧)

𝑘𝑘 2 𝑟𝑟 2
𝑘𝑘
𝑟𝑟
= �𝑧𝑧 − � + (𝑅𝑅𝑚𝑚 )2 ln � � + 𝐶𝐶
2
2
2
𝑅𝑅𝑚𝑚

Where r and z are the cylindrical coordinates, C is a constant, Rm is the radius, and k is
the field curvature. The above equation can be utilized to derive how ions at a given m/z
move within the orbitrap in an axial and radial direction, as well as their rotational
frequency, however, only the frequency of the axial oscillations (ω) is dependent on the
m/z of a given ion:
𝑧𝑧
𝜔𝜔 = �� � 𝑘𝑘
𝑚𝑚

The axially rotation of the ions generates an image current as the ions rotate around the
center electrode and oscillate between the two halves of the outer electrode. The image
current generated as the ions axially oscillate while maintaining their orbital trajectories
is then amplified and converted into corresponding m/z signals using a Fourier transform.
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Orbitraps offer one of the highest resolutions among mass analyzers, rivaled only by FTICR analyzers, with the highest achievable resolution of 250,000.
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Figure 1. 10 Thermo Q Exactive High Resolution Accurate Mass (HRAM) orbitrap mass
spectrometer block diagram.
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Orbitraps also offer high mass accuracy as well, with the use of internal calibrants (lock
masses) resulting in low single digit to sub-ppm accuracies. Drawbacks of the analyzer
arise from the reduction in scan speed as resolution increases as the resolving power is
proportional to the time in which the oscillations are recorded. At low resolution
(17,500), ~8-10 scans can be performed in a second while at high resolution (140,000),
only 1-2 scans can be acquired. Additionally, orbitraps, like FT-ICR analyzers, require
ultra-high vacuum for optimal performance (10-10 mbar). 28,30,39–42
The Thermo Q Exactive High Resolution Accurate Mass (HRAM) orbitrap mass
spectrometer, depicted in Figure 1.10, was the orbitrap instrument utilized in this work. It
is composed on a series of quadrupoles acting as either mass filters or ion guides
(multipoles and flatpoles) followed by a “C-trap” that is used to collect and store packets
of ions to either be pumped into an HCD cell for MS/MS fragmentation (see below) or
pulsed directly into the orbitrap for mass analysis. The implementation of the C-trap also
increases the duty cycle of the particular instrument as ion packets can be collected
concurrently while the orbitrap is being utilized for mass analysis. At the low resolution
end of the instrument (17,500), the duty cycle can approach up to 90% depending on the
mass window utilized. The C-trap is functionally an RF-only quadrupole that employs
varying potentials to collect, store, and thermally equilibrate ion “packets” prior to
ramping the potential to pulse them to either the detector or the collision cell. The high
mass resolution of the Q Exactive paired with it’s high efficiency and speed make it an
invaluable tool for untargeted global metabolomics.
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1.1.3

Tandem Mass Spectrometry

Tandem mass spectrometry (MS/MS) is broadly defined as “the acquisition and
study of the spectra of ions following m/z selection” and is usually coupled to a method
of activation and molecular fragmentation.30 The primary application of MS/MS
experiments is to use fragmentation patterns to provide structural elucidation of select
precursor ions. Tandem mass spectrometry can be divided into two main categories:
MS/MS in space or MS/MS in time. Tandem in space MS/MS instruments, such as beamtype triple quadrupole mass spectrometers (QqQ) have specified regions for ion selection
(uppercase “Q”) and ion fragmentation (lower case “q”, the reaction region). Whereas
tandem in time MS/MS instruments, such as trapping-type quadrupole ion-traps (QIT),
are capable of performing both the isolation and fragmentation in the same mass
analyzer. Fragmentation mechanisms vary from instrument to instrument, but the most
commonly used mechanism is collision induced dissociation (CID). In CID, selected ions
are accelerated by an electric field to a high kinetic energy level. Neutral gas molecules
(He, N2, Ar) pumped into the fragmentation chamber, prior to the ion selection process,
collide with the precursor ions and the kinetic energy is converted into internal energy.
Once resonantly excited, the precursor ions will undergo fragmentation, generally at the
site of the most labile bond, through either homolytic fragmentation or heterolytic
fragmentation. In homolytic fragmentation, each fragment retains one of the electrons
associated with the corresponding most-labile bond. In heterolytic fragmentation, the
electrons remain with only one of the fragments. Following fragmentation, the ions
equilibrate and generally do not undergo further fragmentation as the applied excitation
potential is specific to the precursor ions. 28,30,31
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In this work, the Q Exative HRAM orbitrap mass spectrometer was used for
MS/MS experiments. The Q Exactive employs a type of CID known as “higher-energy
collisional dissociation” (HCD). Conversely to traditional CID in an ion trap, HCD is
non-resonant and can often cause both labile and stronger bonds to break during the
fragmentation process. Because of this, more extensive fragmentation patterns can be
observed when using HCD. Additionally, whereas CID in ion traps is performed in time,
HCD acts more like MS/MS performed in space. Product ions are not equilibrated by
collision cooling as they are in ion traps and can undergo further fragmentation as the
process is not a slow ramping process like it is with ion traps. As depicted in Figure 1.10,
selected ions are collected in the C-trap and then pulsed into the HCD-cell for
fragmentation. After a period of time, the resulting fragments are then pulsed back into
the C-trap, recollected, and then pulsed into the orbitrap for mass detection.28,41–46

Separation Science
The integration of front-end separation techniques to mass spectrometry has
become increasingly common since the initial coupling of ion mobility in the late 30s and
gas chromatography in the late 50s.28,30 Since then, high performance liquid
chromatography (HPLC) and capillary electrophoresis (CE), among others, have also
joined the classification of “hyphenated techniques” coupled to mass spectrometry. These
separation methods aid in quantitation and discovery in separating complex mixtures so
that analytes can be measured independently by the mass spectrometer. Separations
provide a number of advantages in that time-resolved mass spectra can be acquired,
sample analyses can be automated, matrix effects can be reduced, structural/stereo30

isomers can be distinguished, and relative or absolute quantitation can be
performed.30,31,47–49 For the work performed in this dissertation, method development
primarily employed HPLC and CE separation methods, described in detail below.
1.1.4

Liquid Chromatography

Liquid chromatography (LC) is a chromatographic method that utilizes the
chemical characteristics of analytes in solution and how they interact with a solid
“stationary phase” packed in a stainless-steel column for separation. Flow rate and
station-phase characteristics are used to broadly define the type of LC used. Higher flow
rates (100-1000 µL/min) and larger particle sizes (>5 µm ) and column inner diameters
(abbrev. ID, >2.1 mm) define standard high performance liquid chromatography
(HPLC). A reduction in particle size (<2,5 µm) , ID (1-2.1 mm) , and flow rates (<400
µL/min) defines ultra high performance liquid chromatography (stylized as uHPLC,
UHPLC, or UPLC depending on manufacturer, UHPLC used in this dissertation). Further
decreases in the aforementioned parameters define capillary liquid chromatography (CapLC) and nano liquid chromatography (Nano-LC), though the difficulty associated with
their implementation makes them less widely used. Aside from the column, an external
and easily changed part of an LC, LCs are modular instruments. These modules vary
between instruments and applications, however, the average LC consists of a solvent
reservoir system, a binary or quaternary pump, a solvent degasser, an autosampler, and a
column oven/housing unit. Mobile phase, the solution pumped through the system
responsible for changing how analytes react with the stationary phase, is pumped from
the reservoir, mixed and degassed, and delivered to the column. The common effluent is
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then routed to the ion source of the mass spectrometer (usually an API source, such as
ESI) and mass spectral detection is performed. The mobile phase selection is dependent
on the stationary phase and analytes being separated. For “reversed phase” (RP)
stationary phases (Figure 1.11), water and an organic solvent such as acetonitrile or
methanol are used. Separations are performed using either sloping gradients (changing
ratios of aqueous and organic) or isocratic gradients (fixed ratios), depending on the type
of separation being performed. The separation is performed as a function of how the
analytes interact with the stationary phase and how they partition in and out of it versus
the mobile phase. Stationary phases can also be selected based on specific chemical
characteristics of the function group coupled to the silica particles that make up the
stationary phase packing material (Figure 1.11). A fairly nonpolar analyte, for example,
would be injected in a mixture onto the column under high aqueous mobile phase
conditions. Under these conditions, the nonpolar analyte is going to be in equilibrium
partitioning in and out of the stationary as it moved down the column, with the
equilibrium favoring the stationary phase, or it being “retained”. As the gradient changes
to a higher organic concentration in the mobile phase, the equilibrium will begin to shift
towards favoring or being equal with the mobile phase. This principle allows this given
analyte to be separated from more polar analytes that would not have interacted as
favorably with the stationary phase under high aqueous conditions.30,31,47–49
Two theories can be examined when evaluating chromatographic separations in
terms of separation “plates” as a function of equilibrium, Plate theory and Rate
theory.47,50,51 The plate theory assumes instantaneous equilibrium at each integral
separation layer or “plate”. Generally, the number or plates is used to make this
32

Figure 1. 11 Examples of several reversed-phase HPLC column packing materials.
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assessment and, theoretically, the more plates, the better the separation. The number of
plates (N) can be calculated based on the retention time (tR) and full width at half of the
maximum height (w1/2) of a peak:
𝑡𝑡𝑅𝑅
𝑁𝑁 = 5.55 ( )2
𝑤𝑤1
2

From here, the height equivalent of the theoretical plate (HETP) can be calculated as a
function of the number of plates (N) and the length of the column (L):
𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻 =

𝐿𝐿
𝑁𝑁

The HETP can also be calculated using the rate theory, however, here kinetic
factors are taken into account when equilibrium is established rather than it being
understood as instantaneous.50,51 Here, the van Deemter equation is utilized:
𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻 = 𝐴𝐴 + 𝐵𝐵 + 𝐶𝐶

Where A, eddy diffusion = 𝜆𝜆𝑖𝑖 𝑑𝑑𝑝𝑝 : (factor of the packed bed x particle diameter)
Where B, longitudinal (axial) diffusion= 2𝛾𝛾

𝐷𝐷𝑀𝑀
𝑢𝑢

: (obstruction factor (usually 0.5) x

diffusion coefficient/velocity of the mobile phase)
And where C, the resistance to mass transfer = 𝑐𝑐
Rearranged and simplified as:

𝑑𝑑𝑝𝑝 2
𝐷𝐷𝑀𝑀

𝑢𝑢

2

𝑑𝑑𝑝𝑝
𝐷𝐷𝑀𝑀
𝐻𝐻𝐻𝐻𝐻𝐻𝐻𝐻 = 𝜆𝜆𝑖𝑖 𝑑𝑑𝑝𝑝 +
+ 𝑐𝑐
𝑢𝑢
𝑢𝑢
𝐷𝐷𝑀𝑀
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Plotting these parameters results in the van Deemter plot, which can be utilized to
identify the best operating conditions for a given column. Generally, the lower the HETP,
the more equilibrium partitions the analyte will experience and the better the separation
will be.50,51
1.1.5

Capillary Electrophoresis

Electrophoresis is a type of separation method based on the rate in which charged
species migrate as a function of an applied electric field.31,52,53 Electrophoretic
separations can be performed on both the macro and micro scales, with the former being
performed using a solid (paper) or semisolid (gel) medium and the latter being performed
using buffer solution-fused silica capillaries. This microscale electrophoresis method is
known as capillary electrophoresis (CE). This separation technique, though not as widely
applied as LC methods, has been utilized by a number of industries due to its high
resolving power (100,000+ theoretical plates – A and C factors of the van Deemter
equation are eliminated), separation speed, and low sample volume requirements (nL
range).52–55 A standard CE instrument setup can be seen in Figure 1.12 (top). Briefly, a
fused silica capillary with an ID <100 µm is used to bridge two buffer reservoirs
containing a background electrolyte solution (BGE). In the case of positively charged
analytes, a positively charged electrode is placed in the origin side BGE reservoir and a
negatively charged electrode is placed in the detector side BGE reservoir. The capillary is
filled with the BGE driven by both an applied pressure and an applied potential. Once
filled, the origin side of the capillary is placed in a sample vial containing a sample
solvated in either BGE or a differing electrolyte solution depending on the application.
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Figure 1. 12 (Top) Standard capillary electrophoresis block diagram. (Bottom) Capillary
Electrophoresis coupled to mass spectrometry.
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The sample is injected either electrokinetically (voltage-driven), hydrodynamically
(pressure-driven), or using both for a short period of time – i.e. 20 sec = ~ 5 nL.
Following injection, the origin side of the capillary is reinserted into the origin side BGE
reservoir and a high voltage is applied, initiating the separation. In standard CE
experiments, a window is burned into the polyamide coating of the fused silica so a
detector (UV, PDA, Fluorescence) can be implemented on opposite end of the capillary
from the origin. Alternatively, rather than a reservoir on the detector end, CE can be
easily coupled to a mass spectrometer with the inlet at ground acting as the cathode. The
capillary is integrated into housing tubing within the mass spectrometer’s ionization
source allowing for a bulk solution (1-5 µL/min) to be supplied at the end of the capillary
for electrospray ionization.52,54–57
Separations via CE can be performed many ways such as standard capillary zone
electrophoresis (CZE), isotachophoresis (ITP), miceller electrokinetic chromatography
(MEKC), and capillary electrochromatography (CEC). In this work, only CZE and ITP
were applied (discussed below).31,52 The driving factors behind CE-based separations are
electrophoretic and electroosmotic flow.
Electrophoretic flow (Figure 1.13 – bottom left) describes how ions
migrate as a response to the applied potential.52 The electrophoretic mobility (µep) is
directly proportional to velocity (νep) at which the ion moves in an applied electric field
(Eapp) and inversely proportional to the frictional retarding force of the ion, which is a
function of the ion’s size and shape and the viscosity of the BGE, as shown in the
following:
𝜈𝜈𝑒𝑒𝑒𝑒 = 𝜇𝜇𝑒𝑒𝑒𝑒 𝐸𝐸𝑎𝑎𝑎𝑎𝑎𝑎 = 𝜇𝜇𝑒𝑒𝑒𝑒

𝐸𝐸𝑓𝑓
𝐹𝐹𝑓𝑓

𝑤𝑤ℎ𝑒𝑒𝑒𝑒𝑒𝑒 𝐸𝐸𝑓𝑓 = 𝑞𝑞𝑞𝑞 𝑎𝑎𝑎𝑎𝑎𝑎 𝐹𝐹𝑓𝑓 = −6𝜋𝜋𝜋𝜋𝜋𝜋𝜋𝜋
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Figure 1. 13 (Top) Fixed and diffuse layers of capillary electrophoresis, making up the
"double layer" responsible for electroosmotic flow. (Bottom) Total flow of an analyte is
the summation of its electrophoretic mobility and the electroosmotic flow.
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Where Ef is the electrical field strength, q is the charge of the ion, r is the ion’s radius,
ν is the ion’s velocity and η is the solution viscosity. For the case in which positively
charged analytes are of interest, the BGE is acidic, and the origin side is positively
charged, analyte cations will exhibit a forward moving electrophoretic mobility toward
the detector, neutral analytes will not migrate, and analyte anions will migrate towards
the origin anode.
Electrophoretic mobility is not the only driving force behind CE. Electroosmotic
flow (EOF) also occurs and is the result of the formation of an electric double layer
forming between buffer cation/anions and the silanol groups of the fused silica capillary.
Following an initial wash with a high pH solution, such a NaOH, the surface silanols are
deprotonated and negatively charged. Buffer cations, once introduced into the capillary,
interact with the negatively charged silanols and form the fixed or “Stern” layer (see
Figure 1.13). The cations only partially neutralized the negative charge of the capillary
walls so a second, cation-rich layer, called the diffuse layer, forms and the two layers
make up the aforementioned electric double layer. The cations in the double layer migrate
toward the cathode and the ensuing motion generates a “bulk flow” phenomenon. This
phenomenon also causes the solution to adopt a wall flow/flat profile as opposed to the
parabolic profile observed from pressure-induced flow. The magnitude of the EOF is
generally greater than the electrophoretic flow so even negatively charged analytes have a
resulting net flow towards the cathode (Figure 1.13 – bottom middle and bottom right).
The velocity of the EOF (νeo) is defined as:
𝜈𝜈𝑒𝑒𝑒𝑒 = 𝜇𝜇𝑒𝑒𝑒𝑒 𝐸𝐸𝑎𝑎𝑎𝑎𝑎𝑎 =

𝜖𝜖𝜖𝜖
𝐸𝐸
𝜂𝜂

Where ε is the dielectric constant of the buffer and ζ is the zeta potential.
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The zeta potential describes the potential of the double layer on the capillary wall. It is a
function of the pH of the BGE and is reduced as the pH decreases and the number of
cations in solution increases.
The apparent mobility (µapp) of an analyte is the result of the summation of it’s
electrophoretic and the electroosmotic flow of the solution with the apparent velocity
(νapp) being a function of the apparent mobility and the applied field:
𝜇𝜇𝑎𝑎𝑎𝑎𝑎𝑎 = 𝜇𝜇𝑒𝑒𝑒𝑒+ 𝜇𝜇𝑒𝑒𝑒𝑒
𝜐𝜐𝑎𝑎𝑎𝑎𝑎𝑎 = 𝜇𝜇𝑎𝑎𝑎𝑎𝑎𝑎 𝐸𝐸

1.1.6

Microfluidic Capillary Zone Electrophoresis

The work performed in this dissertation involved the utilization of a microfluidic
CZE-MS devices called the ZipChip. First designed in 2008 and later fabricated and
commercialized by 908devices in 2016 for research use, this microfluidic CZE-MS
device has been reported in literature for a variety of uses including the identification of
post-translationally modified peptides, analysis of antibody conjugates and viral capsid
proteins, and for the detection and quantification of pathogenic metabolites in marine
life.58–65 This devices (Figure 1.14) consists of an etched rectangular glass slide with
three wells (S, B, and SW) connected by corresponding channels to an intersection with a
long serpentine separation channel. The serpentine channel meets with another wellsourced channel (P) at the corner of the glass chip. Injections into this device are
hydrodynamic. Pressure is then applied to the “S” well to load the sample into the cross
intersection by
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Figure 1. 14 The 908 Devices "ZipChip" microfluidic CZE-MS device. Consists of an
etched piece of glass with channels connecting to four wells: S - sample well, B background electrolyte well, SW - sample waste well, and P - pressurized ESI spray well.
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pumping it to the waste well (SW) and also concurrently applied at the “B” well, filled
with BGE, to begin the formation of a sample plug in the beginning of the serpentine
separation channel. After a period of time corresponding to a specified injection volume,
pressure is exclusively applied to the “B” well to clear the channel intersection and
endcap the sample plug in BGE. A subsequent potential is applied and the sample is
electrophoretically separated through the serpentine channels before meeting with the “P”
channel where bulk flow and an additional potential is provided to produce electrospray
from the corner of the chip (Figure 1.15). Aside from the difference in scale of this device
(10 cm separation channel) compared to traditional CZE (often >40-50 cm), this device
also employs transient isotachophoresis (tITP, described below) for its separation
mechanism.58–61 Additionally, for the standard HS or HR variety chips (10 cm vs 22 cm
separation channel), the walls of the channels are chemically modified with
aminopropylsilane effectively reducing the zeta potential to 0 as no negatively charged
silanols exist for the double layer to form. This effectively eliminates the EOF, leaving
tITP as the only separation mechanism. Isotachophoresis (ITP) is a type of
preconcentrating electrophoretic mobility method driven by the usage of leading (LE)
and trailing (TE) electrolytes. Ideally, analytes will have an intermediate ionic mobility
compared to the LE (high mobility) and TE (low mobility). Once the potential is applied,
the analytes will stack in between the LE and TE interface and focus as they migrate.
While a reduction in separation efficiency is observed, if separation is observed at all, the
compaction of the analyte band greatly increases the signal intensity and narrows the
peak width. The lack of separation is obviously not ideal, however, the analyte band
compaction and subsequent signal increase is a desirable feature of ITP, which lead to the
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development of tITP. In tITP, the sample is dissolved in a solution containing the leading
electrolyte and the BGE has relatively low conductivity. Upon the application of the high
voltage, the analytes briefly travel with the LE, stacking behind it and
preconcentrating/focusing, before the LE breaks away. Once the LE has broken away, the
analytes are then able to be electrophoretically separated. The utilization of the tITP
phenomenon greatly increases the sensitivity of the method and, coupled with the low
flow rates associated with CE compared to HPLC, makes this method ideal for detection
of trace analytes in complex mixtures. Another important factor for this device is its
speed. Standard analyses can be performed in 3-6 minutes depending on the chip (HS vs
HR) and applied field strength. This speed does not come at the cost of separation
efficiency and the device is reproducibly capable of separating all 20 canonical amino
acids with baseline resolution in less than 1.5 minutes.
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Figure 1. 15 Still image of the ESI corner of the ZipChip while spraying.
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CHAPTER 2. THE ANALYSIS AND CHARACTERIZATION OF TRANSGENIC LOBELIA
CARDINALIS ALKALOIDS VIA HPLC-MS AND CZE-MS
Segments of this dissertation chapter are taken from: Kelley, Z. D.; Rogers, D. T.;
Littleton, J. M.; Lynn, B. C. “Microfluidic Capillary Zone Electrophoresis Mass
Spectrometry Analysis of Alkaloids in Lobelia Cardinalis Transgenic and Mutant Plant
Cell Cultures.” Electrophoresis 2019, 40 (22), 2921–292866
Introduction
Alkaloids, as stated in chapter 1, are a class of secondary metabolites characterized
by the presence of at least one basic nitrogen.67,68 The class is further divided in to
subsets regarding origin and nitrogen arrangement. The “typical” or “true” alkaloids are
derived from amino acid precursors, such as tryptophan and histidine, and contain a type
of heterocyclic nitrogen motif, as depicted in Figure 2.1, or a primary amine while still
being of amino acid origin (see mescaline – tyrosine derived in Figure 1.4).68,69
Additionally, there are “atypical” or “pseudo” alkaloids that, while sometimes still of
amino acid origin, their nitrogen is the result of transamination.69 The biosynthetic
pathways (simplified, Figure 2.2) for the synthesis of both typical and atypical alkaloids
can often be tremendously complex, often involving 20+ enzymatic steps and with
multiple diverging intermediate steps, leading to individual plant species producing a
diverse variety of metabolites sharing similar central motifs.70,71,72 Given the diversity of
alkaloids as a whole, the role of these metabolites in plants is also multifaceted. They can
be utilized as predator defense/determent agents, nitrogen stores, nonspecific basic
catalysts, anti-oxidants, and even as waste product or reactionary byproducts. 67,70,73,74
Adding to the diversity of these molecules, the formation of an informal interaction of the
heterocyclic nitrogen with a free oxygen, an “N-oxide”

Figure 2. 1 Common alkaloid central heterocyclic nitrogen motifs.
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Figure 2. 2 Simplified biosynthetic origins of selected classes of alkaloids.
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interaction, is also common to aid in the aqueous solubility and transport of the
metabolites throughout the plant.2,75,76,29,77
In addition to their role in plants, this diverse class of secondary metabolites is
also of interest to humans for pharmacological applications as “natural” pharmaceuticals.
The medicinal application of alkaloids can be seen in a wide variety of current products
including quinine (Figure 1.2), an antimalarial, reserpine, an antihypertensive, and
vincristine, an antitumor-agent.78,79 Additionally, many addictive or chronically abused
stimulants and hallucinogens, such as nicotine, morphine and its derivatives, and cocaine,
are also found within this group. Given their vast pharmaceutical applications paired with
their complex structures that would be difficult to reproduce synthetically, these
metabolites are often extracted, purified, and tested for pharmacological activity across a
variety of targets.
The alkaloids in question for this chapter are those found in the cardinal flower,
Lobelia cardinalis (Figure 2.3 - left). Lobelia cardinalis produces a binitrogenous
alkaloid, lobinaline (decahydro-1-methyl-5,7-diphenyl-6-(3,4,5,6-tetrahydro-2pyridinyl)-quinoline - C27H34N2 – Figure 2.4), recently shown to have inhibitory activity
on the human dopamine transporter (hDAT).72,80–82 Another member of the Lobelia
genus, Lobelia inflata (Figure 2.3 – right) produces an alkaloid of proposed biosynthetic
origin, lobeline, which has also been reported to have similar activity.83–85 Other than the
hypothesis that lobeline and lobinaline share a biosynthetic precursor, sedamine, very
little is known about L. cardinalis and its other secondary metabolites as few publications
involving the plant have been produced since the 1960s.83,86–88
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Figure 2. 3 Lobelia cardinalis (left) and Lobelia inflata (right). (Free use images. Image
sources: pixabay.com, daledbet (cardinalis) and KatarzynaTyl (inflata)).
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Figure 2. 4 Lobinaline - decahydro-1-methyl-5,7-diphenyl-6-(3,4,5,6-tetrahydro-2pyridinyl)-quinoline - C27H34N2.
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A natural pharmaceutical company based out of Lexington, KY, Naprogenix LLC,
discovered this hDAT inhibitory activity in the mid-2000s.81,82 The focus of their activity
screen centered around the search for atypical hDAT inhibitory secondary metabolites
that could be used as low-to-zero-abuse liability cessation aids for people suffering from
substance use disorders (SUD).89 Naprogenix has since genetically modified L. cardinalis
to produce hairy root cultures expressing the human dopamine transporter (hDAT) using
Agrobacterium rhizogenes-mediated transformation. The cultures were then further
mutated via activation-tagging mutagenesis by the insertion of viral enhancer sequences
into the hairy root cultures genome to induce random gain-of-function mutations.81,82
These transgenic mutants were selected on media containing MPP+ (1-methyl-4phenylpyridinium) which is accumulated intracellularly by activity of the hDAT and
targets the mitochondrial oxidative phosphorylation mechanism. This selection process is
visualized in Figure 2.5. The hypothesis is that surviving progeny hairy roots were
predicted to contain up-regulated or novel secondary metabolites with hDAT inhibitory
activity. To test this, analytical methods were developed to identify those specific
metabolites that are increased in MPP+-resistant mutants relative to wild type (WT).
Here, samples of the surviving hairy root cultures were propagated, harvested, extracted,
and then analyzed using the both LC-MS and a microfluidic CZE-MS device.
Metabolomic profiles were generated from the analyses and used for determination of
lead compounds to be targeted for the pharmacological screening as potential
therapeutics for people suffering from SUDs. Novel metabolites were structurally
characterized using tandem mass spectrometry (MS/MS) analyses and then selected
compounds were purified using a variety of extraction and purification methods.
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Figure 2. 5 Naprogenix mutant transgenic Lobelia cardinalis selection workflow. A)
Hairy root L. cardinalis plant cell. B) Transgenic L. cardinalis expressing the human
dopamine transporter. C) Transgenic L. cardinalis post activation tagging mutagenesis.
D) Cell death following exposure to MPP+ if no hDAT inhibitory metabolites are present
or E) Cell survival if hDAT inhibitory metabolites are present.
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Materials, Methods, and Instrumentation
2.1.1

Extraction Protocol and Sample Preparation – Liquid-Liquid Extractions
Both field grown Lobelia cardinalis plant material and mutant hairy

cultures/culture extracts were provided by Naprogenix Inc. Field grown plant material
was provided as dried, ground, and homogenized biomass. The biomass was extracted in
5 to 25 g batches using 200 mL of ACS grade methanol per 5 g of plant material.
Extractions were performed overnight (approximately 18 hours) in Erlenmeyer flasks
with constant stirring. The solvent from the biomass extraction was recovered via
vacuum filtration, reduced via rotary evaporation, and stored at 4o C. Transgenic hairy
root cultures were provided as methanolic extracts and prepared by Naprogenix Inc as
stated: Briefly, hairy root cultures were collected, rinsed to remove media with sterilized
water, and lyophilized. The lyophilized roots were ground to a fine powder and
transferred to a glass vial. The root powder was extracted with 5mL of MeOH per 100
mg of roots, and the vials were agitated for 24 h. The methanolic extraction was repeated
three times. The combined extracts were centrifuged at 20,000xg. The supernatant was
collected and stored in a freezer at -20o C until analyzed.
Prior to analysis or preparative HPLC separation, methanolic extracts underwent
liquid-liquid partitioning. The field grown plant material methanolic extracts were pooled
and diluted with ACS grade methanol (Fisher Scientific) to a concentration of 500±50 mg
of extracted material per 100 mL of methanol (final concertation of ~5 mg/mL) and 100
mL aliquot was transferred to a 2 L separatory funnel. The methanolic extracts were
further diluted with 200 mL of DI water and 25 mL of 1N HCl to a total volume of 325
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mL. Following the addition of aqueous acid, a liquid-liquid partition was performed 4X
with 400 mL of CHCl3 per partition. To break emulsions that appeared during the initial
partitioning of more concentrated extracts, a saturated NaCl solution was added in 10 mL
aliquots until the emulsion separated. Following each partition, the organic CHCl3 layer
was collected in a 1 L round bottom flask and the CHCl3 was recovered via rotary
evaporation. The remaining residue following rotary evaporation was discarded. The
aqueous acid extract layer was then made basic (pH 12) using 50 mL of 1N NaOH. The
basic aqueous solution was allowed to equilibrate at room temperature for 30 minutes and
was then partitioned 4X with 400 mL of CHCl3 per partition. The CHCl3 layer was
collected in a 500 mL round bottom flask and the volume was reduced via rotary
evaporation. Following volume reduction, the basic CHCl3 extract was reconstituted in
50 mL of ACS grade MeOH, 100 mL DI water, and 20 mL of HCl, total volume of 170
mL, and transferred to a 1 L separatory funnel. The aqueous acid extract was partitioned
2X with 250 mL of histological grade xylenes. The xylenes layer was removed and
discarded. The aqueous acid extract layer was then made basic (pH 12) using 40 mL of
1N NaOH and was extracted as listed above 2X with 200 mL of CHCl3 with the organic
layer being collected after each partition. The resulting basic CHCl3 extract, hereafter
referred to as the “ABCXC extract”, was collected, reduced to dryness via rotary
evaporation, and stored in the freezer at -18o C.
2.1.2

HPLC – Analytical and Preparatory Scale
Following liquid-liquid partitioning, dried ABCXC extracts were reconstituted in

appropriate volumes of HPLC-grade MeOH at concentrations specific to the method
being employed. For general analytical HPLC analysis, the extracts were diluted to
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approximately 1 mg/mL. For preparative HPLC separations, the extracts were diluted to
250 mg/mL. Both preparative and analytical HPLC experiments were performed using an
Agilent 1100 series binary solvent pump coupled to an Agilent 1100 series VWD for UV
detection. Injections were made using a Rheodyne injector with a 10 µL PEEK sample
loop for analytical HPLC analyses (5 or 10 µL injections) or a 200 µL stainless steel
sample loop for preparative separations (50, 100, or 200 µL injections). For both
separation procedures, the 260 nm channel was monitored on the VWD detector.
Analytical separations were performed using a Kromacil Eternity XT 5 µm C18 column
(4.6x150 mm). Preparative separations were performed using two different stationary
phase pHPLC columns; for bulk separations, a Phenomenex Luna 10 µm C18 column
(10x100 mm) was used, for high selectivity separations, a Restek Pinnacle BiPh 5um
biphenyl column (10x150 mm) was used. For analytical separations, a binary gradient
was employed over a 20 minute separation at a rate of 1 mL/min consisting of optima
grade water (solvent A) and optima grade acetonitrile (solvent b) (Fisher Scientific), both
with 0.1% formic acid, starting at 5% B for 2.5 minutes, increasing linearly to 95% B by
12 minutes, being held at 95% B until 16 minutes, and then returning back to starting
conditions, 5% B, by 18 minutes for equilibration. Preparative separations were
performed using column-specific isocratic gradients. For the C18 column, 25% B at a
rate of 5 mL/min was used for the entire 10 minute preparative separation. For the
biphenyl column, 10% B at a rate of 5 mL/min was used for the entire 10 minute
preparative separation. Both preparative columns were washed with 100% ACN w/ 0.1%
for 20 minutes after every four preparative separations and were equilibrated at their
respective organic content percentages for five column volumes following washings.
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Fractions corresponding to analyte peak elutions were collected during the pHPLC
separations. The collected fractions were basified to pH ~12 with 1N NaOH and
extracted with an equal volume of CHCl3 exhaustively. The CHCl3 was removed under a
stream of dry nitrogen and the purified material was stored in a freezer in sealed glass
vials at -18o C.
2.1.3

UHPLC-MS
Samples analyzed via UHPLC-MS were prepared several ways depending on the

nature of the analysis being performed. Prior to the extraction protocols listed above, raw
methanol extracts of both field grown plant material and transgenic hairy root material
were analyzed to establish a baseline for comparison post-liquid-liquid partitioning.
Aliquots of the methanolic extracts were diluted to 1 mg/mL with optima grade methanol.
An additional dilution was made to approximately 50 ug/mL in 1 mL of the appropriate
solvents corresponding to the HPLC gradient starting conditions (listed below).
Chromatographic separations were achieved using a Shimadzu Nexera X2 modular
UHPLC system (Torrance, CA) consisting of the following modules: SIL-30AC, LC30AD, CTO-20A, CBM-20A, and DGU-20A) coupled to either a Restek Pinnacle DB
Biphenyl UHPLC column (1.9 µm, 2.1x50 mm) or a Kromacil Eternity XT C18 UHPLC
column (2.5 µm, 2.1x50 mm). For the use of the Biphenyl column, chromatographic
separation was achieved over 20 minutes using solvent A (0.1% formic acid) and B
(0.1% formic acid in ACN) at 300 µL/min in a gradient flow method consisting of
solvent B at 20% for 2 minutes, increasing linearly to 95% by 14 minutes, being held at
95% until 17 minutes, and then returning to starting conditions by 18 minutes for
equilibration. For the use of the C18 column, chromatographic separation was achieved
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over 20 minutes also using solvent A (0.1% formic acid) and B (0.1% formic acid in
ACN) at 400 µL/min in a gradient flow method consisting of solvent B at 5% for 2.5
minutes, increasing linearly to 95% by 12 minutes, being held at 95% until 16 minutes,
and then returning to starting conditions by 18 minutes for equilibration. The UHPLCMS analyses were performed on a ThermoScientific Q Exactive High Resolution
Accurate Mass (HRAM) Orbitrap mass spectrometer. MS parameters for UHPLC
separations consisted of a scan range of 150 to 2000 m/z, a resolution of 140,000,
microscans set to 3 (~1.7 scans per second), and an AGC target of 3e6. Electrospray
ionization was achieved using a sheath gas flow of 15 L/min, a spray voltage of +3500,
an inlet capillary temperature of 350 oC, a HESI probe temperature of 280 oC.
Additionally, initial exploratory analyses were performed using a Hewlett-Packard series
1100 HPLC with an Agilent 300Extend-C18 column coupled to a Hewlett-Packard ESILCMSD. Chromatographic separations were performed over 36 minutes using solvents A
and B listed above at 750 µL/min in a gradient flow method consisting of solvent B at
10% for 5 minutes, increasing linearly to 90% by 28 minutes, being held at 90% until 30
minutes, and then returning to starting conditions by 32 minutes for equilibration. MS
parameters for these exploratory separations consisted of a scan range of 100 to 600 m/z.
Electrospray ionization was achieved using a sheath gas flow of 12 L/min, a spray
voltage of +3500, and a nebulizer gas temperature of 300 oC.
2.1.4

Microfluidic CZE-MS analysis
Dried methanolic extracts of wild type (WT) hairy roots, virally transformed

hDAT mutants (DAT+) hairy roots, and induced gain of function DAT+ mutants (MUT –
mutant LOB479) of L. cardinalis hairy roots were obtained by Naprogenix Inc. Extracts
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were prepared using a scaled-down version of the liquid-liquid partition listed above as
follows: Aliquots of the dried extracts were weighed and reconstituted in MeOH to
produce 1 mg/mL solutions. A 250 μL aliquot of each sample was diluted in 200 μL of
optima H2O and acidified with 50 mM HCl to pH 2. The acidified extracts were
partitioned with 500 μL of CHCl3 and the organic layer was removed. The pH of the
aqueous layer was increased to pH 10 with 100 mM NaOH and extracted again with 500
μL of CHCl3. The organic layer was collected and reduced to dryness under a stream of
dry nitrogen. The dried CHCl3 extracts were reconstituted in 250 μL of the 908 Devices
metabolites diluent and transferred into autosampler vials with 300 μL inserts for
analysis. Each sample was analyzed in triplicate.
Microfluidic CZE-MS analyses were performed using an HS variety ZipChip
housed in the ZipChip Interface (ZCI) mounted to the inlet of the mass spectrometer.
Each sample was delivered via an accompanying autosampler to the sample well and
loaded into the sample channel for 24 seconds (5.00 nL - default HS Metabolites
method). The sample set was analyzed using the predefined standard HS Metabolites
method, field strength: 1000 V/cm, pressure assist start time: 2.00 minutes. All
separations were performed for 3.00 minutes with approximately three minutes of pre-run
time to transfer the sample from the autosampler to the ZCI. The background electrolyte
was refreshed after every three samples. The ZCI was coupled to a ThermoFisher Q
Exactive HRAM Orbitrap Mass Spectrometer (Thermo Fisher Scientific, Waltham, MA,
USA). Acquisition parameters included a full scan range from m/z 70 to 600, mass
resolution of 17,500, microscans set to 1 (~8 scans per second), sheath gas flow set to 2.0
psi, and an AGC target of 3e6. For comparison to traditional CE-MS, analyses were
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performed on an abbreviated set of samples (triplicate sets of the WT and LOB479) using
a Prince CE100 Capillary Electrophoresis system was coupled to a Finnegan LCQ Deca
mass spectrometer. Electrophoretic separations were performed in a 67 cm fused silica
capillary (Polymicro Technologies) with an ID of 50 µm and an OD of 186 µm. BGE for
CE-MS (FA-BGE) was prepared as follow: 192.5 µL of formic acid was diluted to
100mL in optima H2O and then brought to pH 2.85 with 50mM ammonium formate
solution. The capillary was prepared by flowing 1N NaOH, optima H2O, EtOH, and FABGE each for 3 minutes at 1000 mbar and then FA-BGE again for 20 minutes at 50 mbar
with 25 kV applied. For sample analysis, the capillary was flushed with BGE for 3
minutes at 1000 mbar. Following flushing, the sample was loaded for 0.20 minutes at 100
mbar with 5 kV to mimic the sample loading conditions of the ZipChip. The separation
was then performed over 20 minutes at 50 mbar with 25 kV applied. A sheath fluid
consisting of 50/50 optima H2O and isopropanol was flown at the tip of the capillary in
the ESI source at 1.5 µL/min.
2.1.4.1 Analytical method validation – CZE-MS
A purified lobinaline standard was obtained using the preparative HPLC method
listed above. The subsequent purified lobinaline standard was used to create a calibration
curve for quantification of lobinaline in the plant extracts. Additionally, percent recovery
and the method detection limit (MDL) were assessed using this standard. For percent
recovery, following assessment of the lobinaline concentration naturally found in the
plant extracts, a known amount of lobinaline was spiked into six samples of dry plant
material. Spiked material was extracted and analyzed as stated above. The determined
concentration of the spiked extracts was compared to the theoretical concentration in
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order to assess the recovery percentage. For the MDL determination, the procedure
established by the Environmental Protection Agency (EPA), EPA 821-R-16-006, was
followed. Briefly, seven replicates of lobinaline spiked into surrogate matrices (Sedum
Acre dried plant extracts) at ten times (100 nM) the suspected limit of detection (10 nM)
were compared to seven blank surrogate extracts. This procedure was repeated on three
separate days. The resulting concentrations of lobinaline in the spiked population was
calculated and the standard deviation (S) of the concentrations was used in the following
equation.
𝑀𝑀𝑀𝑀𝑀𝑀𝑠𝑠 = 𝑡𝑡(𝑛𝑛−1,1−𝛼𝛼=0.99) 𝑆𝑆𝑠𝑠

2.1.4.2 Data processing via MZmine2 software

MZmine2 data processing was performed as reported by Olivon et al. with
modifications.90 Data files (.RAW) were converted to .mzXML files using the open
source MSConvert software prior to MZmine2 processing. For CZE-MS analyses, masses
were detected from 0.70-2.50 minutes with an exact mass detector and a noise level of
1.0e5. The mass list was then filtered with an FTMS shoulder peak filter using the
Gaussian function and a mass resolution of 17,500. Chromatograms were built from the
filtered mass lists from 0.70-2.50 minutes with a minimum duration of 0.00 minutes, a
minimum height of 1.5e6, and an m/z tolerance of 0.002. The resulting chromatogram
lists were then deconvoluted using a local minimum search with the following
parameters: a chromatographic threshold of 10.0%, a minimum RT of 0.01 minutes, a
minimum relative intensity of 15.0%, a minimum absolute height of 1.0e6, a minimum
ratio of peak top/edge of 5, and a peak duration range of 0.01 to 0.10. Following
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deconvolution, the electropherograms were then deisotoped with an m/z tolerance of
0.002, RT tolerance of 0.1 absolutes minutes, and represented by the most intense ion.
Alignment for comparison and data export was performed using the RANSAC alignment
tool with tolerances consistent with previous processes along with a threshold value of 1
and the minimum number of points set to 10%. Aligned lists were then gap-filled for
peaks with a 25% intensity tolerance and again with the m/z and RT range gap filler.
Three separate peak lists were then produced corresponding to 1) all features detected, 2)
features present in at least two of the replicates within the population, and 3) features
found in all three replicates for each population. The above workflow was also followed
for HPLC-MS/UHPLC-MS analyses, however time windows were adjusted to
accommodate the longer run times and wider retention time windows.
2.1.4.3 Targeted and untargeted CZE-MS/MS analysis
For microfluidic CZE separations coupled to MS/MS experiments, the separation
times were increased to 6.00 minutes and the initial applied field strength was reduced to
300 V/cm with a linearly increasing field strength gradient from 300 V/cm to 1000 V/cm
over the 6.00 minutes. Pressure assist was initiated at the 3.00 minute mark. Untargeted
MS/MS analyses were performed via the Xcalibur data-dependent acquisition (DDA, Full
MS/dd-MS2) module. Briefly, full scan acquisitions were acquired as listed above. For
the dd-MS2 parameters: a Top3 loop count with a 0.5 s dynamic exclusion was applied at
17,500 resolution with a 1e5 AGC target, 8e3 AGC minimum, 50 ms maximum IT, 2.0
m/z isolation window, and a fixed NCE of 30. Due to the ionization character of the
alkaloids of interest, doubly charged ions and isotopes were also excluded. An exclusion
list was also developed based on a blank full-scan analysis to prevent background ions or
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those attributed to contaminants in the BGE or diluent from being selected by the Top3
experiment. Targeted MS/MS analyses were performed via the Xcalibur Parallel
Reaction Monitoring (PRM) module. An inclusion list formulated based on the average
(n=6) retention times and durations for seven of the ions of interest was applied. All
applicable MS/MS parameters applied for the DDA were also applied for the PRM
experiment. Fragmentation was induced with either 35 or 40 normalized collision energy
(NCE). All analyses were performed in positive ion mode only, as stated previously.

Results and Discussion
2.1.5

Method Development and Characterization
To test the hypothesis that novel metabolites or changes in the observed

metabolite regulation were the source of the in vitro hDAT inhibition observed by
Naprogenix Inc, a metabolomics mass spectrometry-based analysis protocol was
developed to compare wild type, field grown L. cardinalis to transgenic mutants
expressing hDAT. Prior to mutant screening and metabolomic characterization,
preliminary range finding experiments were performed to develop efficient extraction
procedures of the plant material and reproducible chromatographic and electrophoretic
separations methods. Compared to the other member of the Lobelia genus, Lobelia
inflata, few articles have been published that focus on analyzing L. cardinalis since the
1960s.72,80,86 Due to the relatively unknown nature of this plant, developing a putative
“metabolites of interest” list to compare features observed across the mutant species was
crucial. Initial HPLC-MS (Agilent MS) analyses of methanol extracts of whole plant
material yielded mass lists consisting of few features aside from the primary metabolite
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produced by L. cardinalis, lobinaline (Figure 2.4). It was theorized that a majority of the
sample weight was contributed to chemical species outside of the analytical window such
as high-mass molecules (fats/waxes, peptides/proteins, macromolecules and chlorophyll)
or species better suited for different ionization methods such as negative ion mode ESI
(ex. glucosides and acidic molecules). To address this, additional extraction methods
needed to be employed prior to analysis in order to increase the signals of the putative
metabolites of interest, the alkaloids, without concentrating the other interfering
metabolites and possibly shortening the life of the HPLC components (blockages in
transfer lines, insoluble buildup on the front end of the column, binary pump degradation
due to pressure fluctuations, etc). Due to the basic nature of the nitrogen containing
alkaloids, an acidic/basic extraction was developed. A variety of acid/base combinations
and organic solvents were evaluated to determine the most effective, efficient, and
reproducible extraction procedure (discussed in further detail in section 2.3.2.1). It was
determined that, for analytical comparisons of the alkaloid containing fractions of the
cultures, using HCl and NaOH as the acidic and basic components, respectively, and
extracting with chloroform yielded the most comprehensive result. Following the
development of the extraction method, the next issue to be addressed was the analytical
separation method to be employed and coupled to the mass spectrometer.
2.1.5.1 UHPLC-MS method development and evaluation
Following the acid/base extraction, the plant extracts were enriched in
alkaloids/basic analytes and in a suitable state for characterization. Up to this point, all
range-finding analyses were performed on a nominal mass instrument (Aglient MS) with
a solving power of approximately 800 based on the full width at half max (FWHM) for
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an ion at m/z 400. Since little was known about the secondary metabolites produced by L.
cardinalis, a high-resolution accurate mass (HRAM) instrument, with a resolution of
140,000 for an ion at m/z 400 and the capability to accurately determine the mass of an
ion with higher precision (m/z 400 vs m/z 400.0000), was required to narrow down
putative empirical formulas of unknown secondary metabolites. To address this,
subsequent analyses were performed using the Thermo Q Exactive HRAM orbitrap mass
spectrometer. To contribute further robustness to the analysis, chromatographic
separations were performed using on a UHPLC system and column (Shimadzu Nexera)
rather than an HPLC (Agilent 1100 series). The primary difference in UHPLC
separations compared to HPLC separations is in the smaller particle size of the stationary
phase material of the former compared to the latter used inside the column. Recalling that
particle size is directly related to the A and C terms of the van Deemter equation,
reducing the particle size from 5-10 µm (HPLC) to 1.9 µm (UHPLC) can have a drastic
impact on the separation efficiency. As part of the instrument transition, column
stationary phase was also evaluated. Preliminary investigations employed a column
packed with a C18 stationary phase. Stationary phases consisting of phenyl ring or phenyl
ring-like structures were evaluated to determine if pi-stacking interactions between the
stationary phase and the phenyl rings of the lobinaline and lobinaline-like molecules
would enhance separation efficiency. The stationary phases evaluated were biphenyl
(BiPh), pentaflurophenylpropyl (PFPP), and phenylhexyl. The primary evaluation
critique used was the separation of lobinaline (C27H35N2 - m/z 387.2795) from what was
originally theorized to be an oxidized form of lobinaline (C27H35N2O – m/z 403.2740 –
Figure 2.6). A variety of mobile phase conditions, both isocratic and gradient flows, were
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evaluated and examples of the most efficient separations observed can be seen in Figure
2.7. As displayed in Figure 2.7, in terms of peak shape, the C18 column was unparalleled
presenting near baseline-resolved, gaussian distributed peaks. The BiPh column
displayed improved separation between lobinaline and the putative N-oxide, however, the
interaction with the stationary phase and the analytes resulted in band-broadening and
very asymmetric peak shapes, which can complicate back-end data processing. For the
PFPP and phenylhexyl columns, coelution of the two analytes and poor peak shape was
observed independent of whether gradient or isocratic conditions were utilized. Under
most chromatographic conditions, the analytes were retained on the PFPP and
phenylhexyl columns for the duration of the analysis and elution was only observed at
>90% organic (ACN with 0.1% formic acid). Due to the observations made during this
comparison, it was determined that the C18 column was the most suitable stationary
phase for the analyses. The coupling of the optimized UHPLC-HRAM-MS analysis to
the acid/base extraction allowed for increased sensitivity and better separations of
unknown secondary metabolites to begin fully characterizing the l. cardinalis extracts.
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Figure 2. 6 Possible putative structures of the m/z 403.2744 ion used for the evaluation of
the HPLC column separation efficiency evaluation.
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Figure 2. 7 Combined reconstructed ion chromatograms displaying the separation of
lobinaline (m/z 387.2795) from the putative oxidation product (m/z 403.2744) using four
different RP-HPLC columns.
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2.1.5.2 Characterization of Wild Type versus Mutant Strains – UHPLC-MS
Though little primary literature exists regarding L. cardinalis metabolism, it is
accepted that the plant produces lobinaline as a major secondary metabolite. Because of
this, lobinaline content was utilized as the primary screening qualifier during preliminary
GC-MS investigations performed by Naprogenix et al.81,82 Mutant strains were
characterized according to the quantified lobinaline content and then further categorized
as a function of their lobinaline content compared to the observed DA uptake inhibition
corresponding to each strain. Through their approach using GC-MS, they determined
that, though lobinaline content contributed to the observed activity, it could not be
responsible for 100% of the activity observed. The primary objective of our analyses was
to determine what, if anything other than lobinaline, was responsible for the increased
DAT inhibitory activity observed. In addition to the wild type and transgenic mutant
culture extracts, a population in which only the empty viral cassette was inserted (DAT-)
and a population in which hDAT was inserted but no gain-of-function mutations were
induced (DAT+) were also provided as comparison populations that had not undergone
selection.
Comparisons using UHPLC-MS primarily focused first on determining whether
or not prevalent differences were readily evident in base peak chromatograms. No
observable differences were noted between WT and the DAT- population, however,
significant, baseline-resolved differences were apparent in DAT+ and further intensified
in mutant strains compared to WT. Figure 2.8 displays stacked base peak chromatograms
for WT, DAT+ and a mutant strain LOB479 using both the C18 and the BiPh columns.
Note that all samples are produced using the same dry-weight mass of the methanolic
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Figure 2. 8 (Top 3 traces): Base peak chromatogram of WT, DAT+, and Mutant L.
cardinalis plant extracts using a C18 RP-HPLC column. (Bottom 3 traces): Base peak
chromatogram of WT, DAT+, and Mutant L. cardinalis plant extracts using a biphenyl
RP-HPLC column.
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extract (1 mg/mL) so variations in responses of metabolites common to the sample-set
are not attributed to differences in sample concentration, from a dry-weight basis.
Focusing on the C18 base peak chromatograms, the major peak across all populations at
~3.8 minutes corresponds to lobinaline. The mass spectrum for lobinaline can be seen is
Figure 2.9. Note that, in the mass spectrum for lobinaline, both the [M+H+] ion, m/z
387.2795, and the [M+2H+] ion, m/z 194.1436, can be seen in a ~1:2 ratio. This doubly
charged phenomenon, attributed to lobinaline’s the two basic nitrogen (pKa – simulated
using Chemicalize software - tetrahydropyridine nitrogen: 9.06, Nmethyldecahydroquinoline nitrogen: 10.22), was used as one of two motifs used to
identify putative lobinaline-like molecules (discussed in further detail in section 2.3.2).
The area counts for lobinaline increase 2-fold from WT to DAT+ and 5-10-fold from WT
to the mutant strains. In addition to relative increases in lobinaline content, several other
features were observed as baseline resolved peaks not readily apparent in WT cultures;
4.63 minutes – m/z 258.2426, 5.32 minutes – m/z 272.2583, 3.52 and 7.49 minutes – m/z
242.2115, and 4.31 minutes – m/z 403.2745 and m/z 202.1410. As stated in regards to the
column selection process, the ion present at 4.31 minutes, m/z 403.2745, was putatively
identified to have an empirical formula of C27H35N2O and displayed the same doublycharged motif as lobinaline (z=+2: m/z 202.1410). This further indicated that it was likely
a lobinaline-like molecule with the addition of an oxygen, such as an N-oxide, though
additional chemical and mass spectrometry-based assays needed to be performed to
provide further evidence for confirmation (see section 2.3.2.3). The data processing
software, MZmine2, was utilized to process the data in an attempt to identify trace
features not readily visible in the base peak chromatograms of the extract analyses,
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Figure 2. 9 Mass spectrum of lobinaline, m/z 387 (top), m/z 403 (middle), and m/z 419
(bottom) displaying both the single and doubly charged ions for all three analytes, a
common motif of binitrogenous "lobinaline-like" alkaloids.
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however, mainly due to variations in the baseline attributed to the chromatographic
mobile phase gradient (see Figure 2.8, top trace, for example of this increase) and other
inconsistencies, such variations in peak duration and peak asymmetries caused by
interactions with the stationary phase, generating accurate peak lists representative of the
WT and mutant cultures was not possible without significant, manual, post hoc
correction. Additionally, the multiply charged nature of many of the analytes further
complicated the process in that singly charged low mass species (~m/z 200) could be
mistaken for the z = +2 species of higher mass ions (lobinaline z = +2: 194.1415), or vice
versa. Though useful for qualitative identification of differences between the sample
populations, such as the relative increase in lobinaline and its putative N-oxide, and
initial development of peak lists containing features of interest, an alternative comparison
method was necessary to determine the presence of trance analytes. To address the issues
presented in the use of UHPLC-MS, the use of capillary electrophoresis was investigated
due to the high sensitivity and separation efficiency associated with the technique and the
reduced flowrate inducing a lower baseline, further aiding in chromatographic
deconvolution. Also, since the primary focus of this analysis is on small, basic molecules,
CE would be highly applicable as electrophoretic mobility is highly dependent on a
molecule being charged in solution.
2.1.5.3 CZE-MS method development and evaluation
As an alternative approach to using UHPLC for separations and comparison,
capillary electrophoresis was employed to semi-quantitatively assess the differences
between mutant L. cardinalis and WT plant extracts. Both traditional “macro” CE-MS
and microfluidic CZE-MS were evaluated for this approach (example base peak
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electropherograms can been seen in Figure 2.10). Due to instrumental constraints with the
“macro” CE-MS approach, i.e., incompatibility of the ionization source required to
couple the CE instrument to the high-resolution mass spectrometer, the microfluidic
CZE-MS approach was mainly utilized and the macro system was only employed to
determine whether or not CE would be applicable to the analytes of interest. Preliminary
CE-MS trials resulted in sharp, intense, and symmetrical peak-shapes for the ions of
interest previously identified using the UHPLC-MS approach, but little information in
regards to other secondary metabolites was observed, most likely due to the low
sensitivity of the instrument the CE was coupled to. The electrophoretic characteristics
observed of the analytes of interest, however, suggested that utilization of the CZE-MS
would most likely be an effective. As depicted in Figure 2.10, the CZE-MS approach
provided the same sharp, gaussian, and resolved peaks observed in the macro approach
but also introduced other features that were previously unnoticed amongst the baseline
noise. In addition, complex separations could be performed using the microfluidic CZEMS (3 minutes plus sample delivery) approach ~5-7x faster than using the macro-CE
approach (20 minutes plus sample delivery).
In order to make statistical comparisons, triplicate extracts from WT Lobelia
cardinalis hairy roots were analyzed and compared DAT+ mutant culture extracts and
extracts from a representative hDAT mutant culture that suggested to overproduce
protective alkaloids other than just lobinaline. Example base peak electropherograms for
each strain (WT, DAT+, and “Mutant”) are shown in Figure 2.11. Prior to any data
processing, notable differences were observed between the WT sample compared with
the DAT+ and mutant samples as observed in the UHPLC-MS approach. Five additional
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Figure 2. 10 Base peak electropherograms of the Mutant L. cardinalis extract using
macro CE-MS (top) and microfluidic CZE-MS (bottom).
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Figure 2. 11 Base peak electropherograms of WT, DAT+, and Mutant L. cardinalis
extracts using the microfluidic CZE-MS approach.
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peaks for the DAT+ and mutant were observable in the base peak electropherogram. It is
also noteworthy that all of the observed peaks elute between the 0.7 and 1.5-minute
marks making the entire separation approximately ten-times faster than the time required
for a standard HPLC separation of similar material.
To assess the robustness of this approach, intra-day precision of the microfluidic
CZE separation method was also evaluated. A WT extract was analyzed in analytical
triplicate immediately preceding the first blank analysis of the day (t=0) and then again in
triplicate approximately twelve hours later (t=12) with ~60 analyses in-between on the
same HS chip. Twelve hours was chosen as the limit due to the manufacturer stating the
BGE and diluents expire after twelve hours due to pH instability. For this assessment, the
area count and retention time of the lobinaline (m/z 387.2795 – C27H35N2) peak was
compared. At t=0, the average lobinaline area count was 2.4e10 with an RSD of 14% and
at t=12, the average area count was 2.5e10 with an RSD of 3%. Using a paired, two-tailed,
student t-test (α = 0.05) there was no statistical difference between these two means
(p=0.70). A similar trend was observed in the average retention times of the lobinaline
peak at 0.76 min (RSD = 1%) and 0.75 min (RSD = 2%) for the t=0 and t=12,
respectively. Here, again, no statistical difference was observed via the t-test (p=0.48).
This result suggests that the data acquired using this CZE-MS approach will not require
the same post-hoc manual correction that the UHPLC-MS approach required during the
data processing step.
2.1.5.4 MZmine2 data processing
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The .RAW data files corresponding to the triplicate analyses of the WT, DAT+,
and Mutant extracts were converted to .mzXML files and processed using the MZmine2
software following the workflow visualized in Figure 2.12 to increase the depth of
metabolite coverage. Using MZmine2 as a data-mining software, peak lists were
generated to allow for direct comparison between the strains both in the number of
features detected and in area counts corresponding to each of those features. Prior to peak
list generation, however, mass detection and chromatogram building must be performed.
For this data set, a low noise level was set in order to ensure that low intensity signals
corresponding to potential analytes in the samples were not discarded during processing.
Any features associated with background noise that were included in the mass list due to
the low noise level were processed out in a later step based on their peak duration. Here,
the CZE-MS approach was considerably more advantageous than the UHPLC-MS
approach as the baseline noise levels remain consistent throughout the analysis due to the
ESI spray conditions remaining consistent. Masses were also only detected during the
elution window starting with the elution of the leading electrolyte from the separation
channels at approximately 0.70 minutes. Following mass detection and noise filtering, the
resulting mass lists were converted into “chromatogram lists” for processing. Analyte
band compaction during the separation and focusing process in the separation channels
resulted in sharp, narrow electropherographic peaks with durations less than 0.1 minutes,
therefore, the duration parameter in the chromatogram builder module was set to 0.0
minutes as the software utilizes single decimal increments. The resulting peak lists were
then deconvoluted and deisotoped to remove the aforementioned background and noiserelated features and any features that are part of an isotopic distribution. The filtered
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electropherograms were then aligned using the RANSAC aligner tool to allow for direct
comparison of each feature based on common retention times and peak durations. Any
individual feature discarded in a prior process was then reclaimed using the gap-filling
modules. Lastly, any feature not present in at least two replicates was filtered out using a
peak list row filter.
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Figure 2. 12 MZmine2 workflow displaying the changes in the number of detected peaks
after using each module.
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2.1.5.5 Characterization of Wild Type versus Mutant Strains – CZE-MS
Using MZmine2, 139 unique, resolved peaks were detected that appeared in at
least two replicates of the same sample. This strict filtering approach was utilized to
reduce noise/spike related peaks and possible laboratory contaminants that were not
common to all the samples, especially those within each triplicate set. The WT, DAT+,
and mutant sample sets contained 136, 139, and 137 peaks, respectively observed in at
least two of the triplicate samples (full feature list with associated area counts appendix
1). This master peak list was then used to select several known or putatively identified
molecules of interest, such as those previously discussed, for a statistical comparison list.
Lobinaline and lobinaline-like derivatives, henceforth referred to as “lobinalines” were
initially set as top priority molecules due to the hDAT inhibitory activity of lobinaline
reported previously.81,82 The categorization of “lobinalines” was based on the calculated
empirical formulas of the detected features and the common motif that they all share in
the capability to become doubly charged molecules during electrospray ionization
experiments. Figure 2.9 shows an example mass spectrum of lobinaline (Figure 2.9 –
C27H34N2 MW=386.2722, m/z for z: +1 = 387.2795, m/z for z: +2 = 194.1438), the
putative N-oxide version of lobinaline (Figure 2.9B - C27H34N2O, m/z for z: +1 =
403.2740, m/z for z: +2 = 202.1410) and the putative bi-N-oxide (Figure 2.9C C27H34N2O2, m/z for z: +1 = 419.2693, m/z for z: +2 = 210.1387) displaying this
common charge state motif. Additionally, features considered to share similar
biosynthetic precursors to lobinaline, such as putative sedamine-like derivatives, and
those found in relatively high abundance within the samples (i.e., visible in the base
peak) were also added to the comparison list. Table 2.1 displays the final comparison list
80

of all the selected features with the corresponding average area count and relative
standard deviation. Correlating putative structures, as suggested by MS/MS
fragmentation patterns (discussed in more detail below), can be observed in Figure 2.13.
Average area counts for the lobinalines generally display an increasing trend from
the WT to the mutant sample sets. This observation fits with the overarching hypothesis
that lobinalines are protective agents against MPP+ toxicity used in L. cardinalis mutant
selection. The observed abundance increases for the N-oxide (m/z 403.2740 – peak 3)
and bi N-oxide (m/z 419.2693) versions of lobinaline are very promising since N-oxides
tend to increase hydrophilicity, making both molecules excellent targets for further study.
Structures for both m/z 130.1595 (Figure 2.11/2.13 - peak 3) and m/z 200.2362
(Figure 2.11/2.13 - peak 4) are putative and drawn as primary amines for simplicity.
Alternatively, secondary or tertiary amine structures would be equally probable. It
should be noted that m/z 129 [M+•] has been previously reported in a methanolic plant
extract analyzed by GC-MS therefore our observation of m/z 130.1595 [M+H+] was not
deemed a laboratory contaminant.91 Lastly, the lobeline-like molecules, peaks 5-11
(Figure 2.11/2.13) also displayed a generally increasing trend. Though lobeline (8,10diphenyllobelionol - C22H27NO2), the primary alkaloid produced by Lobelia inflata, itself
was not observed in these samples and has not been found in extracts of intact plant
material of L. cardinalis in the past, both lobinaline and lobeline derive from similar
precursors.81
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Table 2. 1 Average area counts and %RSD for each of the most abundant features
corresponding to the peaks in Figure 2.11.
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Figure 2. 13 Putative structures of interest. Group A represents lobinaline and lobinalinelike molecules. Group B consists of conjugated monoamines. Structures shown are
putative as multiple varying chain lengths are possible for both molecules. Group C
consists of lobeline-like molecules which are consistent with similar molecules found in
other Lobelia species.
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Molecules very similar to these have been reported in the literature to have activity both
on the DAT and on nicotinic acetylcholine receptors (nAChRs)17,18.
Preparative HPLC was used to isolate and purify a sample of lobinaline that was used to
develop calibration standards for analysis using the microfluidic device (Figure 2.14).
Based on the resulting calibration curve, the WT, DAT, and mutant extract samples were
found to contain 83±13 µM, 168±13 µM, and 256±15 µM lobinaline, respectively
(calculations for error in concentration values can be found in appendix 2). To translate
these concentrations into a whole plant basis, 1.64 g (wet weight) of hairy roots yielded
68 mg of methanol extractable material or 4.14% of the total mass of extractables.
Lobinaline comprised 3.2% of the methanol extractable material for WT or 0.13% of the
plant (wet weight basis). Similarly, lobinaline comprised 6.5% of the methanol
extractable material for DAT (0.27% plant basis), and 9.8% of the methanol extractable
material for the mutant (0.41% plant basis).
Additionally, the purified standard was also used to assess both the
percent recovery of the extraction method and the method detection limit. The percent
recovery was determined to be 99±22% based on the recovery of lobinaline spiked into
three separate WT samples and three separate mutant samples (6 total samples). The
variation observed in the recovery is most likely due to percent moisture (not determined)
in the plant material. For the MDL determination, lobinaline was spiked into powdered
Sedum acre plant material at a concentration of 100 nM. Following the EPA guidelines
for MDL determination, the MDL for this method was determined to be 74 nM. To make
a global comparison with WT, variations in isolation, extraction, and analysis of all
components must be controlled.
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Figure 2. 14 Calibration curve for the quantitation of lobinaline.
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Borrowing from quantitative western blot analysis, we evaluated the use of a “loading
control” to normalize our data. All nine data sets (3 each from WT, DAT+, and mutant)
were compiled and the variance for each of the detected peaks was calculated. The
putative monoamine (m/z 200.2363 – peak 5) was found to have the lowest variance and
was used as a normalization standard. Several bar graphs displaying normalized area
counts for the prioritized features can be seen in Figure 2.15. Normalized area counts for
all 139 features can also be seen in the appendix 1 list. Statistical analyses were
performed on the prioritized list using the GraphPad Prism 8 software. Tukey’s multiple
comparison test was utilized as a post-hoc test for the selected features of interest.
Statistically significant differences were observed for pairwise comparisons in fourteen of
the sixteen prioritized features. Figure 2.15 also displays the post-hoc test result in
significant differences denoted by stars () under the corresponding bar graphs. From
the resulting data set and statistical analyses, multiple putative features have been
selected as the potential source of the observed hDAT inhibitory activity.
Following the screening for ions of interest and evaluation of the microfluidic
device, tandem mass spectrometry methods were developed to acquire evidence to
support the putative structures. Here, both targeted and untargeted MS/MS was applied
for analysis of the representative mutant plant extract (Mutant). Prior to any MS/MS
experiments, adjustments to the separation method were made to increase the time in
which ions were present to allow for adequate sampling of each ion. The applied field
strength drives the separation event and analyte band compactions in the microfluidic
chip therefore lower field strengths were utilized to broaden the analyte peaks. At the
standard field strength of 1000 V/cm, for example, the lobinaline peak is 2.4 seconds
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Figure 2. 15 Normalized area counts of the sixteen prioritized peaks -  denotes
statistically significant based on post-hoc Tukey’s multiple comparisons test (ns- not
significant).
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wide, approximately 21 scans, under the most inclusive MS acquisition parameters.
Decreasing the field strength to 300 V/cm increases the peak to over 6 seconds wide
consisting of 74 scans. This also changes the retention time, however, increasing it from
0.76 minutes to 2.87. Reducing the field strength to this level also caused the slower
moving ions to remain within the separation channel during the allotted analysis time and
elute in subsequent analyses, regardless of the application of the pressure assist feature.
To address this, a field strength gradient was used. By increasing the field strength
linearly from 300 to 1000 V/cm over the 6 minute separation, peak widths were at least
doubled and no carry-over was observed. The development of this separation method
allowed the data-dependent analysis (DDA – untargeted MS/MS) and parallel reaction
monitoring (PRM – targeted MS/MS) experiments to be performed. For the targeted
MS/MS PRM inclusion list development, seven of the ions of interest were selected:
lobinaline and the mono- and bi- N-oxide versions and the lobeline-like molecule.
Tandem spectra can be found in appendix 3. Six full scan acquisitions were acquired to
record peak durations for each ion of interest. Using the average durations, the peaklist
table was constructed to minimize multiplexing (cycling between more than four ions at
once) while also preventing under-sampling (number of MS/MS scans for each ion: >5).
To compare the efficiency of these parameters, the average number of MS/MS scans for
each feature under both the PRM and DDA experiments was compared to the average
number of scans in which that feature was present in the full scan acquisition. Table 2.2
displays this comparison.
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Table 2. 2 Comparison of the number of times each feature was selected for both the
targeted (PRM) and untargeted (DDA) MS/MS.
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The PRM experiment resulted in >40% coverage of the ions compared to their prevalence
in the full scan experiments. Those with <25% coverage most likely eluted from the
separation channels during multiplexing events, specifically when alternating between
three or four ions at once, or outside of the calculated window. The latter is more likely,
due to retention time inconsistencies being prevalent in CE mobility experiments when
the capillary walls do not have a permanent coating, which is the case for the employed
device. Generally, with the PRM approach, under-sampling did not occur as each ion was
analyzed more than five times with the exception of m/z 419 and the first eluting m/z 242
isomer in the third trial. Conversely, the DDA analysis did not yield similar results.
Despite the usage of the exclusion list and a relatively short dynamic exclusion time, on
average only five of the nine ions of interest were sampled adequately. In some cases,
those with low abundance, such as m/z 419, were missed entirely. These results suggest
that microfluidic CZE is better suited for the targeted MS/MS approach rather than the
untargeted MS/MS approach, an aspect where UHPLC-MS outperforms CZE-MS. While
useful for major metabolites with substantial peaks in the sample, the untargeted
approach is not recommended for the identification of trace components via MS/MS with
the microfluidic device as even broadened bands are missed by the selection algorithm.
The resulting findings from this analysis led to the hypothesis that the lobinaline
N-oxide molecules, both the mono- and bi-N-oxides, were likely the source of the hDAT
inhibitory activity. The reasoning behind this hypothesis is multifaceted. Primarily, novel
inhibitory activity was observed by Naprogenix in their assays using lobinaline, however,
lobinaline is a highly non-polar molecule and has very poor solubility in water (simulated
Log Kow = 4.8, XLOGP3 and 5.6, Chemicalize). The N-oxidation of alkaloids often
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results in an increase in solubility. When performing their primary screening assays using
whole plant extracts, a highly aqueous buffer was used. Since the mutant strains contain
relatively higher quantities of the more hydrophilic lobinaline N-oxides, a higher
concentration of the lobinaline-like alkaloids was available to interact with the
transporter. Additionally, when characterizing their extracts, GC-MS was employed. The
high temperature of the GC inlet will convert N-oxides back to the free-base forms, just
as it would produce a dehydration product for an underivatized hydroxyl group. Due to
the non-covalent nature of an N-oxide association, N-oxides cannot be derivatized. This
aspect caused the N-oxide molecules to go undetected during their analyses leading to the
impression that the activity was not attributed to lobinaline. As this newly discovered
class of lobinalines was of interest for further hDAT inhibitory assays, and the
concentration of this class of secondary metabolites was comparatively high compared to
other identified metabolites, they were selected as the target of subsequent extractions,
purifications, and characterization assays.
2.1.6

Extraction, Isolation, and Analysis of Lobinalines
As the lobinaline and lobinaline-like molecules were identified as the probable

source of hDAT inhibitory activity, purification was required to produce high quality
purified material to be used in further in vitro assays, performed by Naprogenix, to
confirm if they are biologically active. Due to the high concentration of lobinaline in the
plant (3.8% w/w of the methanol extracts of the WT plants), purification of lobinaline
could be performed with relative ease using standard preparative HPLC methods.
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Figure 2. 16 HPLC chromatogram from the pHPLC purification of lobinaline and
lobinlaine N-oxide using the C18 column and UV-Vis detection.
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Following a large-scale acid/base chloroform partition, using a C18 preparative column
and an isocratic gradient, >95% pure lobinaline can be obtained by collecting the leading
half of the largest peak in the chromatogram (Figure 2.16). Two to three subsequent
passes of the collected fraction through the column yields a >99% pure lobinaline
standard. This, however, is not the case for the other lobinaline-like molecules. Assuming
equal response factors given the similarities between the analytes, lobinaline is anywhere
from ten to one thousand times more concentrated in the plant material than the other
secondary metabolites. Additionally, pHPLC conditions provided inadequate separation
of lobinaline from the other analytes of interest with the primary target, the mono-Noxide, always eluting as a shoulder on the tail of the lobinaline peak (Figure 2.16). This
aspect requires additional passes through the column to purify the N-oxide compared to
the number required to purify lobinaline and, due to the comparatively lower
concentration, results in low µg quantities once >90% purity is achieved owing to
diminishing returns. To address this, modifications were made to the front-end liquidliquid partitioning and reimplementation of the biphenyl column, at the preparative level,
was applied.
2.1.6.1 Large-scale Extraction and Purification
In order to simplify the process of producing large quantities of purified material,
specifically, purified lobinaline N-oxide, the liquid-liquid partitioning step was reevaluated. Though the previous acid/base chloroform (ABC) method was ideal for
analytical purposes, the concentration of lobinaline in the basic extract was at least one to
two orders of magnitude higher than the other features of interest detected.
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Figure 2. 17 (Top to bottom): RIC of lobinaline (m/z 387) in the DCM partition layer,
RIC of the lobinaline N-oxide (m/z 403) in the DCM partition layer, RIC of lobinaline in
the xylenes partition layer, and RIC of the lobinaline N-oxide in the xylene partition layer
showing that the N-oxide is more concentrated than lobinaline in the DCM layer than it is
in the xylene layer.

94

A series of modifications were tested and made to the workflow in order to selectively
extract lobinaline from the target molecules. Organic solvents of varying polarity were
evaluated against chloroform in terms of the relative ratios of the N-oxide to lobinaline as
determined by UHPLC-MS analysis. The solvents evaluated were: methylene chloride, nbutyl chloride, diethyl ether, toluene, xylenes, and ethyl acetate. Most of the solvents
(methylene chloride, n-butyl chloride, and diethyl ether) yielded near identical ratios of
the N-oxide to lobinaline to the use of chloroform except toluene and xylenes with the
latter, xylenes, resulting in ratios as high as 10:1, N-oxide to lobinaline (Figure 2.17 –
top), though averaging between 0.5:1 and 1:1. Note that due to the high boiling point of
xylene, it is used during the first half of the partition against aqueous acid, as the organic
layer in that step is discarded. The basic partition is still performed with chloroform. This
method is hereafter referred to as the “XC” partition. It is believed that increase in the
ratio of the N-oxide to lobinaline is most likely attributed to not only the highly nonpolar
nature of both of the phenyl ring-based solvent and lobinaline, but also to pi-stacking
interactions between the two phenyl rings of lobinaline and the solvent itself. Analysis of
the xylene layer displayed low levels of the lobinaline N-oxide compared to lobinaline
(Figure 2.17 – bottom), confirming that, though this approach is not explicitly specific for
lobinaline, the N-oxide group contributes significantly to the molecule’s comparatively
more polar nature and equilibrium favors the aqueous layer. Reproducibility, however,
was difficult when using toluene/xylene as the initial organic partitioning solvent. The
variation observed was believed to be due to the complexity of the matrix, consisting of
fats/waxes, sugars, and chlorophyll, interfering with the system equilibrium during the
pH changes and xylene partitioning step, i.e. formation of an emulsion. The ABC
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partition, using chloroform for both the acidic and basic partition, consistently yielded
reproducible results, as confirmed above during the CZE-MS method validation.
Additionally, even when scaled-up, the end chloroform and basic aqueous layers were
relatively clear aside from a deep yellow color observed in the aqueous layer.
Conversely, the end aqueous base layer, when using xylene as the initial solvent for the
acidic partition, was near opaque and brown/gold. In an attempt to address the
irreproducibility of the partition, the ABC partition was coupled to the XC partition. For
this approach, the chloroform from the basic ABC extraction was reduced to dryness and
the residue was reconstituted in aqueous acid before undergoing the XC extraction –
“ABCXC”. To assess the reproducibility, a triplicate partition evaluation using the same
stock extract and performed simultaneously yielded 0.35:1, 0.3:1, and 0.65:1, N-oxide to
lobinaline. Though the resulting ratios were on the lower end of the distribution (average
– 0.42:1 compared to 1:1-10:1 when using the XC method, alone), the end ABCXC
chloroform fractions were more reproducible, concentrated in lobinalines at a
manageable relative concentration, and contained few detected constituents outside of
other members of the “lobinalines” and “lobeline” classes of compounds. The
implementation of the ABCXC partition greatly reduced the difficulty associated with
using pHPLC to separate the N-oxide from lobinaline, especially since few other analytes
were present in the extracts. Additionally, as depicted in Figure 2.7, using an HPLC
column with a biphenyl stationary phase displayed better separation of lobinaline from
the N-oxide, though sacrificing peak shape. As separation is more significant for pHPLC,
a biphenyl preparative column was also utilized to reduce the risk of diminishing returns
resulting from coeluting peaks. Figure 2.18 displays an example of a standard separation
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using the C18 pHPLC column (top) and the biphenyl pHPLC column (bottom). For the
example C18 chromatogram, lobinaline elutes at 6.18 min and the N-oxide elutes and
6.38 min and for the example Biphenyl chromatogram, lobinaline elutes at ~4.75-5.5 min
and the N-oxide elutes, with separation of two putative isomers, at 6.52 and 7.09 min.
Under the applied conditions, the biphenyl column clearly outperforms the C18 for this
specific application in that sufficient separation of the N-oxide from lobinaline is
observed. Coupling of the ABCXC partitioning method to the use of the biphenyl
preparative HPLC column has led to nearly 200 mg of pure, natural N-oxide and >1 g of
pure, natural lobinaline, to be purified for characterization and pharmacological testing.

97

Figure 2. 18 (Top) Base peak chromatogram of the pHPLC purification of lobinaline and
lobinlaine N-oxide using the C18 column post ABCXC partitioning. (Bottom) Base peak
chromatogram of the pHPLC purification of lobinaline and lobinlaine N-oxide using the
biphenyl column post ABCXC partitioning.
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2.1.6.2 N-Oxide Characterization
Since little literature exists in regards to L. cardinalis secondary metabolites, initial
classification of the previously undetected m/z 403.2740 ion as an “N-oxide” was
hypothesized based on the calculated empirical formula. Supporting evidence of the
oxygen being present in the molecule as part of an N-oxide interaction, rather than a
hydroxyl, was provided through the lack of derivatization with BSTFA and, therefore, the
ion not being detected via GC-MS, however, further evidence was required. Both
chemical and analytical methods were employed to test this hypothesis.
For chemical reaction-based evidence, the first experiment performed was a
reduction reaction using Zn dust and HCl. Though unable to unequivocally determine if
the oxygen was present as an N-oxide and not a hydroxyl group, the Zn/HCl reaction was
intended to confirm that that the oxygen was not involved in the ring structure of the
molecule. Using a column purified standard of the putative N-oxide (~95%), the reaction
resulted in near full conversion to the free base as depicted in Figure 2.19. Note that the
retention time of the lobinaline produced in the reduction reaction matches the retention
of the small lobinaline impurity detected in the “before” sample, suggesting homology of
the two analytes. In addition to this reaction, the inverse was also performed in
chemically converting lobinaline to the putative N-oxide. This reaction was performed
using the peroxy acid metachloroperoxybenzoic acid (mCPBA). Due to the two basic
nitrogen atoms in lobinaline, this reaction produced both the N-oxide of interest, a monoN-oxide, and the bi-N-oxide (structure A8 in Figure 2.13, m/z 419.2693, z =
+1/210.1382, z = +2).
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Figure 2. 19 (Top to bottom): RIC of lobinaline prior to Zn/HCl reduction of the N-oxide
showing trace levels, RIC of the N-oxide prior to Zn/HCl reduction, RIC of lobinaline
post-Zn/HCl reduction, RIC of the N-oxde post-Zn/HCl reduction showing trace levels.
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This putative bi-N-oxide is also found in plant material, however, at concentrations 1-2
orders of magnitude lower than the mono-N-oxide and, therefore, several orders of
magnitude lower than lobinaline. Figure 2.20 displays this reaction in four reconstructed
ion chromatograms. The top trace, for simplicity, represents the “before” pure lobinaline
sample with the channels corresponding to the mono and bi-N-oxides also selected
showing that they are not present in the sample. The bottom three traces present
lobinaline, the mono-N-oxide, and the bi-N-oxide respectively. As depicted, assuming a
1:1 relative response factor, the N-oxide signal is approximately 3/4th that of lobinaline
whereas it was not present in the before sample. In addition, the putative N-oxide
produced has the same retention time as that of the natural N-oxide found in the plant
material (Figure 2.21). This was also observed when another lab member, Masoumeh
Dorrani, reacted pure lobinaline with hydrogen peroxide and ammonium bicarbonate.
The reaction performed by lab member Dorrani yielded complete conversion of
lobinaline to the putative N-oxide, and bi-N-oxide when coupled with a rhenium-based
catalyst, and the resulting compounds have also been isolated for pharmacological testing
to compare them to the results observed using natural N-oxide.
In addition to the aforementioned chemical confirmation experiments, several
analytical experiments were also performed to characterize the putative N-oxide. The first
regarded the hydrophobicity of the analyte. A common characteristic of N-oxides is
increased hydrophilicity compared to their free-base counterparts. Lobinaline has a
reported simulated Log Kow of 4.8 (XLOGP3) and 5.6 (Chemicalize), inferring it is
highly nonpolar and hydrophobic.
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Figure 2. 20 (Top to bottom): combined RIC of lobinaline, lobinaline N-oxide, and
lobinaline bi-N-oxide prior to mCPBA treatment showing one major peak, RIC of
lobinaline post-mCPBA conversion, RIC of the lobinaline N-oxide post-mCPBA
conversion, and RIC of the lobinaline bi-N-oxide post-mCPBA conversion.
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Figure 2. 21 Comparison of the RICs for the natural lobinaline N-oxide and the semisynthetic lobinaline N-oxide.
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The addition of an N-oxide would drastically increase the polarity of the molecule,
comparable to that of a quaternary ammonium salt. To test this, the Log Kow was
determined following the OECD method 117 guidelines for Log Kow determination via
HPLC relative retention time using isocratic separations with varying organic
percentages. The system was evaluated using a seven point calibration curve consisting
of the experimental determined Log Kw values and the accepted Log Kow values of 4methylbenzyl alcohol, p-cresol, 4-methoxyphenol, ethylbenzene, anisole, benzyl
benzoate, and benzyl alcohol – R2 = 0.9724. Using this curve, the Log Kow of the N-oxide
was determined, from the observed Log Kw, to be 1.29 ± 0.19, drastically lower than that
of lobinaline.
Tandem mass spectrometry was also utilized to characterize lobinaline and the
putative N-oxide analytes. The fragmentation pattern of lobinaline was compared to the
fragments produced from the N-oxide precursor ions in order to determine if any
fragments could provide evidence to the location of the oxygen within their respective
molecular structures. Though N-oxide bonds are generally the most labile bonds in the
system, and therefore are usually dissociated immediately when subjected to MS/MS
experiments, their presence could cause shifts in the relative abundances of observed
fragment ions. Additionally, if the oxygen atoms were involved in a covalent bond rather
than as an N-oxide, such as a hydroxyl/phenol or methoxy group, fragment species
corresponding to those precursors would likely be present. Figure 2.22 displays stacked
MS/MS spectra for lobinaline (top), m/z 403.2740 (middle), and m/z 419.2693 (bottom).
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Figure 2. 22 Tandem MS/MS spectra of lobinaline (m/z 387 - top), the lobinaline N-oxide
(m/z 403 - middle), and the lobinaline bi-N-oxide (m/z 419 - bottom).
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As depicted in Figure 2.22, lobinaline displays a characteristic cross-ring cleavage
through the decahydroquinoline ring resulting in the m/z 387 → 186 and m/z 387 → 200
fragmentations to be the predominant fragment ions observed. Additionally, m/z 387 →
304, representing the loss of the tetrahydropyridine ring is also observed as a major
fragment along with a variation of the aforementioned cross-ring cleavage resulting in
m/z 387 → 212. These possible fragmentation patterns can be seen in Figure 2.23. In
viewing and comparing the MS/MS spectra of the three precursor ions, it appears that
there are a number of different fragment ions in the N-oxide/bi-N-oxide spectra compared
to the lobinaline spectrum, however, almost all of the ions overlap. The overt difference
between the spectra is actually predominantly in the relative abundances of the ions
rather than in their presence/absence. Lists of the top 50 fragment ions for each precursor
were generated and compared using excel (only 2 decimals shown to account for slight
variations in mass defects resulting from the loss of the lock mass during MS/MS
experiments) – Table 2.3. Fragment ion lists were compared pair-wise (387 v 403, 387 v
419, and 403 v 419) and fragments that were not present in both sets were denoted as
seen in table 2.3. Two of the differences can be attributed to the loss of water when the
N-oxide bond is dissociated, 419 → 401 and 403 → 385. Again, possible structures for
the fragments highlighted in table 2.3 can be seen in Figure 2.24. Interestingly, three low
abundance fragment ions of the putative bi-N-oxide were calculated to each contain
oxygen, m/z 419 → 372, 419 → 228, and 419 → 247.

106

Table 2. 3 MS/MS Fragmentation list for lobinaline (387), lobinaline N-oxide (403), and
lobinaline bi-N-oxide
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Figure 2. 23 Possible structures for the lobinaline MS/MS fragment ions.

108

Figure 2. 24 Possible structures for the lobinaline N-oxide MS/MS fragment ions.
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The m/z 372 (structure 9, Figure 2.24) and m/z 228 (structure 10-1 and 10-2, Figure 2.24)
fragments, also present in the m/z 403 peak list, contained only one oxygen based on
their calculated empirical formula and the m/z 419 → 247 fragment was calculated to
contain two oxygens according to it’s calculated formula. N-oxides can undergo 1,2
rearrangement, known as the Meisenheimer rearrangement, (structure 10.2, Figure 2.24)
when exposed to a heat source, such as the HESI probe or the inlet capillary, therefore it
is possible that the rearrangement could have occurred to stabilize the N-oxide interaction
and produce those fragments, especially given their low relative abundance. Furthermore,
if the oxygens were present as formal bonds, fragments corresponding to the
characteristic cross-ring cleavage would likely be present with the addition of an oxygen.
Though m/z 202.12 (m/z 186 + 16) is present for both N-oxides, it is also present in
lobinaline, therefore it is likely not attributed to the addition of an oxygen, Likewise, a
m/z 216 (m/z 200 +16) fragment is not present. Though not conclusive evidence to
completely rule out the possibility of the oxygen atoms being involved in formal bonds,
the lack of apparent fragmentation patterns consisting of the addition of oxygen
compared to those found in lobinaline, as well as the supporting data collected from the
semi-synthetic production of the N-oxide, supports the interactions being present as Noxide bonds.

Conclusion
The aim of this chapter was to develop a metabolomic profiling method to
characterize wild type and transgenic mutant L. cardinalis secondary metabolites. This
was performed by developing an extraction and analysis protocol centering around the
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utilization of a microfluidic CZE-MS device. This microfluidic CZE-MS device allowed
for both a fast and sensitive high-throughput method for the screening of secondary
metabolites, specifically plant alkaloids. Previous alkaloid MS screening assays
traditionally rely on HPLC or GC as a separation method. These methods can be, not
only time consuming, but also be unsuitable for the separation certain compounds and
lack the capability of isomeric separation. Here, the utilization of the microfluidic chip
displayed that more efficient separation can be achieved in approximately half the time or
more compared with other methods. When coupled with processing software like
MZmine2, the process is further streamlined resulting in a fast, comprehensive assay for
plant secondary metabolites. These characteristics are particularly valuable for the use
described here in which it is essential to rapidly compare alkaloid profiles in many
different plant extracts in very small sample volumes. This method enables the
identification and separation of novel putatively bioactive metabolites from transgenic
mutant plant cells. The metabolites identified in this work, the lobinaline mono- and biN-oxide, have become a novel source of lead compounds for the pharmaceutical industry
and are currently being tested for pharmacological activity.
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CHAPTER 3. MASS SPECTROMETRY-BASED METHOD DEVELOPMENT FOR THE ANALYSIS
OF PHENOLIC SECONDARY METABOLITES
Introduction
Phenolic plant metabolites are the most widely abundant secondary metabolites found
within the plant kingdom and consist of a wide variety of subclasses, each with unique and
specific roles.11,92 The general requirement for the classification is an aromatic ring with
an associated hydroxyl group (phenolic), however, many natural phenols are much more
conjugated. Figure 3.1 displays generalized carbon backbones of simple monomeric
phenolic secondary metabolites. In nature, these metabolites are often cyclic with bridging
oxygens as well (see Figure 3.1 - C6-C3-C6 flavonoid substructure), aiding to the diversity
and complexity of the class. In addition to existing as single subunit metabolites, these
molecules are also polymerized into varying sized polyphenolic oligomers such as
procyanidins (2-3 flavonoids), tannins (5+ gallic acids linked to a glucoside with further
conjugation), and lignin, one of the three primary structural components of woody plants
(100+ varying linkages of three monolignol subunits). Aside from the structural aspect of
phenolics in lignin, plant phenolics also act as defense agents against both biotic (antibiotic
and antifeeding activity) and abiotic (antioxidant and UVB-blocking) insults.11,92–94
Additionally, smaller phenylpropanol-derived phenols act as attractants for pollinators due
to the color and scent that they confer to the plant.11,94 Conversely to alkaloids, as seen in
chapter 2, many monomeric phenolics can share a degree of homology between unrelated
species.94 Two examples of this would be resveratrol, a stilbene, and quercetin, a flavonoid,
which can be found in a large variety of plants, many of which are commonly consumed
by both humans and animals (grapes, berries, leafy greens, etc).11,93–96

Figure 3. 1 Base carbon structures for phenolic secondary metabolites with examples.97
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Aiding to the homology, most phenolics are generally biosynthesized through fairly
conserved pathways.94 The primary pathways include the shikimate pathway, converting
shikimic acid to tyrosine or phenylalanine, followed by the phenylpropanoid pathway,
which converts the resulting Tyr and Phe to courmaic or cinnamic acid, respectively, and
the polyketide pathway. These biosynthetic pathways (Figure 3.2) generated most of the
aforementioned phenolic classes such as flavonoids, stilbenes, and lignins (shikimate and
phenylpropanoid) and anthraquinones (polyketide).
In addition to phenolic secondary metabolites roles in plants, they are also of
interest to humans as natural pharmaceuticals, as discussed with alkaloids in chapter 2.
Stilbene compounds have a variety of applications as antioxidants, as well as cancer
chemo-preventive agents.98,11 Flavonoids also have been evaluated as anti-cancer, antiinflammatory, and cardiovascular disease therapeutics.11,96,98 Additionally, most phenolic
compounds all share a varying degree of antimicrobial activity, another desirable
application of the metabolite class.11,98 Their commonalities across various edible plants
and fruits and existence in fruit-based beverages, such as wine, has led to their increased
consumption in recent years due to the discovery of the benefits associated with them.96
In recent years, another subclass of phenolic metabolites, the cannabinoids produced by
the genus cannabis, have been the subject of much investigation and controversy.
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Figure 3. 2 Simplified biosynthetic pathway for the phenolic compounds of interest in
this work.
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Cannabinoids, the phenolic secondary metabolites of Cannabis sativa, Cannabis
indica, and Cannabis ruderalis, have been increasingly the subject of much scientific,
political, and ethical controversy, especially in the past decade. The most commonly
studied and abundant cannabinoids (Figure 3.3) present in the Cannabis plant are
cannabidiol (CBD), cannabigerol (CBG), cannabinol (CBN), cannabichromene (CBC),
and Δ9 -tetrahydrocannabinol (Δ9THC) and their corresponding carboxylic acid
precursors as they exist in the plant.99–101 The medicinal aspect of cannabinoids has been
the driving factor of their interest in recent years. Cannabinoids such as CBD, CBN,
CBG, and CBC have shown degrees of activity including anti-inflammatory, analgesic,
anticonvulsant, antipsychotic, and antibiotic activity, making the class very
pharmacologically attractive as a whole.95,99,101–104 Unfortunately, the reason for the
controversy that has plagued the use of Cannabis throughout history is the psychoactive
attributes of one of the primary cannabinoids, Δ9THC.99 This psychoactive attribute has
led to legality constraints placed on cannabis cultivars. In states where the recreational
use of cannabis is still illegal, such as here in KY, a legal classification of the plants is
placed according to their Δ9THC content. According to the 2018 KY farm bill, which
legalized the use of specific cannabis products, cannabis extracts and products can be
deemed as “hemp” products if they contain less than 0.3% Δ9THC w/w%.99,103,105,106 This
determination can be made using a number of analytical techniques, mainly LC-UV, GCMS, or LC-MS.99,103 In accordance with the initial passing of the bill in KY, a mass
influx of local testing companies were established to accommodate the equally large
influx of cultivators and producers setting up in the state.
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Figure 3. 3 Twelve of the cannabinoid class of phenolic secondary metabolites produced
by Cannabis genus plants.
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With no standardized analysis method and the only guideline being a Δ9THC content
limit, inter-lab variation quickly led to many products entering the market outside legal
limitations due to poor analytical method construction, inexperience, and driving factors
such as selected use of agencies consistently under-reporting results to drive produces to
market. The focus of the first aspect of the work found in this chapter was to utilize
example methods corresponding to the three commonly employed analytical approaches,
LC-UV, GC-MS, and LC-MS. The hypothesis of this aspect of the chapter was that the
sources of variation, specifically intra-laboratory and inter-instrumental variation, could
be determined and reduced and, if reduction was not possible, then the mechanisms
responsible could at least be understood and accounted for to minimize variation. Given
that the cannabinoid industry is projected to be a $20+ billion dollar industry by 2022, it
is absolutely crucial that accurate, reproducible, and sensitive methods are developed and
adopted on a federal level to assist in the further ethical and scientific development of the
industry.99
The second aspect of this chapter focuses more on the global metabolomic
analysis of phenolics rather than just of a specific subclass like the cannabinoids. Here,
the development of new analytical methods for the analysis of Polygonum multiflorum
was performed. This research, also in collaboration with Naprogenix LLC (Lexington,
KY) (see chapter 2), focuses on the characterization of p. multiflorum extracts in search
of potential novel compounds resulting from the expression of alpha-synuclein in
transgenic p. multiflorum hairy roots. Literature suggests that the phenolic compounds
produced by p. multiflorum (Figure 3.4), such as TSG, emodin, and physcion, may
present an inhibitory effect on the aggregation of alpha-synuclein into Lewy bodies,
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which are believed to be one of the primary causes of Parkinson’s disease.107–109 In
employing the transgenic plant technology described in chapter 2, Naprogenix is
currently in the process of developing these transgenic p. multiflorum alpha synuclein
hairy root cultures to develop novel therapeutics to potentially treat or halt the
progression of the disease. As these cultures are still in development, the focus of this
work was to analyze whole WT plant extracts to develop a baseline metabolomic
database for future comparisons. In addition to database development, further
development of CE-MS methods for the high-throughput characterization and analysis of
these phenolic compound-rich extracts was also developed. Despite the chemical
attributes of these metabolites making them unideal for electrophoretic separation, the
hypothesis was that certain modifications could allow for the application of capillary
electrophoresis for the analysis of these extracts. Both the potential downstream
pharmaceutical application of this work and the analytical application of CE-MS for
phenolic analytes, which are typically difficult to analyze via CE, are important aspects
of the work performed in the second part of this chapter.
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Figure 3. 4 Polyphenolic compounds of interest produced by Polygonum multiflorum.
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Materials, Methods and Instrumentation
3.1.1

Cannabinoid Potency Testing Evaluation
Analytical cannabinoid reference standards, cannabidivarin (CBDV),

tetrahydrocannabivarin (THCV), cannabichromene (CBC), cannabigerol (CBG),
cannabinol (CBN), cannibindiolic acid (CBDA), cannabinidiol (CBD),
tetrahydrocannabinolic acid (THCA), and ∆8 and ∆9-tetrahydrocannabinol (∆8/∆9-THC),
were purchased from Caymen Chemical (Ann Arbor, MI) as 1 mg/mL solutions as
defined by U.S. Drug Enforcement Administration (DEA) guidelines. Optima H2O,
acetonitrile, methanol and formic acid were purchased from Fisher Scientific (Waltham,
MA). Hemp biomass and an ethanol hemp extract were donated by a local processor in
Lexington, KY. Additional ethanol extracts were provided by Eastern Kentucky
Extractions (Jenkins, KY). Three commercial CBD products were also obtained: a
tincture gel pill and MCT oil tincture from Ananda Hemp (Cynthiana, KY) and a CBD
lotion from BluLeaf Naturals (Lexington, KY).
Cannabinoid potency profiles were generated using three instrumental
approaches: HPLC-UV, GC-MS, and UHPLC-MS. HPLC-UV analyses were performed
using a Hewlett Packard 1100 series UV detector and binary pump coupled to a
Rheodyne manual injector. Separations were performed using a Kromacil C18 column
(4.6 x 150 mm) with a 5 µm particle size. An isocratic gradient consisting of 20% water
with 0.1% formic acid and 80% ACN with 0.1% formic acid at 1.5 mL/min for 12
minutes was employed for the separation. For UV detection, 280 nm was monitored. GCMS analyses were performed using a Hewlett Packard 6890 series GC coupled to an
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Agilent 5973 MS detector. A DB-5HT column (15 meter, 0.10 µm film thickness, 0.250
mm ID) was used with an injector temperature of 260 oC with a 50:1 split and a column
over temperature gradient starting at 50 oC for 3 minutes, increasing by 50 oC to 100 oC
and then holding for 1 minute, then increasing by 15 oC per minute to 280 oC. The oven
was held at 280 oC for 5 minutes (22 minutes total) before returning to starting
temperatures for the next analysis. For MS analysis, ions corresponding to the ten
aforementioned standards were monitored in time dependent SIM mode in which the 5
most abundant fragment ions were used for quantitation. For UHPLC-MS analysis,
separations were performed using a Shimazdu Nexera X2 UHPLC system with a
Kromacil EternityXT C18 column (2.5 µm, 2.1x100 mm). The chromatographic
separation consisted of solvent A (0.1% formic acid in H2O) and B (0.1% formic acid in
ACN) in a gradient flow method starting with solvent B at 55% for 2 minutes, increasing
linearly to 95% over 6 minutes, being held at 95% for 2 minutes, and then returning to
starting conditions for equilibration. The UHPLC-MS analyses were performed on a
Thermo Scientific Q Exactive Orbitrap High-Resolution Accurate Mass (HRAM) Mass
Spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) equipped with a heated
electrospray ionization (HESI) ionization source. Data acquisition was performed in the
positive ion mode with a mass range of m/z 100-800 the following parameters: 10 L/min
sheath gas flow and 4 L/min auxiliary gas flow, inlet capillary temperature of 280 oC and
auxiliary gas temperature (HESI probe temperature) of 280 oC, 3kV spray voltage, scan
resolution of 140,000 with a 3 Hz scan rate, a 3e6 AGC target, and a maxium IT of 200
µs.
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For unprocessed sample preparation, dried hemp plant buds were ground with a
mortar and pestle to a powder and extracted with ethanol exhaustively. The ethanol was
filtered via vacuum filtration to remove residual insoluble biomass and reduced to
dryness via rotary evaporation. The resulting extract was reconstituted in Optima
methanol at 1 mg/mL and analyzed via HPLC-UV without further dilution (5 µL
injections). For UHPLC-MS analyses, samples were further diluted to 10 µg/mL in 50/50
ACN/H2O with 0.1% formic acid (5 µL injections). For GC-MS analysis, a 50 µL aliquot
of the 1 mg/mL extract was reduced to dryness in an autosampler vial insert under a
stream of nitrogen. The sample was reconstituted with 50 µL of a 50/50 BSTFA/pyridine
solution and incubated for 20 minutes at 60 oC for derivatization. Following
derivatization, the samples were analyzed without further dilution (5 µL injections). For
processed sample preparation, 500 mg (wet weight) of ground biomass was dried in an
oven at 60 oC for 30 minutes. The dried biomass was suspended in 5 mL of ACN with
2% formic acid in a 15 mL polypropylene tube. The suspension was diluted with 5 mL of
DI water and shaken for 1 hour at room temperature. A QuEChERS extraction was
performed using the Waters DisQuE AOAC method extraction salts (sodium acetate and
magnesium sulfate). To the 10 mL solution, 1.5 g of the DisQuE salts were added. The
extraction was vortexed for 1 minute and separated via centrifugation. The ACN layer
was collected and filtered with a 0.22 µm nylon filter. The filtered ACN extract was then
loaded onto a prewashed Waters Oasis HLB SPE cartridge. The first 500 µL of flow
through from the cartridge was discarded and the remaining 4.5 mL of the “flow through”
was collected and reduced to dryness under nitrogen. The SPE cartridge was washed with
3 mL of MeOH and the eluent was collected, added to the dried “flow-through” sample,
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and also reduced to dryness. The dried, post-SPE extract was reconstituted in 5 mL of
ACN and stored at -18 oC overnight to precipitate fats and waxes in a “fat crash”. The
post-“fat crash” extract was dried under nitrogen then decarboxylated via heating in an
oven at 120 oC for 24 hours. Following the heat conversion, the samples were
reconstituted as listed above and analyzed. Aliquots (50 µL) from each treatment step
were also collected for quantitation to assess sample loss.
For potency profiles, calibrations curves were generated for the ten standards
listed above spanning at least three orders of magnitude; 10 – 1000 µg/mL for GC and
HPLC-UV, and 10 ng - 100 µg/mL for UHPLC-MS. Provided ethanol extracts were
prepared for analysis as stated above for the ethanol extracts. The tincture encapsulated in
the gel pill was removed with a syringe and transfer to an amber autosampler vial. Both
the MCT tincture and gel pill tincture were diluted 1:10 (1:100 for UHPLC-MS). For the
lotion analysis, the DisQuE extraction listed above was used, with modifications. Briefly,
one “pump” of lotion (~2 mL, suggested usage amount) was suspended in 5 mL of DI
H2O in a 15 mL polypropylene tube. The aqueous sample was further diluted with 5 mL
of ACN. Approximately 1.5 g of the DisQuE salts were added to the tube and the sample
was vortexed for 1 minute. Following vortexing, the sample was centrifuged in a clinical
centrifuge for 10 minutes. The top ACN layer was collected and stored overnight at -18
o

C to crash out any residual fats/waxes. The resulting ACN solution was reduced to

dryness under nitrogen gas, reconstituted in 1 mL of optima MeOH, and diluted 1:10 for
HPLC-UV and GC-MS (derivatized as stated above) analysis and 1:100 for UHPLC-MS
analysis. Calculated concentrations were generated on a mg cannabinoid per 1 mg
extract/product basis.
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3.1.2

HESI Source Induced Degradation of CBDA and THCA
Prior to the performance of the degradation assay, the four cannabinoid standards

were analyzed individually to confirm purity and again as a mixture via UHPLC-MS as
stated above. Following purity confirmation via chromatographic separation, CBDA and
THCA were analyzed individually to assess the rate of instrumental temperature-induced
degradation. Each carboxylic acid cannabinoid was evaluated using both an infusion flow
rate-based approach (5 µL/min – designated as “low flow rate”) via direct infusion and an
LC flow rate-based approach (300 µL/min – designated as “high flow rate”) utilizing
flow-injection analysis (FIA).
For the low flow rate analysis, the standards were individually infused at a
concentration of 5 µg/mL in 50/50 ACN/H2O with 0.1% formic acid. Degradation
induced by either the HESI probe or the inlet capillary was evaluated independently by
varying the temperature of one component while holding the temperature of the other
constant. For evaluation of the HESI probe, the inlet capillary temperature was held
constant at 150 oC while the HESI probe was incrementally increased from 50 oC to 250
o

C in 25 oC increments. Following each temperature increase, the system was allowed to

reach equilibrium as determined by a stabilization in the TIC variation (<5% variation).
Once stabilization was established, 15 scans were acquired and averaged to determine the
ratio of the intact mass (m/z 359) to the degradation products (m/z 341 and 315). A
similar approach was followed for the evaluation of degradation induced by the heat of
the inlet capillary where the HESI probe temperature was held at ambient temperature,
approximately 40 oC, and the inlet capillary temperature was increased from 150 oC to
300 oC in 25 oC increments.
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For the high flow rate analysis, a flow injection analysis (FIA) approach was
utilized by coupling a rheodyne injector to the line supplying a representative mobile
phase, 50/50 ACN/H2O with 0.1% formic acid, to the mass spectrometer by the UHPLC
as defined above. Again, both the degradation induced by the HESI probe and the inlet
capillary were evaluated independently. For evaluation of the HESI probe, the inlet
capillary temperature was held constant at 250 oC, to accommodate for the desolvation
required by increased flow rate, while the HESI probe was incrementally increased from
250 oC to 400 oC in 25 oC increments. Three separate injections were performed at each
temperature increment with time in-between to allow for the signals corresponding to the
intact mass (m/z 359) to reduce to pre-injection baseline levels. Degradation rates were
determined using the ratios of the area counts associated with the peaks corresponding to
the intact carboxylic acid mass (m/z 359) and the two degradation products (m/z 341 and
315). The inlet capillary was evaluated using the same temperature increment patterns as
the HESI probe (250 oC to 400 oC) with the probe being maintained at 250 oC to
accommodate the increased flow rate.
Additionally, solvent composition aiding in the rate of degradation under the high
flow rate conditions was evaluated by analyzing the carboxylic acid cannabinoids in both
50:50 and 75:25 ACN or MeOH to H2O with 0.1% formic acid. For this analysis, only
the HESI probe was evaluated with the inlet capillary temperature being held as 250 oC
while the probe was increased from 250 oC to 400 oC in 50 oC increments.
3.1.3

Polygonum Multiflorum Extraction and Analysis
Standards of the following P. multiflorum secondary metabolites were purchased

from Sigma Aldrich (St. Louis, MO): tetrahydroxystilbene glucoside (TSG),
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rhaponiticin, polydatin, resveratrol, quercetin, emodin, and physcion. The following
lignin model compounds were synthesized and provided by Lynn group member Poorya
Kamali: H, G, and S monolignol, H, G, and S monolignol ethyl esters, and the G-β-O-4G dimer. Commercial p. multiflorum plant material was provided by Naprogenix
(Lexington, KY). The P. multiflorum plants were removed from the potting soil and the
roots were cut from the stem. The stems and leaves (~250 mg) were rinsed with DI water
and separated at the axial bud. For the root preparation, the branch roots were removed
from the primary taproots and discarded. The taproot (100-200mg) was washed
thoroughly with DI water and again with 50% EtOH to remove residual soil. The roots,
leaves, and stems were cut into <1 cm sections and individually ground to a paste with a
mortar and pestle and liquid nitrogen. The ground roots, stems, and leaves were extracted
with up to 20 mL 80% EtOH (~10 mg/mL), individually, overnight on a magnetic stirrer.
The extracts were centrifuged and filtered with a 0.22 µm syringe filter. Samples were
analyzed both individually and pooled via UHPLC-MS analysis. Separations were
performed using a Shimazdu Nexera X2 UHPLC system with a Kromacil EternityXT
C18 column (1.9 µm, 2.1x50 mm). The chromatographic separation consisted of solvent
A (H2O) and B (ACN) in a gradient flow method starting with solvent B at 5% for 2.5
minutes, increasing linearly to 95% by 12 minutes, being held at 95% for 4 minutes, and
then returning to starting conditions by 18 minutes for a 2 minute equilibration, 20
minutes total. The UHPLC-MS analyses were performed on a Thermo Scientific Q
Exactive Orbitrap High-Resolution Accurate Mass (HRAM) Mass Spectrometer (Thermo
Fisher Scientific, Waltham, MA, USA) equipped with a heated electrospray ionization
(HESI) ionization source. Data acquisition was performed in the negative ion mode with
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a mass range of m/z 100-1000 the following parameters: 10 L/min sheath gas flow and 4
L/min auxiliary gas flow, inlet capillary temperature of 280 oC and auxiliary gas
temperature (HESI probe temperature) of 280 oC, 3kV spray voltage, scan resolution of
140,000 with a 3 Hz scan rate, a 3e6 AGC target, and a maximum IT of 200 µs. For
targeted PRM MS/MS analyses, the above method was utilized and an inclusion list was
generated based off of the observed RTs. Selected NCE levels were determined
experimentally via infusion of the individual standards at 10 ug/mL concentrations in
50% methanol.
3.1.4

Dansylation of Polyphenolic Compounds
Cannabinoid and p. multiflorum standards were prepared at 1 mg/mL

concentrations in MeOH with the exception of emodin and physcion which were
prepared in acetone. For each dansylation reaction, 500 µL of the standard solution was
added to a glass 1.5 mL autosampler vial with 250 µL of a 10 mg/mL dansyl chloride
(approximately 5-fold molar excess) solution in ACN and 500 µl 50 mM Na carbonate
buffer (pH 9.4). The reaction mixture was incubated at 60 oC for 2 hours in a water bath.
Following incubation, unreacted dansyl chloride was quenched with 5 µL methylamine
and incubated, again at 60 oC for 30 minutes. Once the reaction was quenched, the
products were extracted with chloroform and ethyl acetate and reduced to dryness prior to
analysis. The products were verified using UHPLC-MS and tandem mass spectrometry,
as stated above, and via flow injection analysis, also as stated above – see “high flow-rate
analysis”. Dansylated standards were also analyzed via CE/CZE-MS using the 908
Devices ZipChip, see below.
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3.1.5

Modified microfluidic CZE-MS
For modified microfluidic CE-MS analyses of unmodified and dansylated

polyphenolic compounds, the 908 Devices Zipchip was employed. A prototype “bare”
HR chip (HRB) in which the capillary walls were stripped of the aminopropyltriethoxysilane coating was supplied by 908 Devices. For negative ion separation of unmodified
polyphenolics, a basic BGE was developed consisting 10% isopropyl alcohol, 10 mM
ammonium acetate, 0.04% ammonium hydroxide, pH 8.5. For lithium assisted positive
ion separation, a Li-based BGE and sample diluent were developed consisting of 20%
isopropyl alcohol, 10% ACN, 100 µM LiCl for the BGE and 80% methanol, 10 mM
LiCl for the diluent. Basic separations were evaluated on the HRB chip using a field
strength ranging from -145 V/cm to -100 V/cm with 1 nL sample injections. Li-assisted
separations were evaluated on both the HS and HRB chips. For HS separations, field
strengths employed ranged from 0 V/cm to 1000 V/cm with 1nL injections. For HRB
separations, field strengths employed ranged from 0 V/cm to 500 V/cm with 0.5 nL
injections. Pressure assist was utilized for all separations. All analyses were performed
using a Thermo Q Exactive HRAM mass spectrometer with the same parameters as listed
above except the mass range was adjusted to m/z 100 to 1000.

Results and Discussion
3.1.6

Cannabinoid Potency Testing Evaluation
The goal of the first part of this chapter was to evaluate the use of HPLC-UV,

GC-MS, and UHPLC-MS in regards to their application for cannabinoid potency testing.
As HPLC-UV is considered the “gold standard” for potency testing, the results from both
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mass spectrometry-based approaches were compared to the HPLC-UV results in terms of
calculated concentration accuracy, reproducibility, sensitivity, and selectivity.
Calibration curves were generated, using each approach, for quantitation of the
selected cannabinoids (Figure 3.3) representing the most common and abundant
cannabinoids found in CBD/cannabis products. Figures 3.5-3.7 display resulting
chromatograms for samples containing equimolar concentrations of the cannabinoid
standards (3.5 – HPLC-UV, 3.6 – GC-MS, 3.7 – UHPLC-MS). Representative calibration
curves can also be seen for each method displaying CBD and THC. All three methods
displayed great linearity for the calibration curves with R2 values all greater than 0.95
with most greater than 0.99. Differences in limits of quantitation (LOQs) for each method
were observed at this point with the HPLC-UV at 100 ng/mL, the GC-MS at 10 µg/mL,
and the UHPLC-MS at 10 ng/mL. The UHPLC-MS method displayed the greatest
sensitivity due to the high resolving power of the instrument allowing for the accurate
mass detection and limiting the impact of noise-related mass peaks near the analyte’s
m/z. Due to the nature of the analytes, specifically the carboxylic acid cannabinoids, the
sensitivity could have been further increased if the analysis was performed in negative
ion mode, however, to maintain consistency with the industrial standard HPLC-UV
method, which uses formic acid in the mobile phase, positive ion mode was selected.
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Figure 3. 5 (Top) Base peak chromatogram for the separation of ten cannabinoid
standards using HPLC-UV detection. (Bottom) Calibration curve for THC and CBD
displaying similar linear response factors for the two cannabinoid subclasses.
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Figure 3. 6 (Top) Base peak chromatogram for the separation of ten cannabinoid
standards using GC-MS detection. (Bottom) Calibration curve for THC and CBD
displaying differing linear response factors for the two cannabinoid subclasses
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Figure 3. 7 (Top) Base peak chromatogram for the separation of ten cannabinoid
standards using UHPLC-MS detection. (Bottom) Calibration curve for THC and CBD
displaying differing linear response factors for the two cannabinoid subclasses.
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Unexpectedly, the HPLC-UV approach appeared to be more sensitive than the GC-MS
approach. A possible explanation for this could be the intense absorbance response of the
cannabinoids at the selected wavelength, 280 nm, due to the aromatic ring moieties of the
analytes. This could also be due to the high heat of the inlet of the GC causing
degradation of the analytes. As depicted in Figure 3.6, at equimolar concentrations, the
peaks corresponding to CBDA and THCA are much lower than those corresponding to
their naturally decarboxylated counterparts, CBD and THC. Though the BSTFA
derivatization (Figure 3.8) is intended to prevent decarboxylation, the reaction may not be
as effective on the acids as it is for the phenolic -OH groups, thus leading to an easily
dissociated, unprotected carboxylic acid. Differences were also observed in the selectivity
of the chromatographic methods used, as well. At equimolar concentrations, baseline
resolution of specific analytes could not be achieved, regardless of any method
modifications tested. For both HPLC and UHPLC, the THC isomers could not be fully
resolved from each other. Generally, for mass spectral approaches, this is less of an issue
as RICs can be generated, as seen in Figure 3.7, but in this case, both analytes have the
exact same m/z. From an application standpoint, ∆8-THC is, on average, at trace levels in
plant extracts, if present at all, therefore this drawback was not deemed to be detrimental
for either method. The selectivity can be improved for the ∆8/∆9 isomers, however, by
altering the mobile phase conditions. This is not ideal as it drastically affects peak shape
and selectivity of the method for other analytes (coelution, peak tailing, etc). In the event
that ∆8-THC is detected, the sample would need to be analyzed twice, once using the
normal method, and again using the optimized method for ∆8/∆9-THC separation.
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Figure 3. 8 BSTFA derivatized cannabinoid structures.
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Additionally, it is worth noting that for GC-MS, CBC and ∆8-THC coelute at higher
concentrations. Though both analytes share the same m/z for their molecular ion ([M+•]=
m/z 386), their fragmentation patterns differ, allowing for chromatographic
deconvolution – CBC: m/z 386 → 304, 303, 246, 231; ∆8-THC: m/z 386 → 343, 330,
303, 265, 246. The ionization process utilized by GC-MS, which induces this
fragmentation, is ideal for the analysis of analytes like the cannabinoids. The
phytocannabinoid family consist of several structural isomers (CBD/THC/CBC,
CBDA/THCA/CBCA/, CBDV/THCV, etc), however, their fragmentation patterns can be
found in common databases such as the NIST database to ease the process of
identification and chromatographic deconvolution.
To assess reproducibility and potency profile accuracy, all three methods were
applied to the EtOH extracts and commercial products. Table 3.1 displays the
quantitation results, on a mg cannabinoid per mg extract/sample basis following analysis
and corrections for dilutions. In terms of mg total cannabinoids per mg sample, the results
were similar across all three methods with the exception of the GC-MS results in regard
to the tincture and gel pill samples. Though both samples totaled the lowest in total
cannabinoids, <50 ug/mg, the GC-MS results were nearly twice that observed for the
HPLC-UV and UHPLC-MS methods. This can most likely be attributed to a matrixeffect as the samples were diluted, rather than extracted, from products containing high
concentrations of oils like MCT oil. Compared to the other products, however, the
calculated total cannabinoid profile of these two products was approximately 10X lower
and predominantly composed of CBD.
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Table 3. 1 Cannabinoid quantitation results for three extracts and three commercial products.
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The primary application of the cannabinoid potency screenings performed by
various testing agencies is to determine the legality of cannabis-products, as ∆9-THC is
considered an illicit substance. In order for a product to be considered legal in the state of
KY, according to the 2018 Farm Bill, it cannot contain more than 0.3% total THC w/w%.
For this calculation, the quantified mass of THCA is multiplied by 0.877 to take into
account its conversion to ∆9-THC in the body and added to the calculated THC
concentration:
𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 𝑇𝑇𝑇𝑇𝑇𝑇 = ∆9 𝑇𝑇𝑇𝑇𝑇𝑇 + (𝑇𝑇𝑇𝑇𝑇𝑇𝑇𝑇 × 0.877)

A similar equation is used for CBD concentration calculations with its respective
carboxylic acids. Table 3.2 displays the w/w% calculated for CBD and THC in the
products using all three methods with this displayed graphically in Figure 3.9. For
products like the in-house made EtOH extract and the commercial EtOH extracts, being
slightly above the 0.3% total THC is common as the extracts will be further diluted when
converted into final commercial products. An interesting trend was observed in that, for
the HPLC-UV method, all the calculated total THC resulted from THCA whereas with
both GC-MS and UHPLC-MS, no THCA was detected and only ∆9-THC was detected at
concentrations above the limit of quantification. For GC-MS, it is possible for
interconversion of THCA to ∆9-THC to occur in the inlet of the GC, as stated above, or
decarboxylation during derivatization as the reaction is performed at an elevated
temperature.
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Table 3. 2 CBD and THC quantitation as w/w% for the extracts and samples. Red texts
denotes THC w/w% greater than the legal limit for sale in the state of KY.
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Figure 3. 9 (Top) CBD (left) and THC (right) w/w% percentages with error bars associated with standard deviation. (Bottom) CBD
(left) and THC (right) w/w% percentages normalized to HPLC-UV results with error bars associated with standard deviation.
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This would not be the case for UHPLC-MS, however, as any decarboxylation that would
occur as a result of heat would be after chromatographic separation during the
electrospray process, therefore it would not contribute to the observed THC response. As
RICs were used for quantitation in UHPLC-MS, corresponding to the intact mass, any
post-column degradation would have an effect on the observed THCA and CBDA
response, however, discussed further in section 3.1.7. If post-column degradation were
the case, as hypothesized, it would explain why the THC and CBD content, as
determined by UHPLC-MS, is significantly lower than that calculated by the other two
methods for a majority of the samples. As depicted in Figure 3.9, there is little agreement
between the total CBD and total THC concentrations determined by each method,
especially evident when normalized to the HPLC-UV results. Compared to GC-MS,
HPLC-UV underrepresented CBD statistically (p<0.05) in all samples except the inhouse extract and the lotion, and THC in the in-house extract (not detected), one of the
commercial extracts, and greatly (7X) in the lotion. In using HPLC-UV to produce a
potency profile for the lotion, the product would be considered legal to sell, however,
according to the GC-MS results, the product contains 5X the legal concentration of total
THC. Though likely more accurate for THC determination that HPLC-UV, the method
lacked precision, as apparent in the relative size of the error bars in Figure 3.9. As stated
previously, this is likely due to conversion of THCA to THC during the derivatization
process and conversion of underivatized THCA to THC in the inlet of the GC causing
inconsistent responses for both analytes. For UHPLC-MS potency profiling, the opposite
is observed from GC-MS. The cannabinoid profiles were similar to those generated using
HPLC-UV and the RSDs were all relatively low, suggesting both accuracy and precision
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for this method, when compared to the HPLC-UV results. Here, again, we see that, for
the lotion, the total THC concentration was determined to be outside the legal limit
whereas it was below the limit when UV detection is used. The total THC content
determined using the UHPLC-MS method may even be underrepresenting the THC
content as THCA was detected using the UV method and not using the MS method, due
to possible degradation or poor ionization efficiency.
Though standard HPLC with UV detection is preferred in the cannabis industrial
for cannabinoid profiling, it is clear that it may not be an accurate enough method for
determining low levels of THC in a product. Though deemed below the legal limit both
by an accredited testing agency and using our HPLC-UV method, the CBD lotion was
determined to have well over the legal concentration of total THC using both mass
spectrometry-based methods. Unfortunately, the cannabinoid profiles generated using
both of the MS approaches did not display statistical similarity, with the GC-MS
potentially overestimating the results, with poor reproducibility, and the UHPLC-MS
method, while more sensitive to the low-level cannabinoids like CBG and CBDV,
potentially slightly underestimating the results. In order for accurate profiles to be
generated, either ancillary methods need to be developed and employed to confirm results
generated by the UV method, or the reason for the UHPLC-MS method underestimation
needs to be determined and corrected. The latter is addressed in the section below.
3.1.7

Source-Induced degradation of CBDA and THCA
During initial investigations and cannabinoid profiling method assessments

involving the carboxylic acid cannabinoids, THCA and CBDA, evidence of instrumentinduced thermal degradation was observed. This was initially discovered when plotting
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reconstructed ion chromatograms (RIC) of CBD and THC (m/z 315.2318) post analysis
of a sample containing all four of the cannabinoids, CBDA, CBD, THCA, and ∆9-THC.
Two low intensity peaks corresponding to CBD and THC, m/z 315.2318, were observed
to be co-eluting with the m/z 359.2216 peaks despite also being resolved as standalone
peaks. This trend was confirmed when analyzing the carboxylic acid cannabinoid
standards independently via UHPLC-MS. Upon further investigation of the mass
spectrums of CBDA and THCA, an ion at m/z 341.2112 was also observed for both
cannabinoids generating similar peaks to the carboxylic acids when plotted as a
reconstructed ion chromatogram (Figure 3.10 - RICs, Figure 3.11 - example mass
spectrum of THCA). The appearance of these two ions was hypothesized to be induced
by the usage of high temperatures provided by the heated electrospray ionization (HESI)
probe in aiding desolvation during the ionization process when coupling the UHPLC to
the mass spectrometer. To determine the source of the degradation, the carboxylic acid
cannabinoids were analyzed under various spray conditions to assess the rate in
degradation.
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Figure 3. 10 (Top) RICs for m/z 359, 341, and 315 from a mix sample consisting of
THCA, CBDA, CBD, and THC. (Middle) RICs for m/z 359, 341, and 315 from a sample
consisting on THCA only. (Bottom) RICs for m/z 359, 341, and 315 from a sample
consisting on CBDA only.
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Figure 3. 11 Mass spectrum of the THCA peak displaying THCA (m/z 359), THC (m/z 315), and an unknown degradative
product (m/z 341).
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Evaluation of the rate of the instrument-induced degradation was first performed
at low flow rates utilizing an “infusion” approach for assessment. Though infusion is not
typical for cannabinoid profiling, the low flow rate (5 µL/min) through the HESI probe
maximizes the time in contact with the heating element – approximately 13 seconds (0.22
minutes) for a 130 mm HESI probe. This approach was intended to elucidate the
maximum extent degradation would occur when employing the HESI probe to aid in
desolvation. The rate of degradation was determined by recording the ratio of the
intensity of the intact mass ion to the intensities of the degradation product ions. Fifteen
scans were acquired at each temperature increment to allow for adequate sampling when
averaging the intensities. Perturbations in the total ion current (TIC) were present during
the temperature increase and for a short time immediately following the temperature
stabilization, therefore sufficient time was allotted at each temperature increment to allow
for the TIC variation to stabilize to ~5% variation. In addition to the assessment of the
HESI probe inducing degradation, the mass spectrometer inlet capillary temperature was
also examined. For the inlet capillary assessment, the HESI probe temperature control
was disengaged and allowed to reach ambient temperature, however, the probes’
proximity to the inlet capillary prevented the probe temperature from reaching
temperatures lower than ~40 oC. Figure 3.12 displays graphs plotting the ratio of the
degradation products to the intact carboxylic acid cannabinoids.
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Figure 3. 12 Low flow rate (infusion) degradation analysis. Top left: THCA degradation
with varying inlet capillary temperature. Top right: CBDA degradation with varying inlet
capillary temperature. Bottom left: THCA degradation with varying HESI probe
temperature. Bottom right: CBDA degradation with varying HESI probe temperature.
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At low flow rates, varying the inlet capillary temperature resulted in minimal
degradation of the carboxylic acids to their degradation products, even at the maximum
temperature employed, 300 oC. The highest observed ratio of the degradation products to
the intact carboxylic acid was ~0.16:1 for CBDA. The slight upward increase in the
degradation trend observed for the low flow inlet capillary experiment is believed to be
due to an increase in response brought about by improved desolvation rather than by an
increase degradation, though this is difficult to prove given that standards the degradation
products representing the loss of H2O (-18.0105) are not commercially available and the
total degradation is largely attributed to an increase in their total signal. Conversely, the
HESI probe had the opposite effect. Near the mid-temperature range, ~225 oC, the
decarboxylated product intensity increased with the ratio reaching as high as ~10:1 for
THCA and ~50:1 for CBDA at the maximum temperature. The rate of the loss of H2O
remained relatively constant at higher temperatures when varying the HESI probe
temperature. This product was believed to be the result of the loss of H2O following
protonation occurring at the carboxylic acid functional group (Figure 3.13), which would
have dissociated at those temperatures, generating an acylium ion. Gas-phase conversion,
at high temperatures, of carboxylic acids to acylium ions has been reported in literature,
therefore it was hypothesized that the cannabinoid acids may be forming these ions
during the high temperature electrospray and desolvation process.110–113 To test this,
MS/MS analyses were performed on the cannabinoid acids, their putative acylium ions,
and their free forms to compare fragmentation patterns. Figure 3.14 displays all six
tandem spectra with putative empirical formulae for selected fragments.
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3.13 dehydration and decarb structures

Figure 3. 13 THCA and CBDA (m/z 359) structures and their heat induced degradation
products: the acylium ion (m/z 341) and the decarboxylated free cannabinoid (m/z 315).
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Figure 3. 14 MS/MS spectra of the cannabinoid acids (m/z 359) , the acylium ion (m/z
341), and the free cannabinoid (m/z 315) for THCA (top three traces) and CBDA (bottom
three traces), respectively.

150

As this analysis was acquired using a HRAM mass spectrometer, empirical formulas are
able to be generated for selected ions within 5 ppm of their theoretical mass.
Fragmentation patterns for the carboxylic acids and the putative acylium ions displayed
homology for both the THC and CBD classes of molecules. Note that most of the
empirical formulas for the fragments ions corresponding to THCA, CBDA, acylium THC
(aTHC), and acylium CBD (aCBD), have been calculated to contain three oxygen, while
the fragments for THC and CBD mostly contain two. This would suggest that the
phenolic -OH groups, shared by all six ions, are likely not the most labile bonds in the
system and that the single oxygen loss in fragment species observed for THCA, CBDA,
aTHC, and aCBD is likely attributed to the carboxylic acid. Carboxylic acids are usually
extremely labile, as depicted in the loss of the -COOH frequently observed in the
previous section, therefore it would be expected that the fragment ions observed during
MS/MS analysis of THCA and CBDA would be calculated to contain only two oxygen
atoms. Further evidence for this phenomenon can be observed in the following
fragmentation pattern, observed for both CBD and THC species: THC/CBD: m/z
315.2320 (C21H31O2) → 259.1691 (C17H23O2) and CBDA/THCA: m/z 359.2216
(C22H31O4) → 285.1486 (C18H21O3), a difference of H2O. The hydrogen atoms can be
accounted for in that CBD/THC would have one hydrogen where the carboxylic acid
attaches and the other would be lost in the acylium (C≡O+) formation as the functional
group is inherently charged and an [M+H+] species would not exist. This evidence
suggests that the occurring is actually due to the formation of an acylium ion during the
gas-phase ionization process.
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This approach, utilized for the evaluation of the HESI probe and the inlet capillary, was
then applied to a higher flow rate (300 µL/min – Figure 3.15) to assess if their effects
were evident on the carboxylic acid cannabinoids under conditions that emulate the
industry standard approach for cannabinoid profiling using HPLC. At this flow rate, the
time in which the analytes are in contact with the heating element of the HESI probe is
greatly reduced from ~13 seconds (0.22 minutes) to ~0.2 seconds (0.004 minutes). To
accommodate for the increased flow rate, the minimum temperature for both the HESI
probe and the mass spectrometer inlet capillary were greatly increased (250 oC) to
prevent moisture interaction with the interior components (S-len) of the instrument. Flow
injection analysis was utilized for this assessment allowing for area counts to be used for
the ratio determination rather than averaged scan-to-scan ion intensities. The reduced
time in contact with the HESI probe, even at the maximum employed HESI probe
temperature, resulted in reduced rates of degradation, as anticipated. At the typical
temperature ranges suggested for HESI probes at this flow rate, the ratio of the
degradation products to the intact acids averaged at ~0.2:1 with the ratios reach as high as
0.4:1 at the maximum temperature. Contrary to the observations made during the infusion
experiment, the inlet capillary temperature had an increased effect, especially for CBDA
with ratios as high as ~4:1 for the acylium ion.
To further assess the carboxylic acid cannabinoid dehydration and acylium ion
formation phenomenon, variations in solvent composition were also considered. Due to
the non-polar characteristic nature of the cannabinoids, higher organic percentages in
mobile phases are required to promote elution from standard reversed phase HPLC
columns as demonstrated in UHPLC gradient mentioned previously.
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Figure 3. 15 High flow rate (LC flow) degradation analysis. Top left: THCA degradation
with varying inlet capillary temperature. Top right: CBDA degradation with varying inlet
capillary temperature. Bottom left: THCA degradation with varying HESI probe
temperature.
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Additionally, due to economic factors, methanol is often utilized as the organic
component for HPLC separations rather than acetonitrile. Therefore, the high-flow rate
experiment was repeated at a higher organic percentage, 75% ACN rather than 50%, and
again with 50/50 and 75/25 MeOH: H2O w/ 0.1% formic acid. Acetonitrile has a higher
heat capacity (~92 J/mol*K than both water (~75 J/mol*K) and methanol (~81.5
J/mol*K) thus it was hypothesized that higher ACN percentages would reduce the rate of
degradation for the ACN/water analyses however, the rate of degradation observed for
the methanol/water experiments would be increased when compared. Figure 3.16 (ACN)
and 3.17 (MeOH) displays the graphical representations of the degradation rates of the
acids with varying mobile phases. As hypothesized, increased ACN concentrations
reduced the degradation rates from 0.25:1 to 0.2:1 for THCA and 0.4 to 0.25 for CBDA,
at the maximum temperature. The hypothesized outcome was not observed, however, for
the MeOH experiment. Despite having a lower heat capacity than acetonitrile, the rates of
degradation were not only lower than those observed when using acetonitrile, but also
consistent across organic concentrations: THCA – 0.16:1 for both 50% and 75% MeOH,
CBDA – 0.25:1 for both 50% and 75%. There are multiple possible explanations for this
phenomenon. The first involves the protic nature of MeOH as opposed to the aprotic
nature of ACN. Given that the solvent composition includes 0.1% formic acid,
approximately pH 2.7, according to Shi and Middlemiss, the gas and liquid-phase
conversion of carboxylic acids to acylium ions is driven towards the products at low pH,
however, in the presence of an alcohol, such as methanol, a Fischer Esterification can
occur.113 This would result in the formation of a stable ester as opposed to or in
conjunction with the formation of the acylium ion. For both acids, m/z 373.2373 would
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be observed if formation of the ester occurs in the presence of methanol. This can be
observed in Figure 3.18 wherein an example of the FIA series for CBDA in 75%
methanol can be seen. The top three RIC traces represent CBDA, the ester ion, and the
acylium ion, respectively. The bottom two traces show CBDA in 75% ACN displaying
no evidence of the m/z 373.2373 ion outside of baseline noise. This ester ion appears at
ratios as high as 0.06:1 for CBDA and 0.07:1 for THCA. Though low in comparison to
the acylium ion and decarboxylated product, this observation adds an addition factor to
be taken into consideration when quantifying cannabinoid acids. In addition to
esterification, methanol also has a higher vaporization enthalpy, 38.3 kJ/mol versus 33.8
kJ/mol for ACN. During the electrospray process, ionization efficiency, which also
contributes to signal intensity, is dependent on the rate of desolvation of the ions as
charged species. As the formation of the acylium ion is hypothesized to be a gas-phase
event, the reduced vaporization enthalpy would imply that, when using ACN, the
analytes are desolvated earlier than they are when using MeOH. This would not only
have an impact on the rate of acylium formation, it could also induce an artificial
inflation of the observed ratios, as the relative signal intensities would be higher when
using ACN than MeOH. The possible formation of the ester product and the acylium ion
and the overall reduction in the signal response paired with the overall poor elutropic
strength of MeOH (1 εo) compared to ACN (3.1 εo) would suggest that, though even at
the lowest operating temperatures, the acylium ion appears, ACN is still the better suited
solvent for cannabinoid profiling. As quantitation of the byproduct is currently not
possible due to the lack of a commercial standard or method of synthesis, the best course
of action would be for profilers to treat the acylium ion, and other degradative products,
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as one would for the doubly and singly charged ions of a molecule possible of forming
such species, in quantitation and use a summation of the area counts to represent the
response of the molecule.
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Figure 3. 16 ACN - High flow rate (LC flow) degradation analysis. Top left: THCA
degradation with varying inlet capillary temperature at 50% ACN. Top right: THCA
degradation with varying inlet capillary temperature at 75% ACN Bottom left: CBDA
degradation with varying inlet capillary temperature at 50% ACN Bottom right: CBDA
degradation with varying inlet capillary temperature at 75% ACN.
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Figure 3. 17 MeOH - High flow rate (LC flow) degradation analysis. Top left: THCA
degradation with varying inlet capillary temperature at 50% MeOH. Top right: THCA
degradation with varying inlet capillary temperature at 75% MeOH Bottom left: CBDA
degradation with varying inlet capillary temperature at 50% MeOH Bottom right: CBDA
degradation with varying inlet capillary temperature at 75% MeOH.
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Figure 3. 18 (Top to bottom): Top three traces - FIA segment RIC for m/z 359 (CBDA),
m/z 373 (putative CBDA methyl ester), and m/z 341 (acylium ion) for MeOH mobile
phase. Bottom two traces – FIA segment RIC for m/z 359 (CBDA) and m/z 373 (methyl
ester – baseline noise) for ACN mobile phase.
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3.1.8

Polygonum multiflorum screening method development
In a similar manner to the work found in chapter 2, this chapter section focuses on

the development of a screening method for plant extracts, In this case, those from
Polygonum mulitflorum. It is hypothesized that P. multiflorum may produce secondary
metabolites that interact with alpha-synuclein and may be used to treat Parkinson’s
disease.107-109 Unlike with L. cardinalis in chapter 2, p multiflorum has been well
characterized in literature and its main secondary metabolites are commercially available,
however, difficulty can be encountered in the metabolomic analysis of P. multiflorum as
most of its secondary metabolites are polyphenolics. Polyphenolics are nonpolar with
poor aqueous solubility and exist as neutrals in most analytical applications. Though
better suited for negative ion mode mass spectral analysis, the goal of this work was to
develop an ancillary or alternative method that could be used to analyze both the
polyphenolics and investigate other unknown metabolites using positive ion mode mass
spectrometry.
Prior to advanced method development, seven commercial standards (trans-TSG,
polydatin, rhaponiticin, resveratrol, emodin, physcion, and quercetin) were used to
evaluate ionization methods and optimize UHPLC-MS separations, as extraction methods
have already been thoroughly investigated in literature.98 As stated previously, typically
for polyphenolics, negative ion mode ESI to produce [M-H]- ions is employed. For this
specific application, however, negative ion mode lead to multiple analytical issues such
as enhancement of common contaminant signals (i.e. SDS and plasticizers), poor
separation as organic modifiers are not typically used in HPLC separation, and poor
MS/MS fragmentation. Poor MS/MS fragmentation is detrimental to this research as the
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mutant P. multiflorum cultures that are to be developed and provided by Naprogenix and
analyzed using this approach in the future will have undergone a similar mutation and
selection process that the L. cardinalis cultures were in chapter 2. In doing so, it is
possible that the cultures will produce novel secondary metabolites or upregulate
previously trace secondary metabolites in response to the mutagenesis that will need to be
characterized using tandem mass spectrometry. In work performed by fellow Lynn group
lab members analyzing lignin monomers and dimers, i.e. polyphenolic compounds, the
use of lithium chloride to produce [M+Li]+ species has been successful in producing
better MS/MS fragmentation patterns. In applying this technique, the P. multiflorum
standards were analyzed using Li, Na, K, and NH4 chloride salts to assess cationization
efficiency, as well as fragmentation. Figure 3.19 displays an example of the MS/MS
spectra of trans-TSG corresponding to the [M-H]-, [M+H]+, and [M+Li]+ ions. As
depicted in the Figure, little structural information can be derived from the [M-H]- and
[M+H]+ MS/MS spectra aside from the loss of the glucose yielding the free stilbene –
[M+H]+: C14H13O4+ - m/z 245.0808 and [M-H]-: C14H11O4- - m/z 243.0663. When
performing the MS/MS experiments on the Li+ adducts, an extensive fragmentation
pattern can be seen, as observed during the lignin MS/MS analyses. In utilizing postcolumn addition of 10 mM chloride salts at 10 uL/min, the area counts corresponding to
the standards forming adducts with the different cations was compared. Table 3.3
displays these area counts and also the area counts corresponding to the [M-H]- and
[M+H]+ ions. A decrease by over an order in magnitude can be observed when switching
from negative to positive ion mode, thus limiting limits of quantification and detection
when using positive ion mode.
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Figure 3. 19 MS/MS spectra for TSG: Top - [M-H]- at 15 NCE, Middle - [M+H]+ at 10
NCE, and Bottom - [M+Li]+ at 34 NCE.
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Table 3. 3 Signal intensities for various polyphenols under differing ionization adduct
conditions.
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Additionally, cationization adducts were only observed for the stilbene glucosides, with
Li+ being either the most responsive or similar in response to the [M+H+] species. This
was expected, however, as the stilbenes and lignin dimers are very similar in structure.
Interestingly, no interaction was observed for resveratrol with any of the cations, despite
it being the free stilbene of polydatin. This would suggest that the Li+ interaction is most
likely either stabilized by the presence of the glucoside or the interaction is occurring
with the glucoside exclusively. No cations outside of the [M+H]+ ions were observed for
the flavonoid or the anthraquinones, which may be explained by the fact that both classes
are relatively planar molecules. This is not necessary problematic, however, as the
flavonoids and anthraquinone standards produced more extensive fragmentation patterns
at higher NCEs than the stilbenes and, in the event that putative novel flavonoids or
anthraquinones are detected, they can be characterized without the requirement of adduct
formation. Through this approach, screens would be performed once using negative ion
mode, in order to ensure low concentration analytes are not missed, with standard
UHPLC separations, and then again switching the polarity and using post column LiCl
with a targeted MS/MS peak list to identify novel metabolites. Though applicable, the
increased time resulting from the requirement of two analyses per sample makes this
method less than ideal for high-throughput metabolomics screenings.
To establish a baseline peak list for downstream comparison, using compiled lists of
known secondary metabolites found in p. multiflorum, trimmings of WT plants (~200 mg
dry weight) were collected from Naprogenix, extracted, and analyzed. Using MZmine2
paired with METLIN and KEGG for database searching, an extensive peak list,
consisting of over 120 identified primary and secondary metabolites, was constructed for
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cross referencing in the event that novel peaks are detected. The list was broken down
into analytes found in root, stem, leaf, and/or whole plant extracts, as well, to aid in
prioritizing analyte procuration from specific tissue sections in down-steam extractions.
This list can be seen in appendix 4.
In order to couple the analysis with characterization, specifically in a highthroughput manner, as utilized in Chapter 2, the use of CZE/CE-MS was explored for this
application as well. Given that polyphenolics generally exist as neutrals at most pH’s in
solution, standard CE would be difficult to employ as neutrals would migrate with the
EOF and not separate. High pH buffers could be employed for standard CE analysis, such
as phosphate or borate BGEs, however such involatile salts can cause irreparable damage
to mass spectrometers. For CE coupled to MS analysis, typically, positive ion mode
acquisitions with low pH BGEs consisting of volatile salts are used. Extracts and
standards were introduced to the ZipChip CZE-MS setup described in chapter 2 and the
previously developed method was applied, as is. As expected, no peaks were observed.
The cationic coating on the walls of the CZE HS chip effectively reduces the zeta
potential and eliminates all electroosmotic flow. Additionally, since the analytes are
neutral, no electrophoretic mobility is observed either. Pressure can be applied at the head
of the BGE well to act as a “pseudo-electroosmotic” flow strictly in terms of providing a
bulk flow in the separation channels. When pressure is applied at the origin side of the
chip, the analytes are eventually forced out, concurrently, after approximately 10
minutes. This mass coelution is obviously disadvantageous as it greatly complicates any
mass spectral data from being interpreted differently than an infusion or flow-injection
analysis. Additionally, seemingly due to interactions with the wall coating increasing the
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impacts of longitudinal diffusion, the pressure eluted peaks are multiple minutes wide
and often result in carry-over, making quantitation, or even relative quantitation, difficult.
To address this, collaboration with 908 Devices was established and the manufacturer
provided a proto-type blank “HR” chip. Aside from being stripped of the cationic
coating, the separation channel was also twice as long (10 cm vs 22 cm), overall making
the application more akin to traditional CE. To correct for the added length, the
maximum allowed applied field strengths are half that applicable to the HS chips: 500
V/cm vs 1000 V/cm. Though the switch to a bare chip allows for more “CE”-like, rather
than CZE, separations and eliminates interactions with the wall coating, the analytes
being neutral would still cause them all coelute with the reestablishment of the
electroosmotic flow. Lithium chloride was added to the BGE and diluent, both
independently and simultaneously, to test if interactions with the cation would allow for
electrophoretic mobility to be observed. Though migratory and peak shape improvements
were observed, as seen in Figure 3.20 for polydatin and rhaponitcin, the least and most
conjugated stilbene glucosides respectively, the migration shifts were believed to be
associated with Li cation migration rather than true Li adduct electrophoretic migration,
causing the analytes to continue to coelute. Negative field strengths coupled with a
NH4OH separation BGE (pH 8.5) and diluent were also evaluated, however, only positive
potentials can be applied to the ESI spray well of the chip requiring analyses to be
acquired in the positive ion mode. Both Li and standard BGEs were tested in the spray
well, however, no ions were detected regardless of applied voltages. It is possible that
any electrophoretic migration occurring is quickly neutralized at the separation channelspray channel intersection and the analytes are also neutralized in the process.
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Figure 3. 20 Reconstructed electropherograms of [M+Li]+ for polydatin and rhaponiticin
at varying field strength voltages.
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As no BGE, diluent, or surface modifications tested resulted in adequate separation of the
analytes, modification of analytes was evaluated.
Borrowing from the common use of derivatizing analytes for GC-MS, derivatizing
with dansyl chloride was investigated for this application. Dansyl chloride is commonly
used as a fluorescence signal amplifier in protein analysis and reacts with primary amines
and alcohols, under basic conditions, to produce sulfonamide or sulfoxide adducts with
terminal tertiary amines. For this application, the tertiary amine of the dansyl group
provided a cationization site (pKa 2.4) for positive ion separation and positive ion mode
mass spectral analysis. Since previous work has been performed using the cannabinoids
and dansyl chloride, also being phenolics, they first were evaluated to determine if
electrophoretic separation was achievable with molecules that are generally highly nonpolar, neutral, and poorly suited for positive electrophoretic separations.114 Figure 3.21
displays the general dansylation reaction and Figure 3.22 displays both the cannabinoids,
both monodansylated (A) and bidansylated, if possible (B), as well as the p. multiflorum
metabolites, both monodansylated (C) and bidansylated, if possible (D). The reactions
were performed using standards to assess reaction conditions and also on cannabis
extracts as a surplus of extract material was available. The methods developed using the
cannabis extracts will be applied to the p. multiflorum extracts when they are available in
the future. Various reaction times, temperatures, and molar ratios were evaluated and it
was determined that a 10-fold molar excess of dansyl chloride to reactant for 2 hours at
60 oC resulted in >99% conversion to the monodansylated or bidansylated species based
on the absence of signals corresponding to the reactants. By 2 hours, most analytes were
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Figure 3. 21 Dansylation reaction with THC.
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Figure 3. 22 – A) Structures and masses corresponding to mono-dansylated cannabinoids.
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Figure 3. 22 – B) Structures and masses corresponding to bi-dansylated cannabinoids.
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Figure 3. 22 – C) Structures and masses corresponding to mono-dansylated polyphenols.
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Figure 3. 22– D) Structures and masses corresponding to bi-dansylated polyphenols.
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successfully monodansylated, however, for analytes like CBD and resveratrol containing
hydroxyl groups with near equivalent pKa’s, bidansylation was possible and observed.
Initial evaluations of dansylated cannabinoid standards (A) as well as dansylated
cannabinoid extracts (B), Figure 3.23, provided evidence of not only electrophoretic
mobility, but adequate separation of the selected analytes as well. Peak shape degraded
between the dansylated standards and the dansylated extract, most likely due to the
extract undergoing minimal cleanup and processing prior to analysis. Though
preliminary, this data provides evidence that this approach would likely be applicable to
the p. multiflorum extracts in the future.
In order to adequately assess method development for the dansylated p. multiflorum
CE-MS analysis, multiple separation and sample preparation conditions were evaluated,
namely, sample diluent concentration, the usage of pressure assist, and the chip wall
coating. Since the HS and HR chip channels are different lengths and the software
prevents the same field strengths from being applied to different chips, retention time was
not used as a comparison metric. Figure 3.24 displays RICs for the variously dansylated
polygonum analytes using the HRB chip. Due to the multiple phenolic sites found on
several of these analytes, like TSG, dansylation can occur at multiple locations. Due to
the steric hindrance incurred by the addition of the bulky nonpolar naphthalene group of
the dansyl modifier, generally one dansylation was observed at the most terminal
phenolic site but a distribution of the dansylated products can be seen in the RICs.
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Figure 3. 23 RICs for CBD and dansylated cannabinoid standards (top) and in an ethanol
extract (bottom).
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Figure 3. 24 RICs for mono and bi-dansylated polyphenolic standards.
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Though adding another layer of complication to the analysis, the fact that they are all
baseline resolved from one another despite being very similar structural isomers
simplifies the downstream data-processing as no forced chromatographic deconvolution
calculations are required, the individual peak area counts can simply be summed for
absolute or relative quantitation. When applying the dansylated polygonum analytes to
the HS chip with the cationic coating, however, the addition of the dansyl group to the
stilbenes did not have the same effect that it did for the cannabinoids. In assessing the use
of pressure assistance and varying leading electrolyte concentrations (0-100µM), very
few conditions resulted in any detectable signals for the dansylated stilbenes. It would
appear that they interact strongly with the cationic wall coatings of the HS chips, a
feature encountered during the non-dansylated attempts without the addition of the Li+ to
the BGE. This observation provides clear evidence that if this dansylation approach is
used for downstream CE-MS applications, the HRB will be a requirement.
In further comparison of the of the HRB and HS chips, as the HRB showed a clear
advantage for stilbene analysis, the chips were compared using relatively less conjugated
phenolic compounds. Here, the chips were evaluated using dansylated lignin ester
monomers and a lignin dimer model compound. Conversely to the application of the HS
chips with the stilbenes, the lignin compounds were successfully analyzed using both
chips across all applied conditions with the exception of turning off the pressure assist
(Figure 2.35). The deactivation of pressure assist was a problem for both chips as stable
spray was the limiter for this applications and droplets were repeatedly building up on the
chip spray corner, causing ESI spray instability. In further investigations of the most ideal
methods for analyzing these dansylated compounds, analytical factors such as peak
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duration, peak asymmetry factors, and peak tailing factors were calculated and compared.
Also, while theoretical plate counts for CE are not typically used as they are more
applicable and better describe true chromatographic methods, the number of theoretical
plates were calculated for each chip strictly for comparison of the CE methods. This
approach was chosen as it normalizes differences observed between the two chips that
could have arisen from the fact that the separation channels are different lengths using the
equation:
𝑡𝑡

2

𝑁𝑁 = 5.54 � 1 � = 𝜇𝜇𝑎𝑎𝑎𝑎𝑎𝑎 ×
𝑤𝑤

2

𝑉𝑉

2𝐷𝐷𝑚𝑚

𝑇𝑇ℎ𝑒𝑒𝑒𝑒. 𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃𝑃
𝑁𝑁 × 100
=
𝑚𝑚
𝑠𝑠𝑠𝑠𝑠𝑠. 𝑐𝑐ℎ𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎𝑎 𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙𝑙ℎ

Figures 3.26 displays a graphical depiction of the changes in peak durations and
migration times as a function of chip and electrolyte/organic solvent concentration.
Additionally, the changes in the number of theoretical plates for each method is
graphically depicted. These results clearly show that the true CE separations using the
bare chip outperform the coated chip for this application. Additionally Figure 3.27 shows
the asymmetry and tailing factors associated with each method. Again, here ideal
conditions can be observed for the HRB chip using 75% diluent with 25% ACN in which
both factors come close to 1 - a truly gaussian distributed peak. Note that the high
aqueous, high salt condition (right-most points) does not contain a high enough organic
solvent composition (0% organic) for these nonpolar analytes and solubility issues to
account for the increased variability.
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Figure 3. 25 RICs for dansylated-lignin model compounds using the bare long channel
chip – HRB (top) and the standard coated chip – HS (bottom).
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Figure 3. 26 Four charts: Changes in migration time (top) and peak duration (bottom) for
dansylated-lignin model compounds using the bare long channel chip – HRB (left) and
the standard coated chip – HS (right). Bottom graph: Changes in the number of
theoretical plates associated with each chip and varying ionic strengths.
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Figure 3. 27 Changes in asymmetry factors (top) and tailing factors (bottom) for
dansylated-lignin model compounds using the bare long channel chip – HRB (left) and
the standard coated chip – HS (right).
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At this concentration, blockages in the separation channels were also observed,
furthermore suggesting that this condition is not suitable for analysis. Though p.
multiflorum hairy root extracts are not yet available to test the dansylation+HRB CZEMS method, the preliminary results from analyzing dansylated p. multiflorum standards
and dansylated cannabis extracts suggests that the downstream application should be
successful.
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Conclusions
In this chapter, the difficulty in the analysis of phenolic secondary metabolites was
the primary focus. Unlike the basic nitrogen containing secondary metabolites found in
chapter 2, these nonpolar, neutral molecules presented an issue in that the methods
primarily used for their analysis, such as GC-MS, HPLC-UV, and even standard
UHPLC-MS, can lack sensitivity, accuracy, and can present unusual problems that were
not previously encountered. In the first half of this chapter, the hypothesis was that the
discrepancy in cannabinoid profiling methods could be understood and either prevented
or corrected. It was shown that the current industry standard method, HPLC-UV, lacked
the sensitivity to accurately quantify low concentrations of THC in products that were
determined to be over the legal limit using other methods. Additionally, the lack of mass
spectral detection can lead to coeluting peaks being grouped incorrectly during
quantification. The use of GC-MS for profiling, while better suited for these types of
molecules, also presented unavoidable issues in that the labile nature of the carboxylic
acids on certain cannabinoids, a critical component of the legal-limit equation, resulted in
large RSDs and poor precision. Even the use of the more sensitive high-end instrument
presented analytical challenges in that source induced degradation was observed. Though
the most manageable, provided that temperatures are monitored, this observation raised
the need for an alternative method to be developed as all three standard methods were
unreliable. In the second part of this chapter, the hypothesis was that certain
modifications could allow for the application of capillary electrophoresis for the analysis
of P. multiflorum extracts. The framework for this alternative method was developed to
be applied to both cannabis and p. multiflorum extracts. The use of the microfluidic CZEMS device coupled with dansylation of the analytes and the prototype bare, long channel
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chip displayed promising results as a future application once the product is commercially
available. Due to restrictions in the number of performable analyses (limit 125 per chip)
and the lack of p. multiflorum hairy root cultures, testing of the applications could only be
applied to cannabis extracts and p. multiflorum standards, however, both applications
displayed promising results and ideal applicable conditions were determined so that
future analyses can be easily performed.
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CHAPTER 4. PHARMACOKINETIC AND METABOLOMIC ANALYSIS OF AN ALZHEIMER’S
DISEASE THERAPEUTIC IN RAT SERUM VIA MICROFLUIDIC CZE-MS
Introduction
Pharmacokinetic profiles are often used to describe the absorption, distribution,
metabolism, and excretion (ADME) of the pharmaceutical therapeutic in
question.115,116,117 Pharmaceutical therapeutics can be administered into the body various
ways, with the method and the medium of administration and certain molecular
characteristics (ie Lipinski’s rule of five) having a significant effect on the ability for it to
accumulate in target areas and tissue.81,115,117 Once administered, they can be absorbed
and circulated, however, transportation into to their target tissues require mechanisms to
allow them to cross numerous biological obstacles (ie crossing blood-brain barrier).
During the absorption and transportation stages, the body can chemically modify or
metabolize the therapeutics to make them more easily transported, or, in some cases,
increase their efficacy. In most cases, these metabolic reactions produce intermediates
with less pharmacologic activity than the parent compound, however, it is also possible
that these metabolites can be toxic and lead to an adverse effect.115,117,118 Following
adsorption, distribution, and metabolism, the end product is excreted through the liver,
kidneys, skin, lungs, and/or intestines. Pharmacokinetic profiling helps to provide a
quantitative description of the behaviors and interactions of therapeutics to better
understand how they function, interact, and metabolize.117 These profiles are developed
by analytically monitoring variations in the circulating concentration of the therapeutic of
interest as a function of time following administration and are performed as a critical
component of clinical and pre-clinical evaluations.119,120 Method development for the
formation of pharmacokinetic profiles typically focuses on high-throughput, highly

sensitive techniques.33,34 These methods generally employ HPLC coupled to either UV or
MS detection and are developed with the primary focus of resolving one or two analytes
of interest.121–123 When involving MS, the industry standard approach utilizes targeted
MS/MS analyses using triple quadrupole (QqQ) mass spectrometers due to their
sensitivity and specificity.124–128 Targeted approaches allow for the preceding HPLC
methods to be more focused on fast, high-throughput separations at the cost of
chromatographic resolution and qualitative aspects, such as primary and secondary
metabolite detection or changes in metabolite expression over time.129,130 While this
approach is advantageous for the determination of a potential therapeutic concentration in
vivo, the sacrifice of metabolic information can lead to the requirement for further testing
at a future stage of development to evaluate changes in metabolism induced by the
candidate therapeutic. To address this untargeted analysis, a method for the use of a
microfluidic capillary zone electrophoresis (CZE) device, coupled to a mass
spectrometer, was developed and evaluated for a metabolomics-inclusive highthroughput pharmacokinetic approach.
The primary focus of this metabolomics-inclusive pharmacokinetic CZE-MS
application centers on a potential Alzheimer’s disease therapeutic in the preclinical
development stage. This therapeutic, BNC-1 (Figure 4.1), was designed by CoPlex
Therapeutics LLC (Lexington, KY) and consists of a functionalized naphthyridine and
has been shown to reduce amyloid burden and improves markers of synaptic integrity in
mouse models (Lovell et al., 2016, US Patent No. 9968574).131 The hypothesis of this
chapter was that the capillary electrophoresis mass spectrometry method could be
modified and applied to perform a global, metabolomics-inclusive DMPK analysis. To
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test this, serum sample extracts from male and female Sprague Dawley rats, treated with
varying doses of BNC-1, were obtained from CoPlex and analyzed using both LC-MS the
novel CZE-MS approach. Pharmacokinetic data generated using traditional UHPLC-MS
approaches were statistically compared to the CZE-MS approach. Additionally, the
metabolomic data obtained from the CZE-MS approach was examined to identify
changes in metabolism potentially linked to the use of the therapeutic.
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Figure 4. 1 Structures for BNC-1 (2,4-dimethyl-5-oxo-5,6dihydrobenzo[c][2,7]naphthyridine-1-carboxylic acid, methyl ester) and the internal
standard (N-methyl-BNC-1).
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Materials, Methods, and Instrumentation
4.1.1

Sample Preparation
Administration of BNC-1 and tail vein blood collection and extraction/sample

preaparation was performed by CoPlex Therapeutics as follows: Serum was extracted
from the collected blood and provided for analysis. Both male and female Sprague
Dawley rats, five each, were treated with 2,4-dimethyl-5-oxo-5,6dihydrobenzo[c][2,7]naphthyridine-1-carboxylic acid, methyl ester (BNC-1, C16H14N2O3
– Figure 4.1) by gastric gavage at the following concentrations: 1, 12.5, 25, and 50 mg/kg
(additionally, a 5 mg/kg dosage was administered intravenously to rats that did not have
the gastric gavage administered). Blood was collected from the tail vein at 0.25, 0.5, 1, 2,
4, 8, 12, and 24 hour intervals by processed into serum by centrifugation. A 50 µL
aliquot of serum was diluted with 50 µL internal standard (50 µM stock, N-methyl
version of BNC-1 - C16H12N2O4) in acetonitrile, 50 µL ammonium acetate (500 mM) and
150 µL of acetonitrile, mixed by vortex and centrifuged to remove proteins. Calibration
standards were prepared similarly: 50 µL of preconcentrated BNC-1 stock solutions in
acetonitrile were diluted with 50 µL internal standard in acetonitrile, 50 µL ammonium
acetate (500 mM) and 150 µL of acetonitrile to 0.5, 2, 10, 25, 50, and 100 µM. Quality
control spike/duplicate samples were prepared consisting of 50 µL horse serum with 50
µL internal standard in acetonitrile, 50 µL of BNC-1 in acetonitrile (10 µM final
concentration), 50 µL ammonium acetate (500 mM) and 150 µL of acetonitrile
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4.1.2

UHPLC-MS and Microfluidic CZE-MS analysis
UHPLC-MS analyses were performed by CoPlex Therapeutics as follows:

UHPLC separations were performed using a Shimadzu Nexera X2 UHPLC system with a
Kromacil EternityXT C18 column (2.5 µm, 2.1x50 mm). Analyses were performed using
5 µL sample injections. The chromatographic separation consisted of solvent A (0.1%
formic acid in H2O) and B (0.1% formic acid in ACN) in a gradient flow method at 300
µL/min starting with solvent B at 5% for 2 minutes, increasing linearly to 95% over 10
minutes, being held at 95% for 5 minutes, and then returning to starting conditions for 2
minutes equilibration, 20 minutes in total. UHPLC-MS analyses were performed on a
Thermo Scientific Q Exactive Orbitrap Mass Spectrometer (Thermo Fisher Scientific,
Waltham, MA, USA). Parameters for the UHPLC-MS analysis consisted of a scan range
of m/z 70 to 800, resolution of 140,000, microscans set to 3 (1.7 scans per second),
sheath gas flow set to 10 psi and the AGC target was maintained. Electrospray was
generated with a 3.0 kV spray voltage and desolvated with a HESI auxiliary gas flow of 4
psi (280 oC) and an inlet capillary temp of 280 oC.
For the CZE-MS analysis, a 50 µL aliquot of the treated sample extract, analyzed
by UHPLC-MS, was diluted with 50 µL of the 908 Devices metabolites diluent
immediately prior to analysis. Capillary zone electrophoresis mass spectral analysis was
performed by the authors using the 908 Devices ZipChip interface (ZCI) following the
method stated in in Chapter 2, with minor modifications. Briefly, 50µL of each sample
was manually transferred to the sample well of a HS chip in the ZCI before analysis. The
sample was loaded into the sample channel for 20 seconds as defined by the default HS
Metabolites method (5.00 nL injection). Samples were analyzed using the HS
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Metabolites background electrolyte (BGE) and method for separation and a field strength
of 1000V/cm was applied to the chip for the duration of the 3 minute separation. The
samples were recollected from the sample well following analysis and then a sample well
washing was performed by the CZE interface for 2 minutes, totaling 6 minutes from
injection to washing, per sample. BGE refreshes were performed every 30 minutes. CZEMS analyses were performed on a Thermo Scientific Q Exactive Orbitrap Mass
Spectrometer (Thermo Fisher Scientific, Waltham, MA, USA). The CZE-MS acquisition
parameters consist of a full scan range from m/z 70 to 600, resolution of 17,500,
microscans set to 1 (8 scans per second), sheath gas flow set to 2.0psi, and a AGC target
of 3e6. Additionally, data dependent MS2 (dd-MS2) acquisition was also utilized for
metabolite structural elucidation following the microfluidic CZE separation. For dd-MS2
acquisition, the CZE method was modified to employ a voltage gradient starting at 300
V/cm and increasing linearly to 1000 V/cm over 6.00 minutes. All dd-MS2 spectra were
acquired using a fixed normalized collision energy (NCE) of 30 and a Top3 filter with a
0.5 minute dynamic exclusion.

4.1.3

Data processing
Resulting data sets from both the UHPLC-MS PK study and the microfluidic

CZE-MS PK comparison were processed using MZmine2 following the workflow stated
in chapter 2 and in Kelley et al 2019.66 Briefly, RAW files were directly imported into the
processing software. Following importation, the data sets were processed with the
following modules: mass detection, ADAP chromatogram builder, chromatogram
deconvolution, deisotoping, alignment using the RANSAC aligner with gap-filling, and,
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additionally, normalization to the internal standard. Both UHPLC separations and CZE
separations were processed using the same modules, however, the time limit parameters
for total run time, maximum and minimum peak width, and retention/migration times
were adjusted. UHPLC-MS time windows were selected based on the average durations
of BNC-1 and the internal standard. CZE-MS time window allowances were selected
based on the average duration of the widest peak observed in each separation. Resulting
aligned datasets putatively identified using MassBank and Chemspider. Statistical
analysis for the comparison of the two methods was performed using Graphpad Prism 8.
Pharmacokinetic data was generated using the PKsolver add-in for Microsoft Excel.

Results and Discussion
4.1.4

Method Assessment

4.1.4.1 Pharmacokinetic method comparison
Using data from both the CZE and UHPLC-based methods, the BNC-1
concentration in each rat serum extract was determined. Figure 4.2 displays examples of
stacked chromatograms from the UHPLC separations (top) and stacked
electropherograms from the CZE separations (bottom) of the first collection time point of
the 50 mg/kg dosage (M50-15min). The peaks for BNC-1 can be seen at 3.80 minutes for
the UHPLC separations and 1.92 minutes for the CZE separations with the internal
standard peaks at 5.41 and 1.77 minutes for each method, respectively. Prior to any
chromatographic peak extraction or data processing by MZmine, observable differences
in the base peak chromatograms/electropherograms are apparent for each method. This
aspect attributed to the nL flow rates employed for the CZE-MS approach compared to
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300 µL/min for the UHPLC-MS approach. This reduced baseline greatly aids in postanalysis data processing, especially in determining peak width and noise level parameters
for MZmine2. As the only consistently observable peak in the baseline of the UHPLCMS analysis was internal standard, it was used in determining peak width allowances.
Using the ratio of a constant concentration of internal standard and varying
concentrations of BNC-1, calibration curves were generated for each method (Figure
4.3A). Calibration standard solutions were generated using both the method described
above (50 µL BNC-1 stock solutions, 50 µL IS, 50 µL 500 mM NH4OAc, and 150 µL
ACN) and a second time replacing 50 µL of the ACN with 50 µL of serum to assess for
matrix effects. Plotting resulting ratio of BNC-1 and the internal standard using both
sample conditions resulted in an R2=0.9995 implying that, due to the nonpolar nature of
BNC-1, the extraction method and presence of serum did not result in any observable ion
suppression or other matrix effects. Additionally, recovery of the internal standard was
evaluated in comparing the average area counts of the internal standard peaks across all
calibration solutions, both with and without serum (n=36) and the internal standard
diluted in ACN (n=3) and a recovery of 96±6% was observed. Subsequently, the
concentration of BNC-1 was determined in each serum extract without correction. Figure
4.3B displays four examples of the concentration of BNC-1 determined with each method
in the serum extracts as a function of time for varying dosages. The difference in
administration methods rationalizes the higher BNC-1 serum concentration observed in
the 5 mg/kg treatment than that observed in the 25 mg/kg gavage treatment. The apparent
Cmax of BNC-1 was reached between 8 and 12 hours.
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Figure 4. 2 Example of the same sample (male, 50 mg/kg, 15 minute collection time)
analyzed using both methods. (Top) UHPLC-MS stacked base peak chromatogram and
RIC for BNC-1 (RT: 3.80 min, m/z 283.1077 and the internal standard (RT: 5.41, m/z
297.1026). (Bottom) CZE-MS stacked base peak electropherograms and RIC for the
internal standard (RT: 1.77 min, m/z 297.1026) and BNC-1 (RT: 1.92, m/z 283.1077).
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Figure 4. 3 A – Calibration curves generated for UHPLC (right) and CZE (left)
separations by analyzing the response ratios from calibration standards containing a fixed
concentration of an internal standard and varying concentrations of the target compound,
BNC-1. Error bars represent SD from triplicate analyses. B – Four examples of overlaid
graphs of calculated BNC-1 concentrations as a function of time using both separation
methods.
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Using PKsolver, pharmacokinetic data was generated from the [BNC-1] versus time data.
An example of the PKsolver data for the 50 mg/kg BNC-1 dosage can be seen in Table
4.1. For cases where the Cmax was reached at t=12hrs, some PK data could not be
calculated as three points indicating the elimination of the therapeutic in serum are
required. The largest variations were observed in the calculation of the AUC0-t values,
however, in most cases, the RSD was below 20% when comparing the values calculated
by both the CZE and UHPLC methods. Additionally, when compared to the UHPLC-MS,
the relative error (RE) for the PK results generated via CZE-MS were all below 10% with
the only outlier being λz (terminal rate constant), at ~20%. Being that this parameter is
both small, increasing the impact of small differences (0.10 and 0.12) and directly related
to another parameter displaying slight variability, t1/2, this observation alone does not
discredit the similarity between the results generated using the two vastly different
separation methods.
Statistical analyses were performed using GraphPad Prism 8. Regression analysis
of the calculated BNC-1 concentrations resulting from both methods displayed significant
linearity with an R2 = 0.9205 (Figure 4.4A). A slope of 1.032 (y-axis: UHPLC-MS
results and x-axis: CZE-MS) indicates that, while corresponding [BNC-1] calculations
generated by each method are similar, the results generated by CZE method are, on
average, slightly lower (<5-10 µM variation) than those generated using the UHPLC
method, however, only four points fell outside of the confidence interval. This was also
observed in comparing the methods using a ratio Bland-Altman plot (Figure 4.4B).
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Table 4. 1 Pharmacokinetic data corresponding to the 50 mg/kg dosage resulting from
using both separation methods and generated using PKsolver.
Paramete
r
Tmax

Unit

CZE

UHPLC

h

8

8

AVERAG
E
8

Cmax

μM

124.9

118.85

t1/2

5.99

AUC0-t

h
(mg/kg)/(μM)/
h
μM*h

AUC0-∞

SD

RSD

RE

0

0.00%

121.88

4.28

3.50%

6.65

6.32

0.47

7.40%

0.00%
5.09%
-9.92%

0.02

0.02

0.02

0

1.50%

1969.95

1964.5

1967.23

3.86

0.20%

μM*h

2160.12

2204.9

2182.51

31.66

1.50%

AUC0-t/0-∞

(unitless)

0.89

0.9

0.01

1.60%

AUMC0-∞

μM*h^2

28000.7

27024.69

1380.28

5.10%

MRT0-∞

h

0.91
26048.6
8
12.06

12.7

12.38

0.45

3.70%

λz

1/h

0.12

0.10

0.11

0.01

7.40%

Vd

(mg/kg)/(μM)

0.20

0.22

0.21

0.01

5.90%

Vss

(mg/kg)/(μM)

0.28

0.29

0.28

0.01

2.20%

Cl
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0.00%
0.28%
-2.03%
2.25%
-6.97%
-5.04%
20.00%
-9.09%
-3.45%

Figure 4. 4 A – Linear regression plot of the serum BNC-1 concentrations resulting from
the use of the CZE method plotted against the same samples analyzed using the UHPLC
method. B – A ratio Bland-Altman plot comparing the serum BNC-1 concentrations
determined using both methods.
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Though three data points (~2% of the total data) were observed outside of the limits of
agreement and not deemed to be outliers, a strong correlation was observed. The
similarity observed in the calculated BNC-1 concentration data suggests that the two
methods could be interchangeable for this application without impacting the results of the
trial. Furthermore, an additional feature of the microfluidic CZE-MS approach compared
to the UHPLC-MS approach is the speed of the separation mechanism. The CZE’s
employment of transient isotachophoresis (tITP) allows for the separations to be
performed in 3 minutes, compared to 10-20 minutes per UHPLC-MS analysis.
Depending on the sample injection method applied, the total run times for the CZE-MS
analyses range from 4 minutes (active – manual injections) to 6 minutes (passive –
autosampler injections) from the time the signal pulse is sent to the instrument to the time
that the sample well is washed, 10-15 samples per hour. For the UHPLC-MS analyses,
only 2-5 samples could be analyzed per hour once the column equilibration and needle
washing times are factored into the total run-time. Given that PK sample sets can often be
large (100+), this high throughput aspect would be advantageous.
4.1.4.2 Evaluation of the CZE-MS approach
In an evaluation of the CZE-MS approach, triplicate analysis of a low-dosage (1
mg/kg) serum extract analyzed consecutively with sample well washes between analyses
displayed high reproducibility. A maximum RSD of 13% (low: 2%) was observed
corresponding to the sample where the BNC-1 serum concentration peaked (tmax = 8
hours) during the time course (Figure 4.5). This variation is likely due to the BNC-1
concentration approaching the onset of overloading for the device (~100-200µM, analyte
dependent).
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Figure 4. 5 Calculated BNC-1 concentration resulting from triplicate analysis of a serum
extract (1 mg/kg) using the CZE approach.
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Additionally, both inter-day and intra-day reproducibility were assessed as large sample
sets, such as the set analyzed in this work (n=96), can often take an extended period to
analyze. Figure 6 displays a stacked extracted electropherogram of the two serum extracts
from the same dosage set (50 mg/kg), one determined to have a low BNC-1 concentration
(sample collected after 15 min) and one with a high BNC-1 concentration (sample
collected after 8 hours), analyzed at time zero – 6A (low) and 6C (high), after 12 hours
(data not shown), and 24 hours after the diluted samples were produced and the CZE
system was initially primed – 6B (low) and 6D (high). This was performed to assess
variation as a function of concentration and time. Calculated concentrations can be seen
in Table 4.2. Although resulting calculated concentrations remain consistent (RSD <5%)
despite an order of magnitude increase between the two samples, the observed CZE
migration times (MT) varied. The BNC-1 peak resulting from samples analyzed on a new
chip with fresh BGE eluted at approximately 1.9 min while the same peak eluted at
approximately 2.3 min after 24 hours using the same chip and BGE. This is most likely
due to degradation of the BGE (consisting of ACN, IPA, H2O, and formic acid) or sample
diluent (MeOH, H2O, NH4OAc, and formic acid) as the manufacturer recommended
lifetime of the BGE and diluent is 12 hours. Additionally, the cationic wall coating of the
chip separation channels and the hydrophobic coating at the spray corner wear over time
during analyses, therefore only 125 separations can be performed on each chip. Although
a shift in migration is observed, migration of BNC-1 relative to the internal standard
(~1.08 minutes) remained constant regardless of concentration or time of analysis.
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Figure 4. 6 Extracted electropherograms corresponding to a low [BNC-1] sample at two
time points (0 and 24 hours 6A-B) and a high [BNC-1] sample at two time points (0 and
24 hours 6C-D).
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Table 4. 2 Area counts of BNC-1/internal standard and resulting BNC-1 concentrations corresponding to triplicate analysis of a low
concentration serum extract (50 mg/kg dosage, 15 min) and a high concentration serum extract (50 mg/kg dosage, 8 hours) analyzed
over twelve hour intervals.
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Due to the consistency in concentration dependent response, no normalization was
applied to later samples during the MZmine2 processing in regards to observed response,
however, migration time allowance windows were increased to 0.5 minutes to allow for
the grouping of similar features despite a difference in MT >10% of the total run time.
4.1.5

Changes in Metabolic Activity
In addition to the monitoring of BNC-1 concentration as a function of time, the

CZE-MS method also provided metabolomics data on a number of analytes as a function
of [BNC-1] concentration. Using MZmine2, over 80 baseline resolved peaks were
detected consistently within the 96-sample data set. The detected features were processed
using both the MassBank and Chemspider database tools in MZmine2 and METLIN
externally. The final resulting data set comprised of 38 putatively identified metabolites,
all 20 amino acids, and 26 features with multiple (n>3) possible identities that would
require further experimentation to determine (denoted as their most probable calculated
empirical formula). Normalized response changes corresponding to each feature from the
t = 15 min mark to the tmax can be seen in appendix 5 for the female rats (left columns –
denoted as F-dosage) and for the male rats (right columns – denoted as M-dosage). For
simplicity, percent changes are expressed as: “-” indicating percent decreases greater than
-25% compared to t=15 min, “NC” (no change) indicating percent changes between -25%
and +25%, “+” indicating percent increases greater than +25% but less than +100%
compared to t=15min, and “+++” indicating increases greater than +100% compared to
t=15min. This approach may be useful in providing evidence to how therapeutics affect
metabolite expression. For example, m/z 146.1648, putatively identified as spermidine,
appears to be down-regulated in eight of the ten rats, regardless of dosage. Spermidine
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has been noted in literature to be upregulated in patients with AD.132–134 Additionally, it
has been reported that polyamines, such as spermidine, play a role in amyloid-beta
fibrillation and increased MAPK function related to the progression of AD symptoms.135–
138

Preliminary evidence from in vivo and in vitro assays performed by CoPlex

Therapeutics involving BNC-1 suggest that the potential therapeutic modulates MAPK
activity, specifically TAK1 kinase, also known as MAP3K7.131,139
This approach can also be used to evaluate the metabolism of the therapeutic itself.
An unidentified metabolite, m/z 299.1028, appeared to be exceptionally increased in all
samples where the [BNC-1] reached the Cmax, and subsequent samples in the time-course,
when compared to t=15min, regardless of initial dose. To obtain evidence to identify this
metabolite, tandem mass spectrometry was utilized. By employing a voltage gradient
method, as discussed in Chapter 2, untargeted MS/MS data-dependent acquisition (DDA)
and targeted MS/MS (PRM) experiments could be performed. The usage of voltage
gradients allows for slight broadening of the analyte peaks in order to adequately sample
each target in the untargeted tandem experiments. The employment of a linear voltage
gradient from 300 V/cm to 1000 V/cm over a six-minute run time allowed for an
approximate doubling of each peaks’ width (ranges from 1.5x to 2.0x). An untargeted
approach was chosen to determine if fragment ions or fragmentation patterns observed
for other selected precursor masses were in common with those produced by the
unidentified metabolite at m/z 299.1028 (putatively calculated as [M+H+] =
C16H15N2O4). In utilizing this method, similar fragmentation patterns were observed for
m/z 299.1028 and BNC-1 (Figure 7); BNC-1: m/z 283 → 251(-32), m/z 283 → 223(-60),
unidentified metabolite: m/z 299 → 281(loss of H2O), m/z 281 → 249(-32), and m/z 281
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→ 221(-60). This evidence suggests that m/z 299.1028 is most likely an oxidized
metabolite of BNC-1, consistent with aromatic hydroxylation.
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Figure 4. 7 Left - Electropherogram of a set constant voltage (1000 V/cm) CZE-based separation (top) and the
same sample analyzed using a voltage gradient (300 V/cm to 1000 V/cm over six minutes - bottom). Right –
MS2 spectra of BNC-1 (top – m/z 283.1069) and the unknown metabolite of interest (bottom – m/z 299.1021).

Conclusions
In this work, the hypothesis was that the capillary electrophoresis mass spectrometry
method could be modified and applied to perform a global metabolomics inclusive
DMPK analysis. Here, the development and usage of a CZE-MS method for highthroughput pharmacokinetic analysis was compared to a traditional UHPLC-MS analysis
method. Traditional approaches heavily rely on streamlining data acquisition at the cost
of separation efficiency and usually result in the absence of information pertaining
analytes other than the target of interest. The CZE-MS approach provided
pharmacokinetic data in approximately six minutes per sample, including sample delivery
and transfer line clearing, without sacrificing separation efficiency or limiting the scope
of the analyses. Statistical comparison of the pharmacokinetic results generated by both
methods suggests that they are interchangeable for this type of analysis. The CZE method
proved capable of not only fast and efficient pharmacokinetic analysis, but also highly
reproducible results. Both the intra-day and inter-day reproducibly of the CZE-MS
method was comparable to that characteristically displayed by UHPLC-MS approaches.
Additionally, the CZE method provided metabolomic data alongside the pharmacokinetic
experiments that was not present in the UHPLC data set. Further data analysis and
mining with processing software like MZmine2 allows for fast comparisons and easy
evaluations of large, complex data sets. This aspect can be useful in understanding the
primary method of action for a potential therapeutic or in how the target is metabolized.
The ease of performing both targeted and untargeted MS2 experiments to this CZE-based
separation is also very advantageous for metabolomics assays.

208

CHAPTER 5. CONCLUSIONS
Metabolomics mass spectrometry focuses on the analysis of small molecules (<1500
Da) associated with the metabolic processes of an organism. The applications of
metabolomics methodologies cover a wide assortment of diverse subjects. Metabolomic
profiles can help analysts understand how an organism responds to disease or external
stressors, how a potential therapeutic in preclinical trials metabolizes and affects
metabolic expression, and what causes certain phenotypic expressions to manifest. While
the mass spectral analysis of primary metabolites, like amino acids and nucleic acids, is
well defined, the analysis of secondary metabolites, specifically those produced by plants,
such as alkaloids and polyphenolic compounds, can be challenging. These challenges
arise in the vast, complex diversity of these secondary metabolites, often unique to a
specific genus or species. The primary focus of this dissertation was the development of
multifaceted metabolomics mass spectrometry methods for the analysis of both primary
and secondary metabolites from different biological sources.
The second chapter of this dissertation focused on the bottom-up method
development for a metabolomics profiling assay to be applied to a relatively unknown
target, Lobelia cardinalis. It was previously discovered that extracts from L. cardinalis
displayed substantial dopamine transporter inhibitory activity. As no recorded history of
abuse of this plant has ever been reported, as is the case for many dopamine transporter
inhibitors, this discovery presented a promising source for naturally derived cessationaids to help combat the global substance abuse disorder crisis. Working in tandem with
Naprogenix LLC, wild type and mutant L. cardinalis extracts were provided for
metabolomic profiling. The hypothesis of chapter two was that mutant survivor strains

likely over-expressed novel hDAT inhibitors compared to wild type plants. If this was the
case, the novel metabolites would be extracted and purified to be tested individually to
verify activity. To test this hypothesis, a metabolomics screening approach was
developed and applied. In this work, both liquid chromatography and capillary
electrophoresis were applied to determine the best separation method for this application.
The analytical complexity attributed to the secondary metabolites observed suggested that
the capillary electrophoresis approach was the best option due to increase sensitivity,
increased selectivity, reduced sample volume/concentration, and reduced analysis time.
Additionally, given that these secondary metabolites were predominantly alkaloids,
capillary electrophoresis was suggested as it is ideal for small, positively charged
analytes. The application of capillary electrophoretic separations coupled to mass
spectrometry was not only applied to characterize wild type L. cardinalis and putatively
identify secondary metabolites naturally produced, but also to identify changes in the
secondary metabolite profile of transgenic plants comparatively. Using the metabolomic
information discovered from this analysis, a metabolite was identified and subsequently
isolated, characterized, and provided to Naprogenix for preclinical trials. This secondary
metabolite, the N-oxide of the main secondary metabolite produced by the plant,
lobinaline, exists at concentrations ten to one hundred times lower than its free base
counterpart in the plant. Extreme difficulty was encountered when trying to purify the
metabolite given its chromatographic similarity to lobinaline during preparative HPLC
purification. Utilizing differing physical characteristics of the two metabolites, mainly
difference polarity, an extraction method was developed and perfected using xylene to
selectively separate lobinaline from the N-oxide, resulting in a hundred-fold enrichment
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of the N-oxide. This led to the production of a substantial quantity of the material to be
provided to Naprogenix for pharmacological testing. Additionally, a method for the semisynthetic production of an analytically identical version of the metabolite via N-oxidation
using mCPBA was also developed. The impact of this chapter centers around the
application of this technology for future pharmaceutical discovery. Despite many of the
advances in modern medicine, there is still a plethora of diseases and conditions,
especially substance abuse disorders, that plague the world on a regular basis. Since
naturally derived pharmaceuticals can potentially treat some of these conditions, like the
lead compound discovered in this work and its impact on potentially treating addiction,
this metabolomic profiling method is pivotal in streamlining the process of identifying
lead compounds for prioritizing and easing the difficult task of purification. Preliminary
investigations, performed by Naprogenix, in testing the purified material have been
promising in that strong inhibitory activity is being observed, supporting the hypothesis
that the upregulated metabolites were likely the source of the activity and that these
changes in regulation could be observed using the developed capillary electrophoresis
mass spectrometry metabolomic profiling assay. As more than one lead compound was
identified, the future developments of this work would be to continue the isolation and
purification process of the other prioritized analytes for pharmacological evaluation.
The third chapter of this dissertation focused on two aspects. The first aspect was
evaluating the common approaches used for secondary metabolite profiling of Cannabis
plant extracts and products. The secondary metabolites of the Cannabis species, the
cannabinoids, have recently been the subject of numerous analytical investigations, as
they present many analytical challenges. This aspect analyzed how using different
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analytical tools for the same application can lead to different results. Given the legal
precedent of the specific application at hand and the tight constraints set to determine
such legality, these analytical variations can result in a product being denoted as legal by
one lab and illegal by the other, allowing illegal products to enter the consumer market.
The hypothesis of this aspect of the chapter was that the sources of variation, specifically
intra-laboratory and inter-instrumental variation, could be determined and reduced and, if
reduction was not possible, then the mechanisms responsible could at least be understood
and accounted for to minimize variation. With the influx of cannabis/hemp products
entering the market since the passage of the 2018 KY farm bill, illegal products entering
the market has become a common and detrimental issue. An unknowing consumer could
risk using these products and potentially losing their careers or facing legal penalties if
they were to test positive for these illicit substances. This was the primary motivation
behind this aspect of the research. Three methods of varying complexity, HPLC-UV, GCMS, and UHPLC-MS, modeling the industry standard approaches, were developed and
utilized for cannabinoid profiling. Inter-instrumental variations were observed as both
potential over- and under-calculation of the cannabinoid concentrations. Interestingly, a
previously unreported phenomenon was observed when generating the cannabinoid
profiles using the UHPLC-MS method; the temperature-induced formation of an acylium
ion and decarboxylation product during the ESI process for the cannabinoid acids.
Though no possible instrument temperature variations or solvent compositions where no
formation of the degradation products was observed could be determined, the discovery
of its formation could lead to better quantitation in the future to prevent illegal products
from passing the cannabinoid profiling step. Implementation of temperature monitoring
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and multiple ion signal summation when developing the quantitation method was
determined to be the best response to the phenomenon. The second aspect of this chapter
focused on providing an alternative or ancillary method to perform metabolomics
analyses on sources that are already well-characterized. Here, more substantial method
evaluations could be performed as a vast wealth of data exists in the literature on this
topic. In this specific case, Polygonum multiflorum extracts were the analytical subject.
This plant produces a vast number of different phenolic compounds, many of which have
been suggested to have a degree of pharmacological activity. One particular aspect in
focus is the potential use of p. multiflorum extracts to treat Parkinson’s disease, as it is
theorized to reduce alpha synuclein toxicity. Through similar a collaboration described in
chapter 2, Naprogenix is in the process of developing a similar plant model to the L.
cardinalis-hDAT mutants but using p. multiflorum and alpha synuclein. The focus of this
aspect was to develop a metabolomic database for future characterizations as well as lay
down the framework to apply the technology developed in chapter 2 to this application to
speed up the discovery and evaluation process, further streamlining the potential target
selection and isolation process. Given the impact that Parkinson’s disease has on the
world population and the current lack of adequate therapies, this application displays
extreme importance due to its role and potential impact in the search for future
therapeutics. The secondary metabolites of p. multiflorum are polyphenolic and not
alkaloids, as in chapter 2, therefore applying the capillary electrophoresis method to them
was particularly challenging, however the hypothesis was that certain modifications
could allow for the application of capillary electrophoresis for the analysis of these
extracts. In collaboration with the manufacturer of the capillary electrophoresis device
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being utilized, a prototype device was procured to allow for separation of these analytes.
Chemical modifications using dansyl chloride and the use of cation-assisted
electrophoresis were developed and evaluated against standards and surrogates, given the
current lack of the subject plant material. Though the method cannot be tested on actual
P. multiflorum material currently, successful electrophoretic separations of the dansylated
polyphenol standards and dansylated surrogate (Cannabis extract) material suggests
promising application in the future. The future applications for this chapter are to apply
the optimized dansylation and capillary electrophoresis methods to the future extracts.
Unfortunately, the capillary electrophoresis device used was a prototype with a
constrained number of allotted analyses, so procurement of additional devices is also
required for continuation.
The fourth chapter focuses on taking the technology developed in chapters two and
three and applying them to another tangential application, drug metabolism
pharmacokinetics (DMPK), a critical component of clinical trials. DMPK helps scientists
to understand how the potential therapeutics discovered or developed, as was the focus of
chapters two and three, interact and metabolize once internalized and processed by an
organism. The information obtained in performing DMPK analyses is absolutely critical
to understanding and predicting how a drug will not only interact with its intended
targets, but also with its unintended targets. The hypothesis of this chapter was that the
capillary electrophoresis mass spectrometry method could be modified and applied to
perform a global metabolomics inclusive DMPK analysis. In this application, the
metabolomics focus was switched from primarily secondary metabolites to primary and
secondary metabolites, as well as xenobiotic metabolites. The DMPK results generated
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using the capillary electrophoresis mass spectrometry approach were statistically similar
to those generated using the standard LC-MS approach, however, extensive
metabolomics data was also acquired. By utilizing this developed method,
pharmacokinetic profilers can not only streamline the extensive DMPK process, thus
streamlining the entrance of much-needed therapeutics into the market, but also easily
monitor changes in metabolite expression of both endogenous metabolites and exogenous
xenobiotic metabolites linked to the therapeutics themselves. The target of interest in this
specific application is an Alzheimer’s disease therapeutic that shows a great deal of
potential as a prophylactic treatment and halting agent of the disease. Again, another
condition that affects millions of people with no reliable treatment. Using this approach,
crucial therapeutics like the one in question can be quickly screened and characterized to
speed up the arduous process of entering clinical trials.
The research found within this dissertation centering around the usage of mass
spectrometry for metabolomics method development displays great adaptability across a
number of applications, especially within the drug-discovery and testing process. Here,
the development of various methods using capillary electrophoresis mass spectrometry
was performed, applicable to the metabolomics-based discovery, quantitation, and
evaluation of various, drastically different types of analytes. Capillary electrophoresis,
though fairly well known, is under-utilized in both industrial and pharmaceutical
industries. Analyses can be difficult to perform when compared to chromatographic
methods like HPLC and GC. This has led to capillary electrophoresis being a solution
looking for a problem. Through this research, it appears that the problem it is the ideal
solution to is high throughput metabolomic mass spectrometry screening. In this work, it
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was demonstrated that, not only did the capillary electrophoresis methods generate
statistically similar quantitative data to traditional chromatographic approaches, it
outperformed in terms of separation efficiency, analysis time, and required sample
volume. The low nL flow rates associated with capillary electrophoresis also reduce
background noise, easing back-end data processing leading to cleaner, more accurate
metabolomic profiles to be generated. As further developments are made in the field of
capillary electrophoresis mass spectrometry, it is possible that an industry shift may occur
towards the more frequent implementation of these methods for crucial steps in the
metabolomics-based drug discovery and evaluation process.
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APPENDICES

APPENDIX 1: NORMALIZED AREA COUNTS FOR THE FEATURES DETECTED
IN WT, DAT, AND MUTANT L. CARDINALIS PLANT EXTRACTS.
Normalized Data set for all 139 features - average area count for m/z
200.2363:

2.00E+08

row m/z

WT-1

WT-2

WT-3

DAT-1

DAT-2

DAT-3

Mutant-1

Mutant-2

Mutant-3

90.0918

1.728

1.771

1.316

0.706

0.757

0.622

0.815

0.957

0.742

91.0542

1.794

0.847

0.735

2.932

0.579

1.597

2.481

3.145

1.661

97.0079

9.462

20.465

16.211

13.363

16.523

19.122

10.964

16.763

24.292

99.0037

1.196

2.435

2.058

1.302

1.952

2.680

1.187

2.114

3.221

102.0915

12.642

9.273

6.738

12.253

8.813

8.800

11.387

9.687

10.696

102.9705

4.632

17.499

9.649

5.682

13.559

19.904

3.692

8.162

30.668

104.0708

1.592

1.142

0.866

0.634

0.410

0.567

0.459

0.082

0.454

104.1073

2.356

1.436

1.123

4.546

2.418

2.827

2.677

1.541

2.612

105.0036

5.764

9.814

8.382

6.118

8.204

12.292

5.255

9.777

12.460

106.0500

0.468

0.226

0.215

0.442

1.893

2.524

0.320

0.132

0.163

111.0233

8.294

11.457

9.733

10.362

9.416

11.399

10.263

10.660

14.062

113.0190

3.175

3.234

3.222

3.712

2.264

3.118

4.049

2.702

4.007

120.9808

4.545

29.947

18.714

6.086

21.789

32.652

4.452

13.668

43.338

121.0075

4.716

1.906

2.649

3.585

2.590

1.392

5.649

2.716

3.612

122.0812

2.248

0.704

0.567

0.756

0.133

0.196

4.324

1.073

1.742

125.0026

1.704

8.068

6.349

2.267

5.619

6.685

4.364

5.880

8.319

126.9984

1.015

2.466

2.462

1.229

2.018

2.193

1.054

2.392

3.363

132.1015

1.138

1.229

0.672

2.159

1.781

2.388

0.761

0.612

0.578

133.0610

1.400

0.574

0.308

2.529

0.992

1.149

2.967

1.097

1.767

134.9869

3.109

3.956

3.350

3.716

3.524

4.217

3.431

2.631

5.175

136.0426

0.000

0.000

0.000

0.000

13.609

17.726

0.000

0.000

0.000

139.0182

8.566

9.429

7.652

12.969

7.782

8.194

10.354

6.777

9.385

140.1437

0.305

0.206

0.167

3.269

1.805

2.302

0.346

0.152

0.285

141.0139

12.077

8.022

7.750

12.335

5.926

9.598

12.379

6.111

10.559

142.1577

1.205

0.632

0.405

1.332

0.500

0.775

2.167

1.405

2.423

144.0478

25.481

16.857

14.289

18.516

10.959

13.213

34.047

21.760

31.975

144.1383

0.929

0.691

0.535

9.601

6.301

7.589

0.781

0.410

0.668

148.9756

3.144

6.908

3.802

4.237

4.668

7.049

2.872

2.814

8.808

149.0026

43.735

21.255

18.548

53.391

18.030

21.279

24.006

19.510

26.110

151.0541

0.000

0.259

0.627

0.000

1.354

1.861

0.000

2.216

3.579

151.0971

0.965

0.783

0.594

0.545

0.538

0.627

0.732

0.544

0.867

152.9974

7.705

15.315

12.723

11.253

11.632

13.879

9.616

12.353

16.311

155.0299

7.231

4.112

3.000

8.916

3.176

4.331

8.659

2.820

4.622

156.0766

0.311

0.098

0.118

0.181

1.705

1.842

0.417

0.132

0.204

158.1175

0.404

0.241

0.087

0.229

0.106

0.156

1.455

0.874

1.186

158.1539

5.131

3.599

3.473

42.927

27.603

35.305

5.768

3.476

5.557

167.0130

29.913

21.806

19.312

42.521

17.182

21.018

18.762

16.264

22.823

170.1539

0.468

0.316

0.297

0.692

0.331

0.643

1.439

0.496

1.883

172.1692

1.213

1.025

1.047

40.483

28.069

36.687

19.447

13.831

22.302

174.1605

1.969

1.674

1.543

0.808

0.464

0.640

0.013

0.090

0.059

180.1272

0.934

0.985

1.381

2.615

0.788

2.609

4.147

3.283

3.218

181.0289

10.658

5.063

3.944

4.246

4.329

5.028

13.483

3.309

4.540

181.0453

0.141

0.384

0.901

0.138

1.376

2.473

0.217

1.934

2.786

186.1276

4.075

7.167

3.787

36.859

17.513

8.811

18.041

31.881

37.636

186.1277

8.532

3.952

5.938

9.315

21.347

26.559

50.975

11.999

38.745

186.1855

0.100

0.057

0.053

7.632

1.928

6.090

0.558

1.122

1.624

189.0335

0.109

0.869

2.563

0.071

7.093

10.390

0.035

8.807

14.455

193.1356

1.788

1.387

0.265

13.241

6.099

8.246

14.637

11.186

14.036

193.1360

2.220

0.457

0.260

7.844

3.287

1.469

5.621

0.379

2.955

199.0942

4.391

1.553

4.444

3.434

1.263

4.570

8.334

1.342

2.830

200.1253

0.105

0.591

0.506

10.802

8.283

12.192

2.029

2.064

3.297

200.1254

0.526

0.591

0.506

12.012

5.464

11.487

1.936

2.064

3.386

201.0442

0.091

0.094

0.171

1.415

1.393

1.849

1.558

1.453

2.193

201.1500

1.593

1.128

0.353

5.549

2.594

1.639

3.289

2.086

2.448

201.1508

1.643

0.077

0.242

2.504

0.947

1.852

3.361

0.365

1.040

207.0443

0.072

0.408

0.798

0.101

2.305

3.944

0.136

1.785

4.770

213.1099

32.693

41.099

54.816

20.652

18.685

25.870

17.252

41.486

12.591

214.1134

0.608

4.151

3.695

8.954

4.373

2.548

1.839

4.104

2.031

216.0431

0.000

0.000

0.000

0.365

0.142

0.198

3.125

1.704

2.444

216.1569

0.073

1.192

0.879

2.957

2.052

2.299

0.011

1.955

2.712

216.1959

9.662

7.719

6.427

3.031

3.910

2.184

0.450

0.797

1.388

216.1962

0.269

8.105

6.633

6.259

1.801

5.441

0.239

0.797

1.388

219.1357

0.179

0.173

0.375

10.339

4.501

8.786

0.492

0.293

0.820

224.1539

0.256

1.021

1.030

3.122

5.307

7.462

4.938

3.532

5.976

218

229.1985

3.874

2.783

2.540

11.518

6.751

9.539

18.929

13.287

20.405

230.2113

45.103

33.506

25.683

35.586

13.878

6.021

3.387

14.406

23.443

230.2113

41.613

3.440

0.391

19.957

5.019

27.799

6.640

3.976

5.831

230.2116

35.774

9.463

4.067

8.912

21.184

17.021

19.014

2.677

8.316

232.1524

0.059

0.171

0.095

1.991

0.449

0.557

0.085

0.220

0.289

235.0928

1.931

0.782

0.667

2.213

0.581

0.935

2.390

0.578

1.001

240.1955

2.124

1.448

1.377

1.694

0.929

0.249

3.002

1.609

3.477

242.2830

3.803

0.072

1.222

5.874

0.063

0.916

324.881

212.834

358.452

244.1908

4.354

3.305

3.033

3.190

2.367

7.705

6.866

5.341

24.076

244.1909

0.193

2.637

2.319

8.597

6.009

2.590

20.361

15.593

7.957

244.2268

6.883

22.296

4.917

91.322

25.048

71.450

46.134

68.169

168.396

244.2270

36.450

27.869

23.256

80.592

56.830

33.658

139.165

30.407

50.558

244.2271

18.463

13.233

12.061

32.359

47.246

63.846

25.941

107.265

147.217

245.1883

5.426

2.043

1.149

8.789

1.928

1.033

1.017

2.866

3.632

247.0756

8.402

4.652

3.781

11.253

3.819

4.663

12.009

2.210

5.456

254.2111

0.302

0.126

0.143

0.995

0.192

0.109

7.004

4.500

7.220

256.2269

11.987

46.881

45.641

139.518

88.195

29.752

448.349

325.985

509.560

256.2270

11.987

8.139

18.135

35.645

23.049

112.926

94.704

66.141

368.145

258.2068

1.844

26.814

25.124

23.323

13.409

6.712

4.309

17.925

28.931

259.2076

13.753

0.404

0.564

1.954

0.565

0.289

1.062

0.318

0.725

259.2454

8.178

4.194

2.939

62.951

23.810

31.293

77.747

41.737

89.402

259.6726

0.048

0.237

0.256

3.321

2.383

2.027

16.244

11.602

17.638

260.2224

11.367

7.710

6.315

7.869

4.004

5.017

2.935

1.786

3.288

260.2487

0.187

0.545

0.210

0.343

2.942

4.598

0.516

1.039

8.262

261.0914

5.016

1.535

1.396

7.632

1.571

1.922

3.053

1.668

1.526

270.2428

2.290

1.340

1.398

7.779

4.675

5.728

24.366

22.203

22.171

270.3152

19.125

12.958

9.396

16.507

7.689

13.256

17.929

12.297

16.884

272.2217

14.888

11.080

9.676

15.551

9.744

12.936

41.945

26.808

43.752

273.1904

1.936

0.710

1.231

0.821

0.295

1.851

4.477

0.824

0.625

273.2177

1.913

0.282

0.571

1.351

0.527

1.229

0.747

0.444

1.677

273.2252

2.726

2.281

2.474

3.305

3.723

3.714

9.201

4.462

9.844

273.2617

2.282

0.203

0.751

34.493

21.662

0.385

89.116

0.800

110.284

274.2370

4.639

1.112

0.221

31.875

17.750

22.624

15.687

8.082

15.298

281.1882

0.077

0.032

0.041

0.048

0.145

0.245

0.944

0.035

0.163

282.2791

5.876

3.852

3.562

4.019

2.236

2.815

0.036

0.067

0.123

286.2381

0.674

0.766

0.327

10.925

6.602

7.868

10.193

7.230

13.856
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288.2179

6.298

4.589

3.592

0.206

1.347

1.996

0.591

3.651

4.030

288.2529

9.034

6.543

0.122

61.936

37.181

0.648

37.792

26.301

40.748

288.5204

0.613

0.413

0.301

3.639

3.029

3.205

3.934

3.220

4.900

289.2040

0.013

0.349

0.948

0.135

0.487

0.639

4.272

1.780

0.498

289.2561

1.327

0.929

0.973

13.767

7.072

9.935

6.955

4.540

6.417

293.1343

0.012

0.116

0.095

4.578

0.837

2.240

3.889

1.703

2.645

296.2948

0.192

1.050

0.651

2.899

0.415

1.753

0.318

0.052

0.102

299.1612

6.945

5.493

8.938

6.901

3.370

3.356

5.495

1.861

1.350

302.2324

1.471

0.258

0.277

1.261

0.276

0.139

2.265

0.110

0.724

302.2694

0.194

0.034

0.101

3.142

0.276

0.308

0.150

0.196

0.232

306.2129

1.764

0.283

0.025

2.736

1.295

1.679

2.961

0.473

1.360

310.1655

1.184

3.631

0.609

0.408

0.244

0.126

5.171

1.333

1.983

313.1913

0.054

0.011

0.010

0.206

0.308

0.514

6.620

0.260

5.197

322.2371

0.080

0.125

0.145

2.227

0.927

1.352

2.684

1.251

4.133

324.2076

0.000

0.031

0.104

0.000

0.010

0.171

0.013

0.019

2.055

325.1336

7.176

3.407

0.108

1.576

0.122

0.000

0.000

0.000

0.000

344.2389

0.124

0.112

0.111

0.152

2.004

0.313

6.004

6.370

3.525

349.2278

0.354

0.173

0.546

2.744

0.054

2.382

0.142

0.251

0.075

366.3362

0.000

0.000

0.000

0.623

0.220

0.152

4.202

0.190

0.694

367.3323

3.057

0.411

2.091

6.011

3.467

4.374

0.116

0.084

0.184

381.3479

0.131

0.387

0.356

6.180

1.239

0.187

0.070

0.116

0.184

432.2771

0.684

0.637

0.568

6.401

4.587

6.950

5.447

4.606

8.354

451.3899

0.067

0.101

0.040

0.000

0.149

0.110

10.884

4.438

6.723

373.2638,
187.1359

44.100

41.468

36.693

52.606

37.050

46.629

90.543

75.096

103.226

387.2795,
194.1415

942.501

872.394

815.170

1891.060

1524.384

1759.488

2670.708

2308.580

2858.175

399.2822,
200.1446

45.905

33.176

30.042

97.719

60.264

76.876

87.888

58.198

94.319

401.2587,
201.1284

5.141

5.290

3.694

26.461

17.515

25.144

33.295

24.223

40.417

403.2740,
202.1410

46.761

41.434

37.410

222.112

151.634

201.371

278.414

206.729

310.481

415.2749,
208.1415

8.236

7.163

5.850

41.007

25.798

37.216

15.961

11.667

18.680

417.2537,
209.1308

4.012

3.265

2.624

1.622

0.904

1.001

2.186

1.400

2.278

419.2693,
210.1383

0.441

0.362

0.322

3.804

3.460

5.039

5.237

4.932

8.298

130.1595

90.164

69.670

54.757

89.153

55.952

81.086

91.112

63.845

102.822
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200.2363

110.668

82.611

73.881

122.000

75.040

107.166

113.176

79.865

135.593

228.1967

46.077

32.804

28.658

108.946

69.950

87.033

161.838

113.509

178.310

242.2115
isomer

55.703

39.533

32.039

107.643

65.919

79.901

213.728

149.076

250.758

242.2115
isomer

35.687

25.427

22.774

59.843

38.608

51.578

136.577

93.104

156.852

242.2115
isomer

196.865

155.823

133.270

317.947

206.694

258.134

748.534

546.598

843.107

258.2437

67.182

47.603

38.916

505.039

313.575

413.151

674.147

474.522

773.172

272.2574

43.757

30.395

28.012

234.213

143.189

195.592

625.380

412.413

681.683
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APPENDIX 2: CONFIDENCE INTERVAL CALCULATION FOR ERROR IN
LOBINALINE CONCENTRATION FROM CALIBRATION CURVE.

µ𝐶𝐶𝐴𝐴 = 𝐶𝐶𝐴𝐴 ± 𝑡𝑡(𝑠𝑠𝐶𝐶𝐴𝐴 )
CA = analyte concentration from the regression equation (y = b1x + b0)
t = t value based on the desired level of confidence and n–2 degrees of freedom (in this
case, at 95% confidence and n-2= 8; t = 2.306)

𝑠𝑠𝐶𝐶𝐴𝐴 =

(𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑟𝑟𝑟𝑟𝑟𝑟 )
𝑏𝑏1

1

(𝑌𝑌�−𝑦𝑦�)2
2
2
1 ) Σ𝑖𝑖 (𝑥𝑥𝑖𝑖 −𝑥𝑥̅ )

1

��𝑚𝑚� + �𝑛𝑛� + (𝑏𝑏

Σ(𝑦𝑦𝑖𝑖 −𝑦𝑦�𝚤𝚤 )2

(𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑟𝑟𝑟𝑟𝑟𝑟 ) = �

𝑛𝑛−2

where 𝑦𝑦𝑖𝑖 = average response for the ith standard and 𝑦𝑦�𝚤𝚤 = the calculated response for that
standard using the regression equation
m = number of internal standard replicates
n = number of points in the curve
𝑌𝑌� = response for analyte in sample
𝑦𝑦� = average response for analyte in all standards
Σ𝑖𝑖 (𝑥𝑥𝑖𝑖 − 𝑥𝑥̅ )2 = standard sum of squares for concentration range of internal standards.
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APPENDIX 3: MS/MS OF PRIORITIZED PEAKS OF INTEREST.
MS/MS spectra for: 1) m/z 387, 2) m/z 403, 3) m/z 419, 4) m/z228, 5) m/z 242-1, 6) m/z
242-2, 7) m/z 242-3, 8) m/z 258, and 9) m/z 272
1) m/z 387

2) m/z 403

223

3) m/z 419

4) m/z 228

224

5) m/z 242-1

6) m/z 242-2

225

7) m/z 242-3

8) m/z 258

226

9) m/z 272

227

APPENDIX 4: POLYGONUM MULTIFLORUM SECONDARY METABOLITE PEAK
LIST

228

APPENDIX 5: METABOLOMICS DATA FOR PK ANALYSIS
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